В ходе подготовки статей по аритмологии и электрофизиологии для пользователей сайта МедУнивер использованы труды следующих авторов:
Sharma PS, Padala SK, Gunda S, et al. Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access. J Cardiovasc Electrophysiol. 2016;27:1160-1166.
Wiles BM, Child N, Roberts PR. How to achieve ultrasound-guided femoral venous access: the new standard of care in the electrophysiology laboratory. J Interv Card Electrophysiol. 2017;49:3-9.
Brass P, Hellmich M, Kolodziej L, et al. Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization. Cochrane Database Syst Rev. 2015;(l):CD011447.
Michowitz Y, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation results from a worldwide survey in 34943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol. 2014;7:274-280.
Baldinger SH, et al. Epicardial radiofrequency ablation failure during ablation procedures for ventricular arrhythmias: reasons and implications for outcomes. Circ Arrhythm Electrophysiol. 2015;8: 1422-1432.
Bradfield JS, Tung R, Boyle NG, et al. Our approach to minimize risk of epicardial access: standard techniques with the addition of electroanatomic mapping guidance. J Cardiovasc Electrophysiol. 2013;24: 723-727.
Tung R, et al. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm. 2013; 10:490-498.
Lim HS, et al. Safety and prevention of complications during percutaneous epicardial access for the ablation of cardiac arrhythmias. Heart Rhythm. 2014;11:1658-1665.
Macias C, Shivkumar K, Tung R. Novel approach to intraprocedural cardiac tamponade: dual-site drainage with continuous suction. Heart Rhythm. 2016;13:2091-2094.
Gianni C, et al. Management of periprocedural and early pericardial effusions with tamponade following ablation of atrial fibrillation with uninterrupted factor Xa inhibitors: a case series. J Cardiovasc Electrophysiol. 2016;27:399-403.
Pedersen MEF, et al. Management of tamponade complicating catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2016;3:367-373.
Yamada T, Kay GN. Recognition and prevention of complications during epicardial ablation. Card Electrophysiol Clin. 2010;2:127-134.
Killu AM, et al. Atypical complications encountered with epicardial electrophysiological procedures. Heart Rhythm. 2013;10: 1613-1621.
Castao A, Crawford T, Yamazaki M, et al. Coronary artery pathophysiology after radiofrequency catheter ablation: review and perspectives. Heart Rhythm. 2011;8:1975-1980.
Garabelli PJ, Stavrakis S, Po SS. A case series and review of the literature regarding coronary artery complications associated with coronary sinus catheter ablation. HeartRhythm Case Rep. 2015;1: 315-319.
Ernst S, Sanchez-Quintana D, Ho SY. Anatomy of the pericardial space and mediastinum: relevance to epicardial mapping and ablation. Card Electrophysiol Clin. 2010;2:1-8.
Reichlin T, et al. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation. J Interv Card Electrophysiol. 2016;47:69-74.
Yamada T, et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit anatomic concepts relevant to ablation. Circ Arrhythm Electrophysiol. 2010;3:616-623.
Lin CY, et al. Radiofrequency catheter ablation of ventricular arrhythmias originating from the continuum between the aortic sinus of Valsalva and the left ventricular summit: electrocardiographic characteristics and correlative anatomy. Heart Rhythm. 2015;13:111-121.
Hutchinson MD, Garcia FC. An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias. J Cardiovasc Electrophysiol. 2013;24:1189-1197.
Nagashima K, et al. Ventricular arrhythmias near the distal great cardiac vein challenging arrhythmia for ablation. Circ Arrhythm Electrophysiol. 2014;7:906-912.
Jauregui Abularach ME, et al. Ablation of ventricular arrhythmias arising near the anterior epicardial veins from the left sinus of Valsalva region: ECG features, anatomic distance, and outcome. Heart Rhythm. 2012;9: 865-873.
Chugh A, et al. Manifestations of coronary arterial injury during catheter ablation of atrial fibrillation and related arrhythmias. Heart Rhythm. 2013;10:1638-1645.
Chatterjee NA, et al. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circ Arrhythm Electrophysiol. 2012; 5:68-76.
Johnsrude C. Cryoablation of focal tachycardia originating from the right atrial free wall during upstream phrenic pacing to avoid phrenic nerve injury. Pacing Clin Electrophysiol. 2015;38:120-128.
Jacobson JT, Kraus A, Lee R, et al. Epicardial/endocardial sinus node ablation after failed endocardial ablation for the treatment of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol. 2014; 25: 236-241.
Rubenstein JC, Kim MH, Jacobson JT. A novel method for sinus node modification and phrenic nerve protection in resistant cases. J Cardiovasc Electrophysiol. 2009;20:689-691.
Fukumoto K, et al. Three-dimensional imaging and mapping of the right and left phrenic nerves: relevance to interventional cardiovascular therapy. Europace. 2013;15:937-943.
Ichihara N, et al. Prevalence and pre-procedural predictors associated with right phrenic nerve injury in electromyography-guided, second-generation cryoballoon ablation. JACC Clin Electrophysiol. 2016;2:508-514.
Huemer M, Wutzler A, Parwani AS, et al. Mapping of the leftsided phrenic nerve course in patients undergoing left atrial catheter ablations. Pacing Clin Electrophysiol. 2014;37,1141-1149.
Kowalski M, Ellenbogen KA, Koneru JN. Prevention of phrenic nerve injury during interventional electrophysiologic procedures. Heart Rhythm. 2014;11:1839-1844.
Mondesert B, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:605-611.
Franceschi F, et al. Electromyographic monitoring for prevention of phrenic nerve palsy in second-generation cryoballoon procedures. Circ Arrhythm Electrophysiol. 2015;8:303-307.
Kumar S, et al. Epicardial phrenic nerve displacement during catheter ablation of atrial and ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2015;8:896-904.
Ibarra-Cortez SH, et al. Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia. Heart Rhythm. 2016;13:1238-1245.
Teunissen C, et al. Incidence of pulmonary vein stenosis after radiofrequency catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2017;3:589-598.
Narui R, et al. Incidence and factors associated with the occurrence of pulmonary vein narrowing after cryoballoon ablation. Circ Arrhythm Electrophysiol. 2017;10:e004588.
Matsuda J, et al. Pulmonary vein stenosis after second-generation cryoballoon ablation. J Cardiovasc Electrophysiol. 2017;28:298-303.
Dukkipati SR, et al. Pulmonary vein isolation using the visually guided laser balloon a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J Am Coll Cardiol. 2015;66:1350-1360.
Kumar N, et al. Pulmonary vein stenosis after laser balloon ablation for atrial fibrillation. JACC Clin Electrophysiol. 2015;1:220-221.
Barbhaiya CR, et al. Global survey of esophageal injury in atrial fibrillation ablation. JACC Clin Electrophysiol. 2016;2:143-150.
Muller P, et al. Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes. Heart Rhythm. 2015;12:1464-1469.
Fumkranz A, et al. Reduced incidence of esophageal lesions by luminal esophageal temperature-guided second-generation cryoballoon ablation. Heart Rhythm. 2015;12:268-274.
Neven K, Metzner A, Schmidt B, et al. Two-year clinical followup after pulmonary vein isolation using high-intensity focused ultrasound (HIFU) and an esophageal temperature-guided safety algorithm. Heart Rhythm. 2012;9:407-413.
Syed FF, Oral H. Esophageal temperature and atrioesophageal fistula: 'If you cannot measure it, you cannot control it'. Heart Rhythm. 2016;13: 2201-2202.
Halbfass P, et al. Progression from esophageal thermal asymptomatic lesion to perforation complicating atrial fibrillation ablation: a single-center registry. Circ Arrhythm Electrophysiol. 2017;10: 1-11.
Black-Maier E, et al. Risk of atrioesophageal fistula formation with contact force-sensing catheters. Heart Rhythm. 2017;14: 1328-1333.
John RM, Kapur S, Ellenbogen KA, et al. Atrio-esophageal fistula formation with cryo-balloon ablation is most commonly related to the left inferior pulmonary vein. Heart Rhythm. 2016;14:184-189.
Eitel C, et al. Successful nonsurgical treatment of esophagoperi-cardial fistulas after atrial fibrillation catheter ablation: a case series. Circ Arrhythm Electrophysiol. 2013;6:675-681.
Miyazaki S, et al. Gastric hypomotility after second-generation cryoballoon ablation—unrecognized silent nerve injury after cryo-balloon ablation. Heart Rhythm. 2017;14:670-677.
Gaita F, Guerra PG, Battaglia A, et al. The dream of near-zero x-rays ablation comes true. Eur Heart J. 2016;37:2749-2755.
Badawy MK, Deb P, Chan R, et al. A review of radiation protection solutions for the staff in the cardiac catheterisation laboratory. Heart Lung Circ. 2016;25:961-967.
Nair GM, Nery PB, Redpath CJ, et al. Radiation safety and ergonomics in the electrophysiology laboratory: update on recent advances. Curr Opin Cardiol. 2016;31:11-22.
Christopoulos G, et al. Optimizing radiation safety in the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2016;87:291-301.
Elmaraezy A, et al. Risk of cataract among interventional cardiologists and catheterization lab staff: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2017;90:1-9.
Seals KF, Lee EW, Cagnon CH, et al. Radiation-induced catarac-togenesis: a critical literature review for the interventional radiologist. Cardiovasc Intervent Radiol. 2016;39:151-160.
Cousins C, et al. ICRP publication 120: radiological protection in cardiology. Ann ICRP. 2013;42:1-125.
Parikh JR, et al. Potential radiation-related effects on radiologists. AJR Am J Roentgenol. 2017;208:595-602.
Nof E, et al. Reducing radiation exposure in the electrophysiology laboratory: it is more than just fluoroscopy times! Pacing Clin Electrophysiol. 2015;38:136-145.
Giaccardi M, et al. Near-zero x-ray in arrhythmia ablation using a 3-dimensional electroanatomic mapping system: a multicenter experience. Heart Rhythm. 2016;13:150-156.
Voskoboinik A, Kalman ES, Savicky Y, et al. Reduction in radiation dose for atrial fibrillation ablation over time: a 12-year single centre experience of 2344 patients. Heart Rhythm. 2017;14:810-816.
Lerman BB, et al. Fluoroless catheter ablation of atrial fibrillation. Heart Rhythm. 2017;14:928-934.
Priori SG, et al. HRS/EHRA/APHRS Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10: 1932-1963.
Belardinelli L, Giles WR, Rajamani S, et al. Cardiac late Na+ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress. Heart Rhythm. 2015;12:440-448.
Giudicessi JR, Ackerman MJ. Calcium revisited. Circ Arrhythm Electrophysiol. 2016;9:e002480.
Boczek NJ, et al. Identification and functional characterization of a novel CACNAlC-mediated cardiac disorder characterized by prolonged QT intervals with hypertrophic cardiomyopathy, congenital heart defects, and sudden cardiac death. Circ Arrhythm Electrophysiol. 2015;8:1122-1132.
Nomikos M, et al. Altered RyR2 regulation by the calmodulin F90L mutation associated with idiopathic ventricular fibrillation and early sudden cardiac death. FEBS Lett. 2014;588: 2898-2902.
Sondergaard MT, et al. Arrhythmogenic calmodulin mutations affect the activation and termination of cardiac ryanodine receptor-mediated Ca2+ release. J Biol Chem. 2015;290:26151-26162.
Altmann HM, et al. Homozygous/compound heterozygous triadin mutations associated with autosomal-recessive long-QT syndrome and pediatric sudden cardiac arrest: elucidation of the triadin knockout syndrome. Circulation. 2015;131: 2051-2060.
Kim JJ, Nemec J, Li Q, et al. Synchronous systolic subcellular Ca2+-elevations underlie ventricular arrhythmia in drug-induced long QT type 2. Circ Arrhythm Electrophysiol. 2015;8:703-712.
Wu J, et al. A molecular mechanism for adrenergic-induced long QT syndrome. J Am Coll Cardiol. 2013;63:819-827.
McCauley M, Vallabhajosyula S, Darbar D. Proarrhythmic and torsadogenic effects of potassium channel blockers in patients. Card Electrophysiol Clin. 2016;8:481-493.
Nguyen TP, Singh N, Xie Y, et al. Repolarization reserve evolves dynamically during the cardiac action potential: effects of transient outward currents on early afterdepolarizations. Circ Arrhythm Electrophysiol. 2015;8:694-702.
Earle N, et al. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome. Heart Rhythm. 2014;11:76-82.
Abehsira G, et al. Complex influence of gonadotropins and sex steroid hormones on QT interval duration. J Clin Endocrinol Metab. 2016;101:2776-2784.
Odening KE, Koren G. How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. Heart Rhythm. 2014;11:2107-2115.
Di Fusco SA, Palazzo S, Colivicchi F, et al. The influence of gender on heart rhythm disease. Pacing Clin Electrophysiol. 2014;37: 650-657.
Salem J-E, Alexandre J, Bachelot A, et al. Influence of steroid hormones on ventricular repolarization. Pharmacol Ther. 2016;167: 38-47.
Lang CN, et al. Electro-mechanical dysfunction in long QT syndrome: role for arrhythmogenic risk prediction and modulation by sex and sex hormones. Prog Biophys Mol Biol. 2016;120:255-269.
Tisdale JE, et al. Influence of oral progesterone administration on drug-induced QT interval lengthening. JACC Clin Electrophysiol. 2016;2:765-774.
Wilde AAM, et al. Clinical aspects of type 3 long-QT syndrome: an international multicenter study. Circulation. 2016; 134:872-882.
Peters CH, Abdelsayed M, Ruben PC. Triggers for arrhythmo-genesis in the Brugada and long QT 3 syndromes. Prog Biophys Mol Biol. 2016;120:77-88.
Miyamoto K, et al. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart Rhythm. 2015;12:596-603.
Postema PG, Wilde AAM. The measurement of the QT interval. Curr Cardiol Rev. 2014;10:287-294.
Bogossian H, et al. New formula for evaluation of the QT interval in patients with left bundle branch block. Heart Rhythm. 2014;11:2273-2277.
Tsai SF, et al. QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacing. Heart Rhythm. 2014;11:485-491.
Wang B, et al. A new formula for estimating the true QT interval in left bundle branch block. J Cardiovasc Electrophysiol. 2017;28:684-689.
Chiladakis JA, et al. Facilitating assessment of QT interval duration during ventricular pacing. Europace. 2013;15:907-914.
Ruan Y, Liu N, Bai R, et al. Congenital long QT syndrome type 3. Card Electrophysiol Clin. 2014;6:705-713.
Sugrue A, et al. Identification of concealed and manifest long QT syndrome using a novel T wave analysis program. Circ Arrhythm Electrophysiol. 2016;9:e003830.
El-Sherif N, et al. Electrophysiological basis of ECG characteristics of torsades de pointes in long QT syndrome. Card Electrophysiol Clin. 2014;6:433-444.
Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124.
Hayashi K, et al. Impact of updated diagnostic criteria for long QT syndrome on clinical detection of diseased patients. JACC Clin Electrophysiol. 2016;2:279-287.
Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J. 2013;34:3109-3116.
Page A, Aktas MK, Soyata T, et al. "QT clock" to improve detection of QT prolongation in long QT syndrome patients. Heart Rhythm. 2016;13:190-198.
Chorin Е, et al. Diagnostic value of T-wave morphology changes during 'QT stretching' in patients with long QT syndrome. Heart Rhythm. 2015;12:2263-2271.
Badri M, et al. Mexiletine prevents recurrent torsades de pointes in acquired long QT syndrome refractory to conventional measures. JACC Clin Electrophysiol. 2015;1:315-322.
Eijkemans MJC, et al. Predicting the unpredictable. Anesthesiology. 2010;112:41-49.
Algalarrondo V, Nattel S. Potassium channel remodeling in heart disease. Card Electrophysiol Clin. 2016;8:337-347.
Rosso R, et al. Long QT syndrome complicating atrioventricular block: arrhythmogenic effects of cardiac memory. Circ Arrhythm Electrophysiol. 2014;7:1129-1135.
Tisdale JE, et al. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2014;7:381-390.
Tisdale JE, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6:479-487.
Yu H, et al. Acquired long QT syndrome in hospitalized patients. Heart Rhythm. 2017;14:974-978.
Weeke P, et al. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome. J Am Coll Cardiol. 2014;63: 1430-1437.
Itoh H, et al. The genetics underlying acquired long QT syndrome: impact for genetic screening. Eur Heart J. 2016;37:1456-1464.
Drew BJ, et al. Prevention of torsade de pointes in hospital settings. J Am Coll Cardiol. 2010;55:934-947.
Mathias A, et al. Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome. Heart Rhythm. 2013;10:720-725.
Mullally J, et al. Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations. Heart Rhythm. 2013;10:378-382.
Amin AS, Wilde AAM. Genetic control of potassium channels. Card Electrophysiol Clin. 2016;8:285-306.
Koponen M, et al. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients. Circ Arrhythm Electrophysiol. 2015;8:815-823.
Obeyesekere MN, Antzelevitch C, Krahn AD. Management of ventricular arrhythmias in suspected channelopathies. Circ Arrhythm Electrophysiol. 2015;8:221-231.
Ackerman MJ, et al. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent? Heart Rhythm. 2016;14:e41-e44.
Gaba P, et al. Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome. Heart Rhythm. 2016;13:879-885.
Schwartz PJ, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation. 2010;122:1272-1282.
Bos JM, Bos KM, Johnson JN, et al. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders. Circ Arrhythm Electrophysiol. 2013;6:705-711.
Waddell-Smith KE, et al. Physical and psychological consequences of left cardiac sympathetic denervation in long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2015;8:1151-1158.
Antiel RM, et al. Quality of life after videoscopic left cardiac sympathetic denervation in patients with potentially lifethreatening cardiac channelopathies/cardiomyopathies. Heart Rhythm. 2016;13:62-69.
Fruh A, Siem G, Holmstrom H. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with p-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome? Heart Rhythm. 2016;13:2186-2192.
Aziz PF, et al. Sports participation in genotype positive children with long QT syndrome. JACC Clin Electrophysiol. 2015;1:62-70.
Zipes DP, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e315-e325.
Mazzanti A, et al. Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. J Am Coll Cardiol. 2016;67:1053-1058.
Chorin E, et al. Ranolazine for congenital long-QT syndrome type III: experimental and long-term clinical data. Circ Arrhythm Electrophysiol. 2016;9:e004370.
Curcio A, Santarpia G, Indolfi C. The Brugada syndrome—from gene to therapy. Circ J. 2017;81:290-297.
Antzelevitch C, Patocskai B. Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects. Curr Probl Cardiol. 2016;41:7-57.
Antzelevitch C, et al. J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Heart Rhythm. 2016;l3:e295-e324.
Hu D, et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J Am Coll Cardiol. 2014;64:66-79.
Varga Z, et al. Direct measurement of cardiac Na+ channel conformations reveals molecular pathologies of inherited mutations. Circ Arrhythm Electrophysiol. 2015;8:1228-1239.
Cald L, et al. A new electrocardiographic marker of sudden death in Brugada syndrome. J Am Coll Cardiol. 2016;67: 1427-1440.
Guillem MS, et al. Spatiotemporal characteristics of QRS complexes enable the diagnosis of Brugada syndrome regardless of the appearance of a type 1 ECG. J Cardiovasc Electrophysiol. 2016;27:563-570.
Adler A, et al. Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm. 2013;10:1375-1382.
Mizusawa Y, et al. The prognostic significance of fever-induced Brugada syndrome. Heart Rhythm. 2016;13:1515-1520.
Kitamura T, et al. Clinical characteristics and long-term prognosis of senior patients with Brugada syndrome. JACC Clin Electrophysiol. 2017;3:57-67.
Adler A, et al. Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing. Heart Rhythm. 2016;13:299-310.
Kawazoe H, et al. Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods. Heart Rhythm. 2016;13:1947-1954.
Nordkamp LRAO, et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes. Heart Rhythm. 2015;12:367-375.
Giustetto C, et al. Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis. Heart Rhythm. 2014; 11:259-265.
Bayes De Luna A, et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol. 2012;45:433-442.
de Luna AB, et al. New electrocardiographic features in Brugada syndrome. Curr Cardiol Rev. 2014;10:175-180.
Savastano S, et al. A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. Heart Rhythm. 2014;ll: 1176-1183.
Curcio A, et al. Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria. J Cardiovasc Electrophysiol. 2016;27:937-943.
Casado-Arroyo R, et al. Long-term trends in newly diagnosed Brugada syndrome implications for risk stratification. J Am Coll Cardiol. 2016;68:614-623.
Adler A. Brugada syndrome: diagnosis, risk stratification, and management. Curr Opin Cardiol. 2016;31:37-45.
Somani R, et al. Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Heart Rhythm. 2014;11:1047-1054.
Calvo D, Rubfn JM, Perez D, et al. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome. Heart Rhythm. 2015;12:350-357.
Subramanian M, et al. The utility of exercise testing in risk stratification of asymptomatic patients with type 1 Brugada pattern. J Cardiovasc Electrophysiol. 2017;28:677-683.
Belhassen B, Michowitz Y. Arrhythmic risk stratification by programmed ventricular stimulation in Brugada syndrome. Circ Arrhythm Electrophysiol. 2015;8:757-759.
Konigstein M, et al. Drug-induced Brugada syndrome: clinical characteristics and risk factors. Heart Rhythm. 2016;13:1083-1087.
Letsas KP, et al. Drug-induced Brugada syndrome by noncardiac agents. Pacing Clin Electrophysiol. 2013;36:1570-1578.
Sieira J, et al. Prognostic value of programmed electrical stimulation in Brugada syndrome. Circ Arrhythm Electrophysiol. 2015;8: 777-784.
Tse G, etal. The T peak 2 T end interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: a systematic review and meta-analysis. Heart Rhythm. 2017;14: 1131-1137.
Maury P, et al. Increased Tpeak-Tend interval is highly and independently related to arrhythmic events in Brugada syndrome. Heart Rhythm. 2015;12:2469-2476.
Tokioka K, et al. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities. J Am Coll Cardiol. 2014;63:2131-2138.
Sieira J, Brugada P. Management of Brugada syndrome 2016: should all high risk patients receive an ICD? All high-risk patients should receive an implantable cardiac defibrillator. Circ Arrhythm Electrophysiol. 20l6;9:e004195.
Conte G, et al. Implantable cardioverter-defibrillator therapy in Brugada syndrome. J Am Coll Cardiol. 2015;65:879-888.
Brugada J, Pappone C, Berruezo A, et al. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol. 2015;8:1373-1381.
Pappone C, et al. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2017;10:e005053.
Patocskai B, Yoon N, Antzelevitch C. Mechanisms underlying epicardial radiofrequency ablation to suppress arrhythmogenesis in experimental models of Brugada syndrome. JACC Clin Electrophysiol. 2016;3:353-363.
Zhang P, Tung R, Zhang Z, et al. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm. 2016;13:2151-2158.
Andorin A, et al. The QUIDAM study: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. Heart Rhythm. 2017;14:1147-1154.
Belhassen B. Management of Brugada syndrome 2016: should all high risk patients receive an ICD? Alternatives to implantable cardiac defibrillator therapy for Brugada syndrome. Circ Arrhythm Electrophysiol. 2016;9:e004185.
Sieira J, et al. Asymptomatic Brugada syndrome clinical characterization and long-term prognosis. Circ Arrhythm Electrophysiol. 2015;8:1144-1150.
Levine BD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 1: classification of sports: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e262-e266.
Khera S, Jacobson JT. Short QT syndrome in current clinical practice. Cardiol Rev. 2015;24:1-17.
Guerrier K, et al. Short QT interval prevalence and clinical outcomes in a pediatric population. Circ Arrhythm Electrophysiol. 2015;8:1460-1464.
Mazzanti A, et al. Novel insight into the natural history of short QT syndrome. J Am Coll Cardiol. 2014;63:1300-1308.
Villafane J, et al. Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol. 2013;61:1183-1191.
Iribarren C, et al. Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis. Ann Noninvasive Electro-cardiol. 2014;19:490-500.
Tuliimen E, et al. PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? Heart Rhythm. 2014;11:1024-1030.
Roussel J, et al. Carnitine deficiency induces a short QT syndrome. Heart Rhythm. 2016;13:165-174.
Imberti JF, Underwood K, Mazzanti A, et al. Clinical challenges in catecholaminergic polymorphic ventricular tachycardia. Heart Lung Circ. 2016;25:777-783.
Gyorke S. Molecular basis of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2009;6:123-129.
Steriotis AK, et al. Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations. Am J Cardiol. 2012;109:1015-1019.
Blich M, et al. Electrocardiographic comparison of ventricular premature complexes during exercise test in patients with CPVT and healthy subjects. Pacing Clin Electrophysiol. 2015;38: 398-402.
Roston TM, etal. Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol. 2015;8:633-642.
Van Der Werf C, Lieve KV. Beta-blockers in the treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2016;13:441-442.
Leren IS, et al. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with pi-selective p-blockers in patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2016; 13:432-440.
Padfield GJ, et al. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of p-blockade. Heart Rhythm. 2016;13: 609-613.
Roses-Noguer F, Jarman JWE, Clague JR, et al. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2014;11:58-66.
Miyake CY, et al. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate. Circ Arrhythm Electrophysiol. 2013;6:579-587.
De Ferrari GM, et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131:2185-2193.
Visser M, et al. Idiopathic ventricular fibrillation: the struggle for definition, diagnosis, and follow-up. Circ Arrhythm Electrophysiol. 2016;9:e003817.
Ten Sande JN, et al. Detailed characterization of familial idiopathic ventricular fibrillation linked to the DPP6 locus. Heart Rhythm. 2016;13:905-912.
Marsman RF, et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. J Am Coll Cardiol. 2014;63:259-266.
Paech C, et al. Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T>C and c.13781A>G, with the clinical presentation of idiopathic ventricular fibrillation. Pediatr Cardiol. 2014;35:1437-1441.
Murakoshi N, Aonuma K. Catheter ablation for ventricular tachyarrhythmia in patients with channelopathies. J Arrhythm. 2016;32: 404-110.
Visser M, et al. Long-term outcome of patients initially diagnosed with idiopathic ventricular fibrillation: a descriptive study. Circ Arrhythm Electrophysiol. 2016;9:e004258.
Aizawa Y, et al. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol. 2013;62:1015-1019.
Aizawa Y, et al. Circadian pattern of fibrillatory events in non-Brugada-type idiopathic ventricular fibrillation with a focus on J waves. Heart Rhythm. 2014;11:2261-2266.
Herman ARM, et al. Outcome of apparently unexplained cardiac arrest: results from investigation and follow-up of the prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry. Circ Arrhythm Electrophysiol. 2016;9:e003619.
Jimenez-Jaimez J, et al. Diagnostic approach to unexplained cardiac arrest (from the FIVI-Gen study). Am J Cardiol. 2015;! 16: 894-899.
Shah AJ, et al. Polymorphic ventricular tachycardia/ventricular fibrillation and sudden cardiac death in the normal heart. Card Electrophysiol Clin. 2016;8:581-591.
Conte G, et al. True idiopathic ventricular fibrillation in out-ofhospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long-term follow-up. Europace. 2017;19:259-266.
Antzelevitch C, Yan GX. J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm. 2015;12:1852-1866.
Adler A, Gollob MH. A practical guide to early repolarization. Curr Opin Cardiol. 2015;30:8-16.
Mahida S, et al. Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome. J Am Coll Cardiol. 2015;65:151-159.
Yan G-X, Lankipalli RS, Burke JF, et al. Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol. 2003;42:401-409.
Patocskai B, et al. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome. Heart Rhythm. 2016;13:1326-1334.
Mahida S, et al. History and clinical significance of early repolarization syndrome. Heart Rhythm. 2015;12:242-249.
Harhash A, Gussak I, Cassuto J, et al. Clinical significance of J waves in patients undergoing therapeutic hypothermia for out-of-hospital cardiac arrest. Pacing Clin Electrophysiol. 2017;40: 154-161.
Benito B, Guasch E, Rivard L, et al. Clinical and mechanistic issues in early repolarization of normal variants and lethal arrhythmia syndromes. J Am Coll Cardiol. 2010;56:1177-1186.
Zhang J, et al. The electrophysiological substrate of early repolarization syndrome: noninvasive mapping in patients. JACC Clin Electrophysiol. 2017;3:894-904.
Aizawa Y, et al. Tachycardia-dependent augmentation of 'notched J waves' in a general patient population without ventricular fibrillation or cardiac arrest: not a repolarization but a depolarization abnormality? Heart Rhythm. 2015;12:376-383.
Gurabi Z, Koncz I, Patocskai B, et al. Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. Circ Arrhythm Electrophysiol. 2014;7:134-142.
Mellor G, et al. The prevalence and significance of the early repolarization pattern in sudden arrhythmic death syndrome families. Circ Arrhythm Electrophysiol. 2016;9:e003960.
Aagaard P, Baranowski B, Aziz P, et al. Early repolarization in athletes: a review. Circ Arrhythm Electrophysiol. 2016;9:1-8.
MacFarlane PW, et al. The early repolarization pattern: a consensus paper. J Am Coll Cardiol. 2015;66:470-477.
Kamakura T, et al. Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome. Eur Heart J. 2016;37:630-637.
Cristoforetti Y, et al. J-wave duration and slope as potential tools to discriminate between benign and malignant early repolarization. Heart Rhythm. 2016;13:806-811.
Roten L, et al. Benign vs malignant inferolateral early repolarization: focus on the T wave. Heart Rhythm. 2016;13:894-902.
Naruse Y, et al. Early repolarization increases the occurrence of sustained ventricular tachyarrhythmias and sudden death in the chronic phase of an acute myocardial infarction. Circ Arrhythm Electrophysiol. 2014;7:626-632.
Naruse Y, et al. J waves are associated with the increased occurrence of life-threatening ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2016;27:1448-1453.
Amin AS, Asghari-Roodsari A, Tan HL. Cardiac sodium channelopathies. Pflugers Arch. 2010;460:223-237.
Priori SG, Blomstrom-Lundqvist C. 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J. 2015;36:2757-2759.
Sherwin ED, Triedman JK, Walsh EP. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythmia Electrophysiol. 2013; 6:1032-1040.
Walsh EP. Interventional electrophysiology in patients with congenital heart disease. Circulation. 2007;115:3224-3234.
Moore JP, et al. Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythmia Electrophysiol. 2013;6:905-911.
Zeppenfeld K, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation. 2007;l 16: 2241-2252.
Khairy P, Stevenson WG. Catheter ablation in tetralogy of Fallot. Heart Rhythm. 2009;6:1069-1074.
Khairy P, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Heart Rhythm. 20l4;ll:el02-e165.
Roos-Hesselink JW, Karamermer Y. Significance of postoperative arrhythmias in congenital heart disease. Pacing Clin Electrophysiol. 2008;31:2-6.
Khairy P, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363-370.
Khairy P, et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010;122:868-875.
Le Gloan L, Khairy P. Management of arrhythmias in patients with tetralogy of Fallot. Curr Opin Cardiol. 2011;26:60-65.
Wu M-H, et al. Arrhythmic burdens in patients with tetralogy of Fallot: a national database study. Heart Rhythm. 2015;12:604-609.
Sabate Rotes A, et al. Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement. Circ Arrhythmia Electrophysiol. 2015;8:110-117.
Walsh EP. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease. Pacing Clin Electrophysiol. 2008;31 (suppl 1):S38-S40.
Kella DK, Merchant FM, Veledar E, et al. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease. Pacing Clin Electrophysiol. 2014;37: 1492-1498.
Tomaske M, Bauersfeld U. Experience with implantable cardioverterdefibrillator therapy in grown-ups with congenital heart disease. Pacing Clin Electrophysiol. 2008;31:35-37.
Garnreiter JM, Pilcher TA, Etheridge SP, et al. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: risk factors and programming strategies. Heart Rhythm. 2015,12:937-942.
Kriebel T, Saul JP, Schneider H, et al. Noncontact mapping and radiofrequency catheter ablation of fast and hemodynamically unstable ventricular tachycardia after surgical repair of tetralogy of Fallot. J Am Coll Cardiol. 2007;50:2162-2168.
Kapel GFL, et al. Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol. 2015;8:102-109.
Tedrow UB, et al. Left-sided ablation of ventricular tachycardia in adults with repaired tetralogy of Fallot: a case series. Circ Arrhythm Electrophysiol. 2014;7:889-897.
Basso С, Corrado D, Ваисе В, et al. Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2012,-5: 1233-1246.
Corrado D, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36:3227-3237.
Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376:61-72.
Marcus F, Mestroni L. Family members of patients with ARVC: who is at risk? At what age? When and how often should we evaluate to determine risk? J Am Coll Cardiol. 2014;64:302-303.
Lorenzon A, et al. Homozygous desmocollin-2 mutations and arrhythmogenic cardiomyopathy. Am J Cardiol. 2015;116:1245-1251.
Marcus Fl, Edson S, Towbin JA. Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol. 2013;61:1945-1948.
Roux-Buisson N, et al. Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/ dysplasia: results of a systematic screening. Heart Rhythm. 2014Д1: 1999-2009.
Hodgkinson KA, et al. Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in TMEM43 following implantable cardioverter defibrillator therapy. Circ Arrhythmia Electrophysiol. 2016;9: e003589.
Thiene G. The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine. Eur Heart J. 2015;36:837-846.
Bhonsale A, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-asso-ciated mutation carriers. Eur Heart J. 2015;36:847-855.
Wichter T, Indik JH, Paul M. Ventricular angiography in arrhythmogenic cardiomyopathy. Card Electrophysiol Clin. 2011; 3:255-267.
Cruz FM, et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol. 2015;65:1438-1450.
Ruwald AC, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2015;36:1735-1743.
Sawant AC, Calkins H. Relationship between arrhythmogenic right ventricular dysplasia and exercise. Card Electrophysiol Clin. 2015;7:195-206.
Shaw RM. Reduced sodium channels in human ARVC. Heart Rhythm. 2013;10:420-421.
Noorman M, et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm. 2013Д0: 412-419.
Philips B, et al. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythmia Electrophysiol. 2013;6:160-166.
Lopez-Ayala JM, et al. Genetics of myocarditis in arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2015;12:766-773.
Berte B, et al. Characterization of the left-sided substrate in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2015;8:1403-1412.
Те Riele ASJM, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24:1311-1320.
Philips B, Cheng A. 2015 Update on the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol. 2015;31:l.
Groeneweg JA, et al. Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype? Heart Rhythm. 2013,40:548-559.
Те Riele ASJM, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy in the pediatric population. JACC Clin Electrophysiol. 2015;1:551-560.
Migliore F, et al. Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythmia Electrophysiol. 2013;6: 167-176.
Bhonsale A, et al. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia patients with late presentation. Heart Rhythm. 2016; 14:883-891.
Choudhary N, et al. Clinical presentation and outcomes by sex in arrhythmogenic right ventricular cardiomyopathy: findings from the North American ARVC Registry. J Cardiovasc Electrophysiol. 2016;27:555-562.
Kimura Y, et al. Potentially lethal ventricular arrhythmias and heart failure in arrhythmogenic right ventricular cardiomyopathy: what are the differences between men and women? JACC Clin Electrophysiol. 2016;2:546-555.
Camm CF, et al. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2013;10:1661-1668.
Etoom Y, et al. Importance of CMR within the task force criteria for the diagnosis of ARVC in children and adolescents. J Am Coll Cardiol. 2015;65:987-995.
Asimaki A, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009;360:1075-1084.
Sen-Chowdhry S, Syrris P, Quarta G, et al. Clinical impact of genetics in arrhythmogenic cardiomyopathy. Card Electrophysiol Clin. 2011;3:205-215.
Groeneweg JA, et al. Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Heart Rhythm. 2014;11:2010-2017.
Marra MP, et al. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythmia Electrophysiol. 2012;5:91-100.
Denis A, et al. Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2014;7:590-597.
Hoffmayer KS, Scheinman MM. Electrocardiographic characteristics of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Card Electrophysiol Clin. 2014;6:595-601.
Hoffmayer KS, et al. Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2011;58:831-838.
Ren L, et al. Electrocardiographic difference between ventricular arrhythmias from the right ventricular outflow tract and idiopathic right ventricular arrhythmias. Pacing Clin Electrophysiol. 2014;37:1658-1664.
Hoffmayer KS, et al. An electrocardiographic scoring system for distinguishing right ventricular outflow tract arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia. Heart Rhythm. 2013;10: 477-482.
Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-1323.
Kumar S, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87-93.
Dechering DG, et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2013; 10:158-164.
Tung R, et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis. Heart Rhythm. 2015;12:2488-2498.
Philips B, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythmia Electrophysiol. 2014;7:230-236.
Zaidi A, et al. Clinical differentiation between physiological remodeling and arrhythmogenic right ventricular cardiomyopathy in athletes with marked electrocardiographic repolarization anomalies. J Am Coll Cardiol. 2015;65:2702-2711.
Zaidi A, et al. Clinical significance of electrocardiographic right ventricular hypertrophy in athletes: comparison with arrhythmogenic right ventricular cardiomyopathy and pulmonary hypertension. Eur Heart J. 2013;34:3649-3656.
La Gerche A, et al. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart. 2010;96:1268-1274.
Zaidi A, et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation. 2013;127:1783-1792.
La Gerche A, Heidbuchel H. Exercise-induced arrhythmogenic right ventricular cardiomyopathy. Card Electrophysiol Clin. 2013;5:97-105.
La Gerche A, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015;36:1998-2010.
Те Riele ASJM, et al. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J. 2016;37:755-763.
Bhonsale A, et al. Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. Circ Arrhythmia Electrophysiol. 2013;6:569-578.
Link MS, et al. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. J Am Coll Cardiol. 2014;64:119-125.
Kikuchi N, Yumino D, Shiga T, et al. Long-term prognostic role of the diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy/dysplasia. JACC Clin Electrophysiol. 2016;2:107-115.
Brun F, et al. Risk stratification in arrhythmic right ventricular cardiomyopathy without implantable cardioverter-defibrillators. JACC Clin Electrophysiol. 2016;2:558-564.
Priori SG, Blomstrom-Lundqvist C, Mazzanti A. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;8:746-837.
Ermakov S, Gerstenfeld EP, Svetlichnaya Y, et al. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2016; 14:564-569.
Miissigbrodt A, et al. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? J Interv Card Electrophysiol. 2017;48:193-199.
Herman ARM, et al. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2016;13:1964-1970.
Schinkel AFL. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythmia Electrophysiol. 2013;6:562-568.
Mugnai G, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular cardiomyopathy: the course of electronic parameters, clinical features, and complications during long-term follow-up. J Interv Card Electrophysiol. 2014;41:23-29.
Maron BJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis. J Am Coll Cardiol. 2015;66:2362-2371.
Sawant AC, et al. Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. Heart Rhythm. 2016;13:199-207.
Perrin MJ, et al. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2013;62:1772-1779.
Те Riele ASJM, et al. Yield of serial evaluation in at-risk family members of patients with ARVD/C. J Am Coll Cardiol. 2014; 64:293-301.
Те Riele ASJM, et al. Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity. Heart Rhythm. 2013;10:1484-1491.
Tanawuttiwat T, et al. Electroanatomic correlates of depolarization abnormalities in arrhythmogenic right ventricular dysplasia/ cardiomyopathy. J Cardiovasc Electrophysiol. 2016;27:443-452.
Bae MH, et al. Changes in follow-up ECG and signal-averaged ECG in patients with arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol. 2014;37:430-438.
Zorzi A, et al. Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol. 2013;24:1321-1327.
Zhang L, Liu L, Kowey PR, et al. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014;10:237-245.
Platonov PG, et al. High interobserver variability in the assessment of epsilon waves: implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2016;13:208-216.
Tschabrunn CM, Haqqani HM, Santangeli P, et al. 12-lead electrocardiogram to localize region of abnormal electroanatomic substrate in arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2017;3:654-665.
Haqqani HM, Marchlinski FE. Electroanatomic mapping and catheter ablation of ventricular tachycardia in arrhythmogenic cardiomyopathy. Card Electrophysiol Clin. 2011;3:299-310.
Santangeli P, et al. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2015;8:1413-1421.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: part I: concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36:508-532.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Wong KCK, Rajappan K, Bashir Y, et al. Entrainment with long postpacing intervals from within the flutter circuit: what is the mechanism? Circ Arrhythm Electrophysiol. 2012;5:e90-e92.
Proietti R, et al. A historical perspective on the role of functional lines of block in the re-entrant circuit of ventricular tachycardia. Pacing Clin Electrophysiol. 2016;39:490-496.
Nayyar S, et al. High-density mapping of ventricular scar: a comparison of ventricular tachycardia (VT) supporting channels with channels that do not support VT. Circ Arrhythmia Electrophysiol. 2014;7:90-98.
Baldinger SH, et al. Electrogram analysis and pacing are complimentary for recognition of abnormal conduction and far-field potentials during substrate mapping of infarct-related ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2015;8:874-881.
Berruezo A, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythmia Electrophysiol. 2012;5:111-121.
Tanawuttiwat T, Nazarian S, Calkins H. The role of catheter ablation in the management of ventricular tachycardia. Eur Heart J. 2016;37:594-609.
Fernandez-Armenta J, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014;ll: 747-754.
Kumar P, Mounsey JP, Chung EH. Adjusting voltage criteria can unmask conducting channels in a patient with arrhythmogenic right ventricular cardiomyopathy and ventricular tachycardia. Heart Case Reports. 2015;1:275-278.
Philips B, et al. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015;12:716-725.
Lerman BB. Eliminating ventricular tachycardia by targeting premature ventricular contractions in arrhythmogenic right ventricular dysplasia/cardiomyopathy: innocent bystander or heart of the matter? Circ Arrhythmia Electrophysiol. 2013;6:7-9.
Berte B, et al. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J Cardiovasc Electrophysiol. 2016;27:80-87.
Gersh BJ, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58: e212-e260.
Maron BJ, et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64:89-99.
Nijenkamp LLAM, Guclu A, Appelman Y, et al. Sex-dependent pathophysiological mechanisms in hypertrophic cardiomyopathy: implications for rhythm disorders. Heart Rhythm. 2015;12: 433-439.
Popescu BA, Rosca M, Schwammenthal E. Dynamic obstruction in hypertrophic cardiomyopathy. Curr Opin Cardiol. 2015;30: 468-474.
Elliott PM, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733-2779.
Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65:1249-1254.
Sherrid MV, Arabadjian M, Koulova A. Thin-filament mutations, hypertrophic cardiomyopathy, and risk. J Am Coll Cardiol. 2014;64: 2601-2604.
Baudhuin LM, Kotzer KE, Kluge ML, et al. What is the true prevalence of hypertrophic cardiomyopathy? J Am Coll Cardiol. 2015;66:1845-1846.
Maron MS, Hellawell JL, Lucove JC, et al. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States. Am J Cardiol. 2016;117:1651-1654.
Maron MS, et al. Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016;67:1399-1409.
Maron BJ, et al. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. J Am Coll Cardiol. 2015;65:1915-1928.
Spirito P, et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119:1703-1710.
Williams L, Frenneaux M. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace. 2007;9:817-822.
Wilke I, et al. High incidence of de novo and subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac rhythm management device. J Cardiovasc Electrophysiol. 2016;27:779-784.
Guttmann OP, Rahman MS, O'Mahony C, et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart. 2014;100:465-472.
Link MS, et al. Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy and defibrillators: triggers, treatment, and implications. J Cardiovasc Electrophysiol. 2017;28:531-537.
Greulich S, et al. Incremental value of late gadolinium enhancement for management of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012;110:1207-1212.
Wahbi K, et al. Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases. Eur Heart J. 2015;36:2886-2893.
Chandra N, Bastiaenen R, Papadakis M, et al. Sudden cardiac death in young athletes. J Am Coll Cardiol. 2013;61:1027-1040.
Wasfy MM, Weiner RB. Differentiating the athlete's heart from hypertrophic cardiomyopathy. Curr Opin Cardiol. 2015;30:l.
Rawlins J, Bhan A, Sharma S. Left ventricular hypertrophy in athletes. Eur J Echocardiogr. 2009;10:350-356.
Basavarajaiah S, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2256-2262.
Wang W, et al. Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2017;10:1-8.
McLellan AJ, et al. Diffuse ventricular fibrosis on cardiac magnetic resonance imaging associates with ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2016;27:571-580.
Vriesendorp PA, et al. Validation of the 2014 ESC guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8:829-835.
Fraiche A, Wang A. Hypertrophic cardiomyopathy: new evidence since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline. Curr Cardiol Rep. 2016;18:70.
Veselka J, et al. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. Eur Heart J. 2016;37:1517-1523.
Maron BJ, et al. Low operative mortality achieved with surgical septal myectomy. J Am Coll Cardiol. 2015;66:1307-1308.
Yue-Cheng H, et al. Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2013;36:86-93.
Maron BJ, et al. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;61:1527-1535.
Maron BJ, Maron MS. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. Heart Rhythm. 2016;13:1155-1165.
Thavikulwat AC, Tomson TT, Knight BP, et al. Appropriate implantable defibrillator therapy in adults with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2016;27:953-960.
Maron BJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis. J Am Coll Cardiol. 2015;66:2362-2371.
Komatsu Y, et al. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia. J Am Coll Cardiol. 2014; 63:1416-1426.
Sarkozy A, et al. Epicardial ablation of ventricular tachycardia in ischemic heart disease. Circ Arrhythm Electrophysiol. 2013;6:1115-1122.
Yoshiga Y, et al. Correlation between substrate location and ablation strategy in patients with ventricular tachycardia late after myocardial infarction. Heart Rhythm. 2012;9:1192-1199.
Kosmidou I, et al. Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm. 2011;8: 1516-1522.
Yokokawa M, et al. Computerized analysis of the 12-lead electrocardiogram to identify epicardial ventricular tachycardia exit sites. Heart Rhythm. 2014;11:1966-1973.
Valles E, Bazan V, Marchlinski FE. ECG criteria to identify epicardial ventricular tachycardia in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2010;3:63-71.
Zhang L, Liu L, Kowey PR, et al. The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. Curr Cardiol Rev. 2014;10:237-245.
Haqqani HM, Marchlinski FE. Electroanatomic mapping and catheter ablation of ventricular tachycardia in arrhythmogenic cardiomyopathy. Card Electrophysiol Clin. 2011;3:299-310.
Hutchinson MD, Garcia FC. An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias. J Cardiovasc Electrophysiol. 2013;24:1189-1197.
Daniels DV, et al. Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of Valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram. Circulation. 2006;113: 1659-1666.
Yamada T, et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit anatomic concepts relevant to ablation. Circ Arrhythm Electrophysiol. 2010;3:616-623.
Lin CY, et al. Radiofrequency catheter ablation of ventricular arrhythmias originating from the continuum between the aortic sinus of Valsalva and the left ventricular summit: electrocardiographic characteristics and correlative anatomy. Heart Rhythm. 2015;13:111-121.
Santangeli P, Lin D, Marchlinski FE. Catheter ablation of ventricular arrhythmias arising from the left ventricular summit. Card Electrophysiol Clin. 2016;8:99-107.
Ouyang F, et al. Ventricular arrhythmias arising from the left ventricular outfow tract below the aortic sinus cusps: mapping and catheter ablation via transseptal approach and electrocardiographic characteristics. Circ Arrhythm Electrophysiol. 2014;7: 445-455.
De Riva M, Watanabe M, Zeppenfeld K. Twelve-lead ECG of ventricular tachycardia in structural heart disease. Circ Arrhythm Electrophysiol. 2015;8:951-962.
Martinek M, Stevenson WG, Inada K, et al. QRS characteristics fail to reliably identify ventricular tachycardias that require epicardial ablation in ischemic heart disease. J Cardiovasc Electrophysiol. 2012;23:188-193.
Fernandez-Armenta J, Berruezo A. How to recognize epicardial origin of ventricular tachycardias? Curr Cardiol Rev. 2014;10:246-256.
Garikipati NV, Paruchuri V, Mittal S. How to learn epicardial intervention techniques in electrophysiology. Card Electrophysiol Clin. 2010;2:35-43.
Soejima K, et al. Epicardial catheter ablation of ventricular tachycardia in no entry left ventricle: mechanical aortic and mitral valves. Circ Arrhythm Electrophysiol. 2015;8:381-389.
Bradfield JS, Tung R, Boyle NG, et al. Our approach to minimize risk of epicardial access: standard techniques with the addition of electroanatomic mapping guidance. J Cardiovasc Electrophysiol. 2013;24:723-727.
Berte B, et al. Characterization of the left-sided substrate in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8:1403-1412.
Fernandez-Armenta J, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014;11: 747-754.
Acosta J, et al. Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy. Heart Rhythm. 2016;13:85-95.
Izquierdo M, et al. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease. Circ Arrhythm Electrophysiol. 2015;8:882-889.
Tzou WS, et al. Endocardial electrogram characteristics of epicardial ventricular arrhythmias. J Cardiovasc Electrophysiol. 2013;24: 649-654.
Philips B, et al. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015;12:716-725.
Pisani CF, Lara S, Scanavacca M. Epicardial ablation for cardiac arrhythmias: techniques, indications and results. Curr Opin Cardiol. 2014;29:59-67.
Page SP, et al. Epicardial catheter ablation for ventricular tachycardia in heparinized patients. Europace. 2013;15:284-289.
Njeim M. Value of cardiac magnetic resonance imaging in patients with failed ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:183-189.
Komatsu Y, et al. Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythm Electrophysiol. 2013;6:342-350.
Yalin K, et al. Infarct characteristics by CMR identifies substrate for monomorphic VT in post-MI patients with relatively preserved systolic function and NS-VT. Pacing Clin Electrophysiol. 2014;37: 447-453.
El Aidi H, et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol. 2014;63:1031-1045.
Stevens SM, et al. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. Heart Rhythm. 2014;11:289-298.
Syed F, et al. The pericardial space: obtaining access and an approach to fluoroscopic anatomy. Card Electrophysiol Clin. 2010; 2:9-23.
Rodriguez ER, Tan CD. Structure and anatomy of the human pericardium. Prog Cardiovasc Dis. 2017;59:327-340.
Ernst S, Sanchez-Quintana D, Ho SY. Anatomy of the pericardial space and mediastinum: relevance to epicardial mapping and ablation. Card Electrophysiol Clin. 2010;2:1-8.
Boyle NG, Shivkumar K. Epicardial interventions in electrophysiology. Circulation. 2012;126:1752-1769.
Lim HS, et al. Safety and prevention of complications during percutaneous epicardial access for the ablation of cardiac arrhythmias. Heart Rhythm. 2014;11:1658-1665.
Yamada T. Transthoracic epicardial catheter ablation. Circ J. 2013;77: 1672-1680.
Yamada T, Kay GN. Recognition and prevention of complications during epicardial ablation. Card Electrophysiol Clin. 2010;2: 127-134.
DAvila A, Koruth JS, Dukkipati S, et al. Epicardial access for the treatment of cardiac arrhythmias. Europace. 2012;14:13-18.
Killu AM, et al. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery. Circ Arrhythm Electrophysiol. 2015;8: 94-101.
Tschabrunn CM, et al. Percutaneous epicardial ventricular tachycardia ablation after noncoronary cardiac surgery or pericarditis. Heart Rhythm. 2013;10:165-169.
Bertaso AG, Bertol D, Duncan BB, et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013;101:el8-e28.
Baldinger SH, et al. Epicardial radiofrequency ablation failure during ablation procedures for ventricular arrhythmias: reasons and implications for outcomes. Circ Arrhythm Electrophysiol. 2015;8: 1422-1432.
Tung R, et al. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm. 2013;10:490-498.
Kumar S, et al. "Needle-in-needle" epicardial access: preliminary observations with a modified technique for facilitating epicardial interventional procedures. Heart Rhythm. 2015;12:1691-1697.
Gunda S, et al. Differences in complication rates between large bore needle and a long micropuncture needle during epicardial access. Circ Arrhythm Electrophysiol. 2015;8:890-895.
Swale M, et al. Epicardial access: patient selection, anatomy, and a stepwise approach. J Innov Card Rhythm Manag. 2011;2:239-249.
Killu AM, et al. Pericardial effusion following drain removal after percutaneous epicardial access for an electrophysiology procedure. Pacing Clin Electrophysiol. 2015;38:383-390.
Killu AM, et al. Atypical complications encountered with epicardial electrophysiological procedures. Heart Rhythm. 2013;10:1613-1621.
Loukas M, Bilinsky S, Bilinsky E, et al. Cardiac veins: a review of the literature. Clin Anat. 2009;22:129-145.
Randhawa A, Saini A, Aggarwal A, et al. Variance in coronary venous anatomy: a critical determinant in optimal candidate selection for cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2013;36:94-102.
Noheria A, et al. Anatomy of the coronary sinus and epicardial coronary venous system in 620 hearts: an electrophysiology perspective.) Cardiovasc Electrophysiol. 2013;24:1-6.
Spencer JH, Larson AA, Drake R, et al. A detailed assessment of the human coronary venous system using contrast computed tomography of perfusion-fixed specimens. Heart Rhythm. 2014;11: 282-288.
Kawamura M, et al. Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum epicardial idiopathic ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2014;7: 1152-1158.
Kawamura M, et al. Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias with right bundle branch block and superior axis: comparison of apical crux area and posterior septal left ventricle. Heart Rhythm. 2015;12:1137-1144.
Nagashima K, et al. Ventricular arrhythmias near the distal great cardiac vein challenging arrhythmia for ablation. Circ Arrhythm Electrophysiol. 2014;7:906-912.
Jauregui Abularach ME, et al. Ablation of ventricular arrhythmias arising near the anterior epicardial veins from the left sinus of Valsalva region: ECG features, anatomic distance, and outcome. Heart Rhythm. 2012;9:865-873.
Garabelli PJ, Stavrakis S, Po SS. A case series and review of the literature regarding coronary artery complications associated with coronary sinus catheter ablation. HeartRhythm Case Rep. 2015;1:315-319.
Nazer B, et al. Importance of ventricular tachycardia induction and mapping for patients referred for epicardial ablation. Pacing Clin Electrophysiol. 2015;38:1333-1342.
Nayyar S, Young GD, Sanders P, et al. Paradoxical ventricular activation sequence and paraHisian entrainment response: do they challenge the diagnosis? Circ Arrhythm Electrophysiol. 2013;6: el-e6.
Roberts JD, et al. Bundle branch re-entrant ventricular tachycardia. JACC Clin Electrophysiol. 2017;3:276-288.
Reithmann C, Herkommer B, Remp T, et al. Atypical surface ECG complicating the diagnosis of bundle branch reentry tachycardia. Pacing Clin Electrophysiol. 2017;40:191-198.
Balasundaram R, Rao HB, Kalavakolanu S, et al. Catheter ablation of bundle branch reentrant ventricular tachycardia. Heart Rhythm. 2008;5:S68-S72.
Sakata T, Tanner H, Stuber T, et al. His-Purkinje system re-entry in patients with clustering ventricular tachycardia episodes. Europace. 2008;10:289-293.
Machino T, Tada H, Sekiguchi Y, et al. Three-dimensional visualization of the entire reentrant circuit of bundle branch reentrant tachycardia. Heart Rhythm. 2013;10:459-460.
Schmidt B, et al. Left bundle branch-Purkinje system in patients with bundle branch reentrant tachycardia: lessons from catheter ablation and electroanatomic mapping. Heart Rhythm. 2009;6:51-58.
Blanck Z, Sra J, Akhtar M. Incessant interfascicular reentrant ventricular tachycardia as a result of catheter ablation of the right bundle branch: case report and review of the literature. J Cardiovasc Electrophysiol. 2009;20:l279-1283.
Okishige K, et al. The radio frequency catheter ablation of interfascicular reentrant tachycardia: new insights into the electrophysiological and anatomical characteristics. J Interv Card Electrophysiol. 2014;41:39-54.
Arbustini E, et al. The MOGE(S) classification for a phenotypegenotype nomenclature of cardiomyopathy endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62:2046-2072.
Liuba I, et al. Scar progression in patients with nonischemic cardiomyopathy and ventricular arrhythmias. Heart Rhythm. 2014; 11:755-762.
Piers SRD, et al. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy implications for the ablation strategy. Circ Arrhythm Electrophysiol. 2013;6:875-883.
Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guide. Circulation. 2013;127:e283-e352.
Memon S, Ganga HV, Kluger J. Late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy. Pacing Clin Electrophysiol. 2016;39:731-747.
Kusumoto FM, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014;64:1143-1177.
Disertori M, et al. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace. 2013;15:1693-1701.
Schliamser JE, et al. Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE). Heart Rhythm. 2013;10:838-846.
Gatzoulis KA, et al. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population reappraisal of the role of programmed ventricular stimulation. Circ Arrhythmia Electrophysiol. 2013;6:504-512.
Pezawas T, et al. Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls. Circ Arrhythmia Electrophysiol. 2014;7:1101-1108.
Piers SRD, et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm. 2015;12:2106-2114.
Perazzolo Marra M, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm. 2014;11:856-863.
Di Marco A, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy. JACC Heart Fail. 2017;5:28-38.
Priori SG, Blomstrom-Lundqvist C, Mazzanti A. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;8:746-837.
Katz DF, et al. Survival after secondary prevention implantable cardioverter-defibrillator placement. JACC Clin Electrophysiol. 2017;3:20-28.
Al-Khatib SM, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Heart Rhythm. 2017;[Epub ahead of print].
Betts TR, et al. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis. Europace. 2013;15:813-819.
Kober L, et aL Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375: 1221-1230.
Luni FK, et al. Mortality Effect of ICD in primary prevention of nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. J Cardiovasc Electrophysiol. 2017;28:538-543.
Stavrakis S, Asad Z, Reynolds D. Implantable cardioverter defibrillators for primary prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. J Cardiovasc Electrophysiol. 2017;28:659-665.
Poole JE. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy. Circulation. 2014;129:383-394.
Voskoboinik A, Bloom J, Taylor A, et al. Early implantation of primary prevention implantable cardioverter defibrillators for patients with newly diagnosed severe nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2016;39:992-998.
Losurdo P, et al. Early arrhythmic events in idiopathic dilated cardiomyopathy. JACC Clin Electrophysiol. 2016;2:535-543.
Singh М, et al. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy a decade-long single-center experience. J Am Coll Cardiol. 2015;66:2607-2613.
Russo AM, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/ SCMR 2013 appropriate use criteria for implantable cardioverterdefibrillators and cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61:1318-1368.
Betensky BP, Marchlinski FE. Outcomes of catheter ablation of ventricular tachycardia in the setting of structural heart disease. Curr Cardiol Rep. 2O16;18:68.
Dinov B, et al. Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and long-term outcomes: results from the heart center of Leipzig ventricular tachycardia registry. Circ Arrhythmia Electrophysiol. 2014;7:1144-1151.
Piers SR, et al. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of non-inducibility. Circ Arrhythm Electrophysiol. 2013;6:513-521.
Muser D, et al. Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy. Circ Arrhythm Electrophysiol. 2016;9:e004328.
Aliot EM, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS). Heart Rhythm. 2009;6:886-933.
De Riva M, Watanabe M, Zeppenfeld K. Twelve-lead ECG of ventricular tachycardia in structural heart disease. Circ Arrhythmia Electrophysiol. 2015;8:951-962.
Haqqani HM, et al. Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. Heart Rhythm. 2011;8:1169-1176.
Valles E, Bazan V, Marchlinski FE. ECG criteria to identify epicardial ventricular tachycardia in nonischemic cardiomyopathy. Circ Arrhythmia Electrophysiol. 2010;3:63-71.
Makimoto H, et al. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol. 2015;38:630-640.
Anter E, Li J, Tschabrunn CM, et al. Mapping of a postinfarction left ventricular aneurysm-dependent macroreentrant ventricular tachycardia. Heart Case Reports. 2015;1:472-476.
Nayyar S, et al. High-density mapping of ventricular scar: a comparison of ventricular tachycardia (VT) supporting channels with channels that do not support VT. Circ Arrhythmia Electrophysiol. 2014;7:90-98.
Tschabrunn CM, et al. High-resolution mapping of ventricular scar. Circ Arrhythmia Electrophysiol. 2016;9:e003841.
Njeim M. Value of cardiac magnetic resonance imaging in patients with failed ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:183-189.
Komatsu Y, et al. Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythmia Electrophysiol. 2013;6:342-350.
Miller MA, et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythmia Electrophysiol. 2013;6:151-159.
Reddy YM, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation multicenter experience. Circ Arrhythmia Electrophysiol. 2014;7:244-250.
Miller MA, Reddy VY. Percutaneous hemodynamic support during scar-ventricular tachycardia ablation is the juice worth the squeeze? Circ Arrhythmia Electrophysiol. 2014;7:192-194.
Tanawuttiwat T, Nazarian S, Calkins H. The role of catheter ablation in the management of ventricular tachycardia. Eur Heart J. 2016;37:594-609.
Aryana A, et al. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm. 2014;11:1122-1130.
Desjardins B, et al. Characteristics of intramural scar in patients with nonischemic cardiomyopathy and relation to intramural ventricular arrhythmias. Circ Arrhythmia Electrophysiol. 2013;6:891-897.
Berruezo A, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythmia Electrophysiol. 2012;5:111-121.
Hutchinson MD, et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2011;4:49-55.
Fernandez-Armenta J, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014; 11:747-754.
Proietti R, et al. A historical perspective on the role of functional lines of block in the re-entrant circuit of ventricular tachycardia. Pacing Clin Electrophysiol. 2016;39:490-496.
Kumar P, Mounsey JP, Chung EH. Adjusting voltage criteria can unmask conducting channels in a patient with arrhythmogenic right ventricular cardiomyopathy and ventricular tachycardia. Heart Case Reports. 2015;1:275-278.
Baldinger SH, et al. Electrogram analysis and pacing are complimentary for recognition of abnormal conduction and far-field potentials during substrate mapping of infarct-related ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2015;8:874-881.
Tsiachris D, et al. Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation. Circ Arrhythmia Electrophysiol. 2015;8:863-873.
Acosta J, et al. Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy. Heart Rhythm. 2016;13:85-95.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Wong KCK, et al. Entrainment with long postpacing intervals from within the flutter circuit: what is the mechanism? Circ Arrhythm Electrophysiol. 2012;5:e90-e92.
Tokuda M, et al. Characteristics of clinical and induced ventricular tachycardia throughout multiple ablation procedures. J Cardiovasc Electrophysiol. 2016;27:88-94.
Komatsu Y, et al. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia. J Am Coll Cardiol. 2014;63:1416-1426.
Di Biase L, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy the VISTA randomized multicenter trial. J Am Coll Cardiol. 2015;66:2872-2882.
Marchlinski FE, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial. J Am Coll Cardiol. 2016;67:674-683.
Tung R, Kottkamp H. A moving target for catheter ablation of ventricular tachycardia ablation of scar or arrhythmia? J Am Coll Cardiol. 2015;66:2883-2885.
Gokoglan Y, et al. Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2016;68:1990-1998.
Berruezo A, et al. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythmia Electrophysiol. 2015;8:326-336.
Tzou WS, et al. Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias. Circ Arrhythmia Electrophysiol. 2015;8:353-361.
Proietti R, Roux J-F, Essebag V. Recent advances in ablation of ventricular tachycardia associated with structural heart disease. Curr Opin Cardiol. 2016;31:64-71.
Kumar S, et al. Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail. Circ Arrhythmia Electrophysiol. 2015;8:606-615.
Dinov B, et al. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality? Circ Arrhythmia Electrophysiol. 2016;8:598-605.
Ghanbari H, et al. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes a meta-analysis. Circ Arrhythmia Electrophysiol. 2014;7:677-683.
Yokokawa M, et al. Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2015;65:1954-1959.
Tzou WS, et al. Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: an analysis from the International VT Ablation Center Collaborative Group. Heart Rhythm. 2017;14:991-997.
Birnie DH, et al. Cardiac sarcoidosis. J Am Coll Cardiol. 2016;68: 411-421.
Orii M, et al. Comparison of cardiac MRI and 18 F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block. Heart Rhythm. 2015;12:2477-2485.
Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-1323.
Kumar S, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87-93.
Naruse Y, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2014;7:407-413.
Deleted in review.
Segawa M, et al. Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis. Circ Arrhythmia Electrophysiol. 2016;9:e003353.
Nery PB, Leung E, Birnie DH. Arrhythmias in cardiac sarcoidosis: diagnosis and treatment. Curr Opin Cardiol. 2012;27:181-189.
Nery PB, et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2014;37:364-375.
Tung R, et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis. Heart Rhythm. 2015;12:2488-2498.
Dechering DG, et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2013;10:158-164.
Philips B, et al. Arrhythmogenic right ventricular dysplasia/ cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythmia Electrophysiol. 2014;7:230-236.
Panda S, et al. Pleomorphism during ventricular tachycardia: a distinguishing feature between cardiac sarcoidosis and idiopathic VT. Pacing Clin Electrophysiol. 2015;38:694-699.
Kron J, et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace. 2013;15:347-354.
Muser D, et al. Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2016;9:e004333.
Zipse MM, Sauer WH. Cardiac sarcoidosis. Curr Cardiol Rep. 2O14;16:514.
Betensky BP, et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm. 2012;9:884-891.
Perez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391:82-94.
Healy C, Viles-gonzalez JF, Saenz LC, et al. Arrhythmias in Chagasic cardiomyopathy. Card Electrophysiol Clin. 2015;7:251-268.
Nunes MCP, Dones W, Morillo CA, et al. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62:767-776.
Andrade JP, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011;96:434-442.
Cardoso R, et al. The prevalence of atrial fibrillation and conduction abnormalities in Chagas' disease: a meta-analysis. J Cardiovasc Electryphysiol. 2016;27:161-169.
Benznidazole for chronic Chagas' cardiomyopathy. N Engl J Med. 2016;374:188-190.
Pereira FT, et al. Long-term follow-up of patients with chronic Chagas disease and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2014;37:751-756.
Barbosa MP, et al. Efficacy and safety of implantable cardioverterdefibrillators in patients with Chagas disease. Europace. 2013; 15:957-962.
Mittal S. 'Focal' ventricular tachycardia: insights from catheter ablation. Heart Rhythm. 2008;5:S64-S67.
Maury P, Rollin A, Mondoly P, et al. Management of outflow tract ventricular arrhythmias. Curr Opin Cardiol. 2015;30:50-57.
Sadek MM, et al. Idiopathic ventricular arrhythmias originating from the moderator band: electrocardiographic characteristics and treatment by catheter ablation. Heart Rhythm. 2015;12:67-75.
Potfay J, et al. Abnormal left ventricular mechanics of ventricular ectopic beats: insights into origin and coupling interval in premature ventricular contraction induced cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8:1194-1200.
Wang Y, et al. Cellular mechanism of premature ventricular contraction-induced cardiomyopathy. Heart Rhythm. 2014;ll: 2064-2072.
Sadron Blaye-Felice M, et al. Premature ventricular contraction-induced cardiomyopathy: related clinical and electrophysiologic parameters. Heart Rhythm. 2016;13:103-110.
Cha YM, Lee GK, Klarich KW, et al. Premature ventricular contraction-induced cardiomyopathy: a treatable condition. Circ Arrhythm Electrophysiol. 2012;5:229-236.
Lee YH, et al. Frequency, origin, and outcome of ventricular premature complexes in patients with or without heart diseases. Am J Cardiol. 2014;114:1373-1378.
Carballeira Pol L, et al. Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy. Heart Rhythm. 2014;11:299-306.
Ban J-E, et al. Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease. Europace. 2013;15:735-741.
Bas HD, et al. Effect of circadian variability in frequency of premature ventricular complexes on left ventricular function. Heart Rhythm. 2015; 13:98-102.
Deyell MW, et al. Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations. Heart Rhythm. 2012;9:1465-1472.
Hamon D, et al. A new combined parameter to predict premature ventricular complexes induced cardiomyopathy: impact and recognition of epicardial origin. J Cardiovasc Electrophysiol. 2016;27:10-12.
Hutchinson MD, Garcia FC. An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias. J Cardiovasc Electrophysiol. 2013;24:1189-1198.
Acosta J, et al. Impact of earliest activation site location in the septal right ventricular outflow tract for identification of left vs right outflow tract origin of idiopathic ventricular arrhythmias. Heart Rhythm. 2015;12:726-734.
Anderson R. Clinical anatomy of the aortic root. Heart. 2000;84: 670-673.
Hai JJ, Lachman N, Syed FF, et al. The anatomic basis for ventricular arrhythmia in the normal heart: what the student of anatomy needs to know. Clin Anat. 2014;27:885-893.
Liao Z, et al. Idiopathic ventricular arrhythmias originating from the pulmonary sinus cusp. J Am Coll Cardiol. 2015;66:2633-2644.
Liu CF, et al. Ubiquitous myocardial extensions into the pulmonary artery demonstrated by integrated intracardiac echocardiography and electroanatomic mapping changing the paradigm of idiopathic right ventricular outflow tract arrhythmias. Circ Arrhythm ElectrophysioL 2014;7:691-700.
Ho SY. Structure and anatomy of the aortic root. Eur J Echocardiogr. 2009;10:3-10.
Ouyang F, et al. Ventricular arrhythmias arising from the left ventricular outfow tract below the aortic sinus cusps: mapping and catheter ablation via transseptal approach and electrocardiographic characteristics. Circ Arrhythm Electrophysiol. 2014; 7:445-455.
Anderson RH. The surgical anatomy of the aortic root. Multimed Man Cardiothorac Surg. 2007;2007:mmcts.2006.002527.
Yamada T, et al. Prevalence and clinical, electrocardiographic, and electrophysiologic characteristics of ventricular arrhythmias originating from the noncoronary sinus of Valsalva. Heart Rhythm. 2013;10:1605-1612.
Faletra FF, Ho SY, Auricchio A. Anatomy of right atrial structures by real-time 3D transesophageal echocardiography. JACC Cardiovasc Imaging. 2010;3:966-975.
Enriquez A, et al. How to map and ablate left ventricular summit arrhythmias. Heart Rhythm. 2017;14:141-148.
Yamada T, et al. Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract: efficacy of sequential versus simultaneous unipolar catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:344-352.
Enriquez A, Supple GE, Marchlinski FE, et al. How to map and ablate papillary muscle ventricular arrhythmias. Heart Rhythm. 2017;14:1721-1728.
Naksuk N, Kapa S, Asirvatham SJ. Spectrum of ventricular arrhythmias arising from papillary muscle in the structurally normal heart. Card Electrophysiol Clin. 2016;8:555-565.
Kawamura M, et al. Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum epicardial idiopathic ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2014;7:1152-1158.
Kawamura M, et al. Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias with right bundle branch block and superior axis: comparison of apical crux area and posterior septal left ventricle. Heart Rhythm. 2015;12:1137-1144.
Sirichand S, et al. Incidence of idiopathic ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2017;10:e004662.
Luebbert J, Auberson D, Marchlinski F. Premature ventricular complexes in apparently normal hearts. Card Electrophysiol Clin. 2016;8:503-514.
van Huis van Taxis CFB, et al. Fatigue as presenting symptom and a high burden of premature ventricular contractions are independently associated with increased ventricular wall stress in patients with normal left ventricular function. Circ Arrhythm Electrophysiol. 2015;8:1452-1459.
Penela D, et al. Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: safety of withholding the implant. Heart Rhythm. 2015;12:2434-2442.
Peachey H, et al. EHRA/HRS/APHRS Expert consensus on ventricular arrhythmias. Heart Rhythm. 2014;ll:el66-el96.
Nucifora G, et al. Prevalence and prognostic value of concealed structural abnormalities in patients with apparently idiopathic ventricular arrhythmias of left versus right ventricular origin: a magnetic resonance imaging study. Circ Arrhythm Electrophysiol. 2014;7:456-462.
Hoffmayer KS, Scheinman MM. Electrocardiographic characteristics of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Card Electrophysiol Clin. 2014;6:595-601.
Hoffmayer KS, et al. Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2011;58:831-838.
Ren L, et al. Electrocardiographic difference between ventricular arrhythmias from the right ventricular outflow tract and idiopathic right ventricular arrhythmias. Pacing Clin Electrophysiol. 2014;37:1658-1664.
Hoffmayer KS, et al. An electrocardiographic scoring system for distinguishing right ventricular outflow tract arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia. Heart Rhythm. 2013;10:477-482.
Denis A, et al. Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2014;7:590-597.
El Kadri M, et al. Effect of ablation of frequent premature ventricular complexes on left ventricular function in patients with nonischemic cardiomyopathy. Heart Rhythm. 2015;12:706-713.
Penela D, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol. 2013;62:1195-1202.
Van Herendael H, et al. Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers. Heart Rhythm. 2014;11:566-573.
Kim YR, et al. Second coupling interval of nonsustained ventricular tachycardia to distinguish malignant from benign outflow tract ventricular tachycardias. Heart Rhythm. 2014;ll: 2222-2229.
Yokokawa M, et al. Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy. Heart Rhythm. 2012;9:92-95.
Gopinathannair R, et al. Arrhythmia-induced cardiomyopathies mechanisms, recognition, and management. J Am Coll Cardiol. 2015;66:1714-1728.
Ling Z, et al. Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract prospective randomized study. Circ Arrhythm Electrophysiol. 2014;7:237-243.
Zhong L, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study. Heart Rhythm. 2014; 11:187-193.
Lamba J, et al. Radiofrequency catheter ablation for the treatment of idiopathic premature ventricular contractions originating from the right ventricular outflow tract: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2014;37:73-78.
Tanawuttiwat T, Nazarian S, Calkins H. The role of catheter ablation in the management of ventricular tachycardia. Eur Heart J. 2016;37:594-609.
Hasdemir C, et al. Time course of recovery of left ventricular systolic dysfunction in patients with premature ventricular contraction-induced cardiomyopathy. Pacing Clin Electrophysiol. 2013;0:1-6.
Baser K, et al. Recurrence of PVCs in patients with PVC-induced cardiomyopathy. Heart Rhythm. 2015;12:1519-1523.
Wasmer K, et al. Ventricular arrhythmias from the mitral annulus: patient characteristics, electrophysiological findings, ablation, and prognosis. Heart Rhythm. 2013;10:783-788.
Yamada T, McElderry HT, Doppalapudi H, et al. Catheter ablation of ventricular arrhythmias originating in the vicinity of the His bundle: significance of mapping the aortic sinus cusp. Heart Rhythm. 2008;5:37-42.
Anter E, Frankel DS, Marchlinski FE, et al. Effect of electrocardiographic lead placement on localization of outflow tract tachycardias. Heart Rhythm. 2012;9:697-703.
Ouyang F, et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol. 2002;39:500-508.
Betensky BP, et al. The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin. J Am Coll Cardiol. 2011;57: 2255-2262.
Yoshida N, et al. A novel electrocardiographic criterion for differentiating a left from right ventricular outflow tract tachycardia origin: the V2S/V3R index. J Cardiovasc Electrophysiol. 2014; 25:747-753.
Yoshida N, et al. Novel transitional zone index allows more accurate differentiation between idiopathic right ventricular outflow tract and aortic sinus cusp ventricular arrhythmias. Heart Rhythm. 2011;8:349-356.
Bradfield JS, Homsi M, Shivkumar K, et al. Coupling interval variability differentiates ventricular ectopic complexes arising in the aortic sinus of Valsalva and great cardiac vein from other sources: mechanistic and arrhythmic risk implications. J Am Coll Cardiol. 2014;63:2152-2158.
Lin D, et al. Twelve-lead electrocardiographic characteristics of the aortic cusp region guided by intracardiac echocardiography and electroanatomic mapping. Heart Rhythm. 2008;5:663-669.
Yamada T, et al. Idiopathic ventricular arrhythmias originating from the aortic root. Prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation. J Am Coll Cardiol. 2008;52:139-147.
Yamada T, et al. Electrocardiographic characteristics of ventricular arrhythmias originating from the junction of the left and right coronary sinuses of Valsalva in the aorta: the activation pattern as a rationale for the electrocardiographic characteristics. Heart Rhythm. 2008;5:184-192.
Bala R, et al. Electrocardiographic and electrophysiologic features of ventricular arrhythmias originating from the right/left coronary cusp commissure. Heart Rhythm. 2010;7:312-322.
Alasady M, Singleton CB, McGavigan AD. Left ventricular outflow tract ventricular tachycardia originating from the noncoronary cusp: electrocardiographic and electrophysiological characterization and radiofrequency ablation. J Cardiovasc Electrophysiol. 2009;20:1287-1290.
Hayashi T, et al. Outcomes of catheter ablation of idiopathic outflow tract ventricular arrhythmias with an R wave pattern break in lead V2: a distinct clinical entity. J Cardiovasc Electrophysiol. 2017;28:504-514.
Daniels DV, et al. Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of Valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram. Circulation. 2006;13: 1659-1666.
Yamada T, et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit anatomic concepts relevant to ablation. Circ Arrhythm Electrophysiol. 2010;3:616-623.
Lin CY, et al. Radiofrequency catheter ablation of ventricular arrhythmias originating from the continuum between the aortic sinus of Valsalva and the left ventricular summit: electrocardiographic characteristics and correlative anatomy. Heart Rhythm. 2015;13:111-121.
Yamada T, Doppalapudi H, Litovsky SH, et al. Challenging radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from the left ventricular summit near the left main coronary artery. Circ Arrhythm Electrophysiol. 2016;9: e004202.
AlAref SJ, et al. Differentiation of papillary muscle from fascicular and mitral annular ventricular arrhythmias in patients with and without structural heart disease. Circ Arrhythm Electrophysiol. 2015;8:616-624.
Chen M, et al. Idiopathic accelerated idioventricular rhythm or ventricular tachycardia originating from the right bundle branch: unusual type of ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2014;7:1159-1167.
Li T, et al. Combined approach improves the outcomes of catheter ablation of idiopathic ventricular arrhythmias originating from the vicinity of tricuspid annulus. Pacing Clin Electrophysiol. 2014;37:624-629.
Ban JE, et al. Idiopathic ventricular arrhythmia originating from the para-Hisian area: prevalence, electrocardiographic and electrophysiological characteristics. J Arrhythmia. 2014;30:48-54.
Sorgente A, et al. Negative concordance pattern in bipolar and unipolar recordings: an additional mapping criterion to localize the site of origin of focal ventricular arrhythmias. Heart Rhythm. 2016;13:519-526.
Luther V, Qureshi N, Kanagaratnam P, et al. Automated activation and pace-mapping to guide ablation within the outflow tract. J Cardiovasc Electrophysiol. 2015;27:127-128.
Luker J, et al. Automated template matching correlates with earliest activation during mapping of idiopathic premature ventricular contractions. Int J Cardiol Heart Vessel. 2014;4:25-29.
Zhang F, et al. Noncontact mapping to guide ablation of right ventricular outflow tract arrhythmias. Heart Rhythm. 2O13;1O: 1895-1902.
Hoffmayer KS, et al. Safety of radiofrequency catheter ablation without coronary angiography in aortic cusp ventricular arrhythmias. Heart Rhythm. 2014;11:1117-1121.
Andreu D, et al. Displacement of the target ablation site and ventricles during premature ventricular contractions: relevance for radiofrequency catheter ablation. Heart Rhythm. 2012;9: 1050-1057.
Miyazawa K, et al. Rapid mapping and differentiation in ventricular outflow tract arrhythmia using non-contact mapping. J Interv Card Electrophysiol. 2017;49:41-49.
Sasaki T, et al. Utility of distinctive local electrogram pattern and aortographic anatomical position in catheter manipulation at coronary cusps. J Cardiovasc Electrophysiol. 2011;22:521-529.
Hachiya H, et al. Discrete prepotential as an indicator of successful ablation in patients with coronary cusp ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2013;6:898-904.
Nagashima K, et al. Ventricular arrhythmias near the distal great cardiac vein challenging arrhythmia for ablation. Circ Arrhythm Electrophysiol. 2014;7:906-912.
Jauregui Abularach ME, et al. Ablation of ventricular arrhythmias arising near the anterior epicardial veins from the left sinus of Valsalva region: ECG features, anatomic distance, and outcome. Heart Rhythm. 2012;9:865-873.
Mountantonakis SE, et al. Ventricular arrhythmias from the coronary venous system: prevalence, mapping, and ablation. Heart Rhythm. 2015;12:1145-1153.
Proietti R, et al. Intracardiac echo-facilitated 3D electroanatomical mapping of ventricular arrhythmias from the papillary muscles: assessing the 'fourth dimension' during ablation. Europace. 2016;19:euw099.
Wo H-T, et al. Circumferential ablation at the base of the left ventricular papillary muscles: a highly effective approach for ventricular arrhythmias originating from the papillary muscles. Int J Cardiol. 2016;220:876-882.
Yamada T, et al. Prevalence and electrocardiographic and electrophysiological characteristics of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract. Circ Arrhythm Electrophysiol. 2016;9:e004079.
Chen H, et al. Intramural outflow tract ventricular tachycardia anatomy, mapping, and ablation. Circ Arrhythm Electrophysiol. 2014;7:978-981.
Yokokawa M, Morady F, Bogun F. Injection of cold saline for diagnosis of intramural ventricular arrhythmias. Heart Rhythm. 2015;13:78-82.
Yokokawa M, et al. Intramural idiopathic ventricular arrhythmias originating in the intraventricular septum mapping and ablation. Circ Arrhythm Electrophysiol. 2012;5:258-263.
Latchamsetty R, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clin Electrophysiol. 2015;1:116-123.
McDonnell K, Rhee E, Srivathsan K, et al. Novel utility of cryoablation for ventricular arrhythmias arising from the left aortic cusp near the left main coronary artery: a case series. Heart Rhythm. 2014;11:34-38.
Peachey Н, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014;ll:el66-el96.
Natale A, et al. Venice chart international consensus document on ventricular tachycardia/ventricular fibrillation ablation: special article. J Cardiovasc Electrophysiol. 2010;21:339-379.
Liang JJ, Prasad A, Cha Y-M. Temporal evolution and implications of ventricular arrhythmias associated with acute myocardial infarction. Cardiol Rev. 2013;21:289-294.
Gorenek B, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAP-CI Task Force. EuroIntervention. 2015;10:1095-1108.
Shenthar J, Deora S, Rai M, et al. Prolonged Tpeak-end and Tpeak-end/QT ratio as predictors of malignant ventricular arrhythmias in the acute phase of ST-segment elevation myocardial infarction: a prospective case-control study. Heart Rhythm. 2015;12: 484-489.
Hsieh CHC, et al. Evolution of ventricular tachycardia and its electrophysiological substrate early after myocardial infarction: an ovine model. Circ Arrhythm Electrophysiol. 2013;6:1010-1017.
Liuba I, et al. Scar progression in patients with nonischemic cardiomyopathy and ventricular arrhythmias. Heart Rhythm. 2014; 11:755-762.
Piers SRD, et al. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy implications for the ablation strategy. Circ Arrhythm Electrophysiol. 2013;6:875-883.
Proietti R, et al. A historical perspective on the role of functional lines of block in the re-entrant circuit of ventricular tachycardia. Pacing Clin Electrophysiol. 2016;39:490-496.
Haqqani HM, et al. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol. 2009;54:166-173.
Das MK, Scott LR, Miller JM. Focal mechanism of ventricular tachycardia in coronary artery disease. Heart Rhythm. 2010;7: 305-311.
Aldhoon B, et al. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease. Heart Rhythm. 2013;10:1622-1627.
Priori SG, Blomstrom-Lundqvist C, Mazzanti A. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;8:746-837.
Kusumoto FM, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014;64:1143-1177.
Piccini JP, et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012;126:41-49.
van der Weg K, et al. Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEM1. Int J Cardiol. 2015;195:136-142.
Majidi M, et al. Implications of ventricular arrhythmia 'bursts' with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury 'downstream of downstream'. Eur Heart J Acute Cardiovasc Care. 2015;4:51-59.
Bui AH, et al. Relationship between early and late nonsustained ventricular tachycardia and cardiovascular death in patients with acute coronary syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circ Arrhythm Electrophysiol. 2016;9: e002951.
Fordyce CB, et al. Long-term post-discharge risks in older survivors of myocardial infarction with and without out-of-hospital cardiac arrest. J Am Coll Cardiol. 2016;67:1981-1990.
Dagres N, Hindricks G. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? Eur Heart J. 2013;34:1964-1971.
Lerma C, Gorelick A, Ghanem RN, et al. Patterns of ectopy leading to increased risk of fatal or near-fatal cardiac arrhythmia in patients with depressed left ventricular function after an acute myocardial infarction. Europace. 2013;15:1304-1312.
Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guide. Circulation. 2013;127:e2 83-e352.
Verrier RL, et al. Elevated Т-Wave alternans predicts nonsustained ventricular tachycardia in association with percutaneous coronary intervention in st-segment elevation myocardial infarction (STEMI) patients. J Cardiovasc Electrophysiol. 2013; 24:658-663.
Au-Yeung WTM, et al. SCD-HeFT: use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. Heart Rhythm. 2015;12:2058-2066.
Disertori M, et al. Heart rate turbulence is a powerful predictor of cardiac death and ventricular arrhythmias in postmyocar-dial infarction and heart failure patients: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2016;9:e0046l0.
Rosengarten JA, Scott PA, Morgan JM. Fragmented QRS for the prediction of sudden cardiac death: a meta-analysis. Europace. 2015;17:969-977.
Jain R, Singh R, Yamini S, et al. Fragmented ECG as a risk marker in cardiovascular diseases. Curr Cardiol Rev. 2014;10:277-286.
Yalin K, et al. Infarct characteristics by CMR identifies substrate for monomorphic VT in post-MI patients with relatively preserved systolic function and NS-VT. Pacing Clin Electrophysiol. 2014;37: 447-453.
El Aidi H, et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol. 2014;63:1031-1045.
Reinstadler SJ, Thiele H, Eitel I. Risk stratification by cardiac magnetic resonance imaging after ST-elevation myocardial infarction. Curr Opin Cardiol. 2015;30:681-689.
Al-Ahmad A, Shenasa M, Shenasa H, et al. Incessant ventricular tachycardia and fibrillation: electrical storms. Card Electrophysiol Clin. 2014;6:613-621.
Remo BF, et al. Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. Heart Rhythm. 2014;11:541-546.
Vaseghi M, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;ll: 360-366.
Nedios S, et al. Electrical storm in patients with implantable cardioverter-defibrillator in the era of catheter ablation: implications for better rhythm control. Heart Rhythm. 2015;12:2419-2425.
Santangeli P, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552-1559.
Nair GM, Nery PB, Redpath CJ, et al. Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction. Curr Opin Cardiol. 2014;29:152-159.
Al-Khatib SM, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Heart Rhythm. 2017 Oct 26. [Epub ahead of print],
Mondesert B, et al. Impact of revascularization in patients with sustained ventricular arrhythmias, prior myocardial infarction and preserved left ventricular ejection fraction. Heart Rhythm. 2016;13:1221-1227.
Poole JE. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy. Circulation. 2014;129:383-394.
Russo AM, etal. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/ SCMR 2013 appropriate use criteria for implantable cardioverterdefibrillators and cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61:1318-1368.
Guerra F, et al. Implantable cardioverter-defibrillator programming and electrical storm: results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD). Heart Rhythm. 2016;13:1987-1992.
Katritsis DG, et al. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverterdefibrillators: meta-analysis of primary prevention trials. Heart Rhythm. 2013;10:200-206.
Epstein AE, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62:2000-2007.
Singh M, et al. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: a decade-long single-center experience. J Am Coll Cardiol. 2015;66:2607-2613.
Kron J, Ellenbogen KA. Life vest: sink or swim. Circ Arrhythm Electrophysiol. 2013;6:5-6.
Chung MK. The role of the wearable cardioverter defibrillator in clinical practice. Cardiol Clin. 2014;32:253-270.
Aliot EM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6:886-933.
Bunch TJ, et al. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm. 2014; 11:533-540.
Liang JJ, et al. Amiodarone discontinuation or dose reduction following catheter ablation for ventricular tachycardia in structural heart disease. JACC Clin Electrophysiol. 2017;3:503-511.
Patel D, et al. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease a systematic review and a meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2016;45:111-117.
Delacretaz E, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): an on-treatment analysis. J Cardiovasc Electrophysiol. 2013;24:525-529.
Tanawuttiwat T, Nazarian S, Calkins H. The role of catheter ablation in the management of ventricular tachycardia. Eur Heart J. 2016;37:594-609.
Dinov B, et al. Early referral for ablation of scar-related ventricular tachycardia is associated with improved acute and longterm outcomes: results from the Heart Center of Leipzig Ventricular Tachycardia Registry. Circ Arrhythm Electrophysiol. 2014;7:1144-1151.
De Riva M, et al. Reassessing noninducibility as ablation endpoint of post-infarction ventricular tachycardia. Circ Arrhythm Electrophysiol. 2015;8:853-862.
Kuck K-H, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease. Circ Arrhythm Electrophysiol. 2017; 10:e004422.
Kumar S, et al. Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail. Circ Arrhythm Electrophysiol. 2015; 8:606-615.
Kumar S, Tedrow UB, Stevenson WG. Adjunctive interventional techniques when percutaneous catheter ablation for drug refractory ventricular arrhythmias fail: a contemporary review. Circ Arrhythm Electrophysiol. 2017;10:e003676.
De Riva M, Watanabe M, Zeppenfeld K. Twelve-lead ECG of ventricular tachycardia in structural heart disease. Circ Arrhythm Electrophysiol. 2015;8:951-962.
Miller JM, Marchlinski FE, Buxton AE, et al. Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease. Circulation. 1988;77:759-766.
Segal OR, et al. A novel algorithm for determining endocardial VT exit site from 12-lead surface ECG characteristics in human, infarct-related ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:161-168.
Yokokawa M, et al. Automated analysis of the 12-lead electrocardiogram to identify the exit site of postinfarction ventricular tachycardia. Heart Rhythm. 2012;9:330-334.
Martinek M, Stevenson WG, Inada K, et al. QRS characteristics fail to reliably identify ventricular tachycardias that require epicardial ablation in ischemic heart disease. J Cardiovasc Electrophysiol. 2012;23:188-193.
Fernandez-Armenta J, Berruezo A. How to recognize epicardial origin of ventricular tachycardias? Curr Cardiol Rev. 2014;10: 246-256.
Di Biase L, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA Randomized Multicenter Trial. J Am Coll Cardiol. 2015;66:2872-2882.
Josephson ME. Programmed stimulation for risk stratification for postinfarction sudden cardiac arrest: why and how? Pacing Clin Electrophysiol. 2014;37:791-794.
Zaman S, et al. Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-segment-elevation myocardial infarction. Circ Arrhythm Electrophysiol. 2013;6:884-890.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: part I: concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36: 508-532.
Almendral J. Resetting and entrainment of reentrant arrhythmias: part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Vereckei A, Du ray G, Szenasi G, et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5:89-98.
Peichl P, Wichterle D, Cihak R, et al. Catheter ablation of ventricular tachycardia in the presence of an old endocavitary thrombus guided by intracardiac echocardiography. Pacing Clin Electrophysiol. 2016;39:581-587.
Rao HB, et al. Ventricular tachycardia ablation in the presence of left ventricular thrombus: safety and efficacy. J Cardiovasc Electrophysiol. 2016;27:453-459.
Hussein A, et al. Assessment of ventricular tachycardia scar substrate by intracardiac echocardiography. Pacing Clin Electrophysiol. 2014;37:412-421.
Njeim M, et al. Value of cardiac magnetic resonance imaging in patients with failed ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:183-189.
Komatsu Y, et al. Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythm Electrophysiol. 2013;6:342-350.
Stevens SM, et al. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverterdefibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping. Heart Rhythm. 2014;11:289-298.
Duell J, Dilsizian V, Smith M, et al. Nuclear imaging guidance for ablation of ventricular arrhythmias. Curr Cardiol Rep. 2016; 18:1-7.
Yamashita S, et al. Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia. Heart Rhythm. 2017;14:155-163.
Miller MA, et al. Percutaneous hemodynamic support with Im-pella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circ Arrhythm Electrophysiol. 2013;6:151-159.
Reddy YM, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation multicenter experience. Circ Arrhythm Electrophysiol. 2014;7:244-250.
Miller MA, Reddy VY. Percutaneous hemodynamic support during scar-ventricular tachycardia ablation is the juice worth the squeeze? Circ Arrhythm Electrophysiol. 2014;7:192-194.
Baratto F, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2016;9:e004492.
Mathuria N, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017;48:27-34.
Aryana A, et al. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm. 2014;ll: 1122-1130.
Anter E, Li J, Tschabrunn CM, et al. Mapping of a postinfarction left ventricular aneurysm-dependent macroreentrant ventricular tachycardia. HeartRhythm Case Rep. 2015;1:472-476.
Nayyar S, et al. High-density mapping of ventricular scar: a comparison of ventricular tachycardia (VT) supporting channels with channels that do not support VT. Circ Arrhythm Electrophysiol. 2014;7:90-98.
Yamashita S, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythm Electrophysiol. 2016;9: e003901.
Yokokawa M, et al. Reasons for recurrent ventricular tachycardia after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2013;61:66-73.
Das M, et al. Temporal-component analysis of diastolic electrograms in ventricular tachycardia differentiates non-vulnerable regions of the circuit. Heart Rhythm. 2015;12:1737-1744.
Derejko P, et al. Effect of the restitution properties of cardiac tissue on the repeatability of entrainment mapping response. Circ Arrhythm Electrophysiol. 2014;7:497-504.
Wong KCK, Rajappan K, Bashir Y, et al. Entrainment with long postpacing intervals from within the flutter circuit: what is the mechanism? Circ Arrhythm Electrophysiol. 2012;5:e90-e92.
Tokuda M, et al. Characteristics of clinical and induced ventricular tachycardia throughout multiple ablation procedures. J Cardiovasc Electrophysiol. 2016;27:88-94.
Berte B, et al. Characterization of the left-sided substrate in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8:1403-1412.
Irie T, et al. Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mapping. Circ Arrhythm Electrophysiol. 2015;8:390-399.
Baldinger SH, et al. Electrogram analysis and pacing are complimentary for recognition of abnormal conduction and farfield potentials during substrate mapping of infarct-related ventricular tachycardia. Circ Arrhythm Electrophysiol. 2015; 8:874-881.
Tsiachris D, et al. Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2015;8: 863-873.
Komatsu Y, et al. Electrophysiologic characterization of local abnormal ventricular activities in postinfarction ventricular tachycardia with respect to their anatomic location. Heart Rhythm. 2013;10:1630-1637.
Acosta J, et al. Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy. Heart Rhythm. 2016;13:85-95.
Tschabrunn CM, et al. High-resolution mapping of ventricular scar. Circ Arrhythm Electrophysiol. 2016;9:e003841.
Silberbauer J, et al. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7:424-435.
Anter E, Josephson ME. Bipolar voltage amplitude: what does it really mean? Heart Rhythm. 2016;13:326-327.
Josephson ME, Anter E. Substrate mapping for ventricular tachycardia assumptions and misconceptions. JACC Clin Electrophysiol. 2015;1:341-352.
Gianni C, Natale A. Voltage mapping for ventricular tachycardia ablation: we can work it out. Heart Rhythm. 2016;13:2003.
Tung R, Josephson ME, Bradfield JS, et al. Directional influences of ventricular activation on myocardial scar characterization: voltage mapping with multiple wavefronts during ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2016;9.
Mountantonakis SE, et al. Relationship between voltage map 'channels' and the location of critical isthmus sites in patients with post-infarction cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2013;61:2088-2095.
Makimoto H, et al. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol. 2015;38:630-640.
Komatsu Y, et al. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia. J Am Coll Cardiol. 2014;63:1416-1426.
Yoshiga Y, et al. Correlation between substrate location and ablation strategy in patients with ventricular tachycardia late after myocardial infarction. Heart Rhythm. 2012;9:1192-1199.
Kosmidou I, et al. Role of repeat procedures for catheter ablation of postinfarction ventricular tachycardia. Heart Rhythm. 201l;8: 1516-1522.
Izquierdo M, et al. Endo-epicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease. Circ Arrhythm Electrophysiol. 2015;8:882-889.
Marchlinski FE, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial. J Am Coll Cardiol. 2016; 67:674-683.
Tung R, Kottkamp H. A moving target for catheter ablation of ventricular tachycardia ablation of scar or arrhythmia? J Am Coll Cardiol. 2015;66:2883-2885.
Berruezo A, et al. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol. 2015;8:326-336.
Santangeli P, Frankel DS, Marchlinski FE. End points for ablation of scar-related ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7:949-960.
Tzou WS, et al. Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias. Circ Arrhythm Electrophysiol. 2015;8:353-361.
Proietti R, Roux J-F, Essebag V. Recent advances in ablation of ventricular tachycardia associated with structural heart disease. Curr Opin Cardiol. 2016;31:64-71.
Ghanbari H, et al. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes a meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:677-683.
Yokokawa M, et al. Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2015;65:1954-1959.
Kumar S, et al. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm. 2016;13:1957-1963.
Kumar S, et al. Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1437-1447.
Tung R, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study. Heart Rhythm. 2015; 12:1997-2007.
Sapp JL, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;275:111-121.
Siontis КС, et al. Prognostic impact of the timing of recurrence of infarct-related ventricular tachycardia after catheter ablation. Circ Arrhythm Electrophysiol. 2016;9:e004432.
Santangeli P, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68-75.
Santangeli P, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68-75.
Katz DF, et al. Safety of ventricular tachycardia ablation in clinical practice. Circ Arrhythm Electrophysiol. 2015;8:362-370.
Yu R, et al. Catheter ablation of scar-based ventricular tachycardia: relationship of procedure duration to outcomes and hospital mortality. Heart Rhythm. 2015;12:86-94.
Surawicz В, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee. Circulation. 2009;119:e235-e240.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Yadav AV, et al. Utility of conventional electrocardiographic criteria in patients with idiopathic ventricular tachycardia. JACC Clin Electrophysiol. 2017;3:669-677.
Datino Romaniega T, et al. Specificity of electrocardiographic criteria for the differential diagnosis of wide QRS complex tachycardia in patients with intraventricular conduction defect. Heart Rhythm. 2013;10:1393-1401.
Das MK, Rajdev A, Kalra V. Wide complex tachycardia. Card Electrophysiol Clin. 2014;6:511-523.
Tzogias L, et al. Electrocardiographic features and prevalence of bilateral bundle-branch delay. Circ Arrhythm Electrophysiol. 2014; 7:640-644.
Josephson ME, Wellens HJJ. The ECG in left bundle branch block and heart failure. Heart Rhythm. 2015;12:250-251.
Galeotti L, van Dam PM, Loring Z, et al. Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations. Europace. 2013;15:1816-1821.
Datino T, et al. Rate-related changes in QRS morphology in patients with fixed bundle branch block: implications for differential diagnosis of wide QRS complex tachycardia. Eur Heart J. 2008;29:2351-2358.
Blomstrom-Lundqvist C, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias — executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology. Circulation. 2003;108:1871-1909.
Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83:1649-1659.
Jastrzebski M, Kukla P, Czarnecka D, et al. Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace. 2012;14:1165-1171.
Vereckei A, Duray G, Szenasi G, et al. Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia. Eur Heart J. 2007;28:589-600.
Dendi R, Josephson ME. A new algorithm in the differential diagnosis of wide complex tachycardia. Eur Heart J. 2007;28:525-526.
Vereckei A. Current algorithms for the diagnosis of wide QRS complex tachycardias. Curr Cardiol Rev. 2014;10:262-276.
Vereckei A, Duray G, Szenasi G, et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5:89-98.
Pava LF, et al. R-wave peak time at Dll: a new criterion for differentiating between wide complex QRS tachycardias. Heart Rhythm. 2010;7:922-926.
Foreman JR, Steinberg LA, Prystowsky EN, et al. Mechanism of a wide QRS complex tachycardia with variable atrial, His, and ventricular relationships. Circ Arrhythmia Electrophysiol. 2015;8: 981-984.
Abdelwahab A, et al. A technique for the rapid diagnosis of wide complex tachycardia with 1:1 AV relationship in the electrophysiology laboratory. Pacing Clin Electrophysiol. 2009;32:475-483.
Badhwar N, Scheinman MM. Electrophysiological diagnosis of wide complex tachycardia: Editorial. Pacing Clin Electrophysiol. 2009;32:473-474.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Porter MJ, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;l: 393-396.
Gonzalez-Torrecilla E, et al. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol. 2009; 53:2353-2358.
Hillock RJ, Kalman JM, Roberts-Thomson КС, et al. Multiple focal atrial tachycardias in a healthy adult population: characterization and description of successful radiofrequency ablation. Heart Rhythm. 2007;4:435-438.
Brembilla-Perrot B, Delobelle J. Prevalence of stroke among patients with paroxysmal supraventricular tachycardia. Pacing Clin Electrophysiol. 2013;36:180-186.
Medi C, et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009;53:1791-1797.
Pablo Costabel J, et al. High-sensitivity cardiac troponin levels in supraventricular tachyarrhythmias. Pacing Clin Electrophysiol. 2016;39:588-591.
Liu CF, et al. Unifying algorithm for mechanistic diagnosis of atrial tachycardia. Circ Arrhythm Electrophysiol. 2016;9:e004028.
Mills MF, et al. Is there a difference in tachycardia cycle length during SVT in children with AVRT and AVNRT ? Pacing Clin Electrophysiol. 2016;39:1206-1212.
Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation. 2010;122:831-840.
Castillo Castillo J, Penafiel Verdu P, Martinez Sanchez J, et al. Narrow irregular QRS tachycardia with AV dissociation: what is the mechanism? J Cardiovasc Electrophysiol. 2013;24:364-366.
Issa ZF. Mechanism of paroxysmal supraventricular tachycardia with ventriculoatrial conduction block. Europace. 2009;1l: 1235-1237.
Lim PCY, et al. Paroxysmal supraventricular tachycardia with ventriculoatrial block and qrs duration shortening: what is the mechanism? J Cardiovasc Electrophysiol. 2016;27:616-617.
Yang Y, et al. Quantitative effects of functional bundle branch block in patients with atrioventricular reentrant tachycardia. Am J Cardiol. 2000;85:826-831.
Wright JM, Singh D, Price A, et al. Two cases of supraventricular tachycardia after accessory pathway ablation. Circ Arrhythm Electrophysiol. 2013;6:26-31.
Derval N, et al. Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction. Heart Rhythm. 2013;10:1785-1791.
Kapa S, et al. Utilization of retrograde right bundle branch block to differentiate atrioventricular nodal from accessory pathway conduction. J Cardiovasc Electrophysiol. 2009;20:751-758.
Nakagawa H, Jackman WM. Para-Hisian pacing: useful clinical technique to differentiate retrograde conduction between accessory atrioventricular pathways and atrioventricular nodal pathways. Heart Rhythm. 2005;2:667-672.
Sauer WH, Lowery CM, Cooper JM, et al. Sequential dual chamber extrastimulation: a novel pacing maneuver to identify the presence of a slowly conducting concealed accessory pathway. Heart Rhythm. 2008;5:248-252.
Obeyesekere M, et al. Tachycardia induction with ventricular extrastimuli differentiates atypical atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2012;9:335-341.
Knight BP, et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2000;36:574-582.
Nagashima K, et al. Ventriculoatrial intervals <70 ms in orthodromic atrioventricular reciprocating tachycardia. Pacing Clin Electrophysiol. 2016;39:1108-1115.
Crawford TC, et al. Utility of atrial and ventricular cycle length variability in determining the mechanism of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:698-703.
Efimova E, et al. Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast atrioventricular nodal reentrant tachycardia: a prospective study. Heart Rhythm. 2014;11:871-876.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Maruyama M, et al. The VA relationship after differential atrial overdrive pacing: a novel tool for the diagnosis of atrial tachycardia in the electrophysiologic laboratory. J Cardiovasc Electrophysiol. 2007;18:1127-1133.
Calvo D, et al. Differential responses of the septal ventricle and the atrial signals during ongoing entrainment. Circ Arrhythm Electrophysiol. 2015;8:1201-1209.
Ho RT, Frisch DR, Pavri BB, et al. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias. Circ Arrhythm Electrophysiol. 2013;6:597-605.
Boyle PM, Veenhuyzen GD, Vigmond EJ. Fusion during entrainment of orthodromic reciprocating tachycardia is enhanced for basal pacing sites but diminished when pacing near Purkinje system end points. Heart Rhythm. 2013;10:444-451.
Almendral J. Resetting and entrainment of reentrant arrhythmias: part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Akerstrom F, et al. Performance of the SA-VA difference to differentiate atrioventricular nodal reentrant tachycardia from orthodromic reentrant tachycardia in a large cohort of consecutive patients. Pacing Clin Electrophysiol. 2015;38:1066-1072.
Gonzalez-Torrecilla E, et al. Differences in ventriculoatrial intervals during entrainment and tachycardia: a simpler method for distinguishing paroxysmal supraventricular tachycardia with long ventriculoatrial intervals. J Cardiovasc Electrophysiol. 2011; 22:915-921.
Platonov M, Schroeder K, Veenhuyzen GD. Differential entrainment: beware from where you pace. Heart Rhythm. 2007;4:1097-1099.
Kannankeril PJ, Bonney WJ, Dzurik MV, et al. Entrainment to distinguish orthodromic reciprocating tachycardia from atrioventricular nodal reentry tachycardia in children. Pacing Clin Electrophysiol. 2010;33:469-474.
Gonzalez-Torrecilla E, et al. First postpacing interval after tachycardia entrainment with correction for atrioventricular node delay: a simple maneuver for differential diagnosis of atrioventricular nodal reentrant tachycardias versus orthodromic reciprocating tachycardias. Heart Rhythm. 2006;3:674-679.
Boonyapisit W, et al. Determining the site of accessory pathways in orthodromic reciprocating tachycardia by using the response to right ventricular pacing. Pacing Clin Electrophysiol. 2015;39: 115-121.
Javier Garcia-Fernandez F, et al. Differentiation of atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia by the resetting response to ventricular extrastimuli: comparison to response to continuous ventricular pacing. J Cardiovasc Electrophysiol. 2013;24:534-541.
Segal OR, et al. Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2009;6:493-500.
Nagashima K, et al. Anterograde conduction to the His bundle during right ventricular overdrive pacing distinguishes septal pathway atrioventricular reentry from atypical atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2015;12:735-743.
Kaiser DW, et al. The precise timing of tachycardia entrainment is determined by the postpacing interval, the tachycardia cycle length, and the pacing rate: theoretical insights and practical applications. Heart Rhythm. 2016;13:695-703.
Dandamudi G, et al. A novel approach to differentiating orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2010;7:1326-1329.
Rosman JZ, et al. Resetting criteria during ventricular overdrive pacing successfully differentiate orthodromic reentrant tachycardia from atrioventricular nodal reentrant tachycardia despite interobserver disagreement concerning QRS fusion. Heart Rhythm. 2011;8:2-7.
AlMahameed ST, Buxton AE, Michaud GF. New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010;3:578-584.
Vijayaraman P, Lee BP, Kalahasty G, et al. Reanalysis of the 'pseudo A-A-V' response to ventricular entrainment of supraventricular tachycardia: importance of His-bundle timing. J Cardiovasc Electrophysiol. 2006;17:25-28.
Perez-Rod on J, et al. Entrainment from the para-Hisian region for differentiating atrioventricular node reentrant tachycardia from orthodromic atrioventricular reentrant tachycardia. Europace. 2008;10:1205-1211.
Singh DK, et al. His overdrive pacing during supraventricular tachycardia: a novel maneuver for distinguishing atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia. Heart Rhythm. 2014;11:1327-1335.
Bhatia A, Sra J, Akhtar М. Preexcitation syndromes. Curr Probl Cardiol. 2016;41:99-137.
Benditt DG, Lu F. Atriofascicular pathways: fuzzy nomenclature or merely wishful thinking? J Cardiovasc Electrophysiol. 2006; 17:261-265.
Sternick EB, et al. The atrioventricular interval during pre-excited tachycardia: a simple way to distinguish between decrementally or rapidly conducting accessory pathways. Heart Rhythm. 2009;6: 1351-1358.
Kothari S, et al. Atriofascicular pathways: where to ablate? Pacing Clin Electrophysiol. 2006;29:1226-1233.
Sternick EB, et al. Short atrioventricular Mahaim fibers: observations on their clinical, electrocardiographic, and electrophysiologic profile. J Cardiovasc Electrophysiol. 2005;16:127-134.
Sternick EB, et al. Postablation-acquired short atrioventricular Mahaim-type fibers: observations on their clinical, electrocardiographic, and electrophysiologic profile. Heart Rhythm. 2012;9: 850-858.
Sternick ЕВ, et al. Electrocardiogram during tachycardia in patients with anterograde conduction over a Mahaim fiber: old criteria revisited. Heart Rhythm. 2004;1:406-413.
Sternick EB, et al. Effects of right bundle branch block on the antidromic circus movement tachycardia in patients with presumed atriofascicular pathways. J Cardiovasc Electrophysiol. 2006;17: 256-260.
Lapage MJ, Walsh MJ, Reed JH, et al. Adenosine mapping for adenosine-dependent accessory pathway ablation. Pacing Clin Electrophysiol. 2014;37:610-615.
Monnig G, et al. Predictors of long-term success after catheter ablation of atriofascicular accessory pathways. Heart Rhythm. 2012;9:704-708.
Ozturk E, et al. Electroanatomic mapping guided cryoablation of mahaim pathways in children with limited fluoroscopy exposure. Pacing Clin Electrophysiol. 2015;38:362-367.
Hoffmayer KS, et al. Variable clinical features and ablation of manifest nodofascicular/ventricular pathways. Circ Arrhythm Electrophysiol. 2015;8:117-127.
Modi S, Foster W, Todd DM, et al. Postoperative wide complex tachycardia: an alternative hypothesis. Heart Rhythm. 2012;10: 305-307.
Ali H, et al. Nodo- and fasciculoventricular pathways: electrophysiological features and a proposed diagnostic algorithm for preexcitation variants. Heart Rhythm. 2015;12:1677-1682.
Ho RT, et al. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias. Circ Arrhythm Electrophysiol. 2013;6:597-605.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Brembilla-Perrot B, et al. Incidence and prognostic significance of spontaneous and inducible antidromic tachycardia. Europace. 2013; 15:871-876.
Kang KT, et al. Permanent junctional reciprocating tachycardia in children: a multicenter experience. Heart Rhythm. 2014;11:1426-1432.
Bunch TJ, et al. Long-term natural history of adult Wolff-Parkinson-White syndrome patients treated with and without catheter ablation. Circ Arrhythmia Electrophysiol. 2015;8:1465-1471.
Cohen MI, et al. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern. Heart Rhythm. 2012;9:1006-1024.
Cain N, Irving C, Webber S, et al. Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol. 2013;112:961-965.
Obeyesekere MN, et al. Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis. Circulation. 2012;125:2308-2315.
Huang SY, et al. Gender differences of electrophysiologic characteristics in patients with accessory atrioventricular pathways. Heart Rhythm. 2011;8:571-574.
Kim SS, Knight BP. Long term risk of Wolff-Parkinson-White pattern and syndrome. Trends Cardiovasc Med. 2017;27:260-268.
Lalani SR, et al. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet. 2009;46:168-175.
Brembilla-Perrot B, et al. Age-related prognosis of syncope associated with a preexcitation syndrome. Pacing Clin Electrophysiol. 2013;36:803-810.
Mah DY, et al. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol. 2013;36:1117-1123.
Kiger ME, et al. Intermittent versus persistent Wolff-Parkinson-White Syndrome in children: electrophysiologic properties and clinical outcomes. Pacing Clin Electrophysiol. 2015;39:14-20.
Czosek RJ, Anderson J, Cassedy A, et al. Cost-effectiveness of various risk stratification methods for asymptomatic ventricular pre-excitation. Am J Cardiol. 2013;112:245-250.
Al-Khatib SM, et al. Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Circulation. 2016;133:e575-e586.
Cohen M, Triedman J. Guidelines for management of asymptomatic ventricular pre-excitation brave new world or Pandora's box? Circ Arrhythmia Electrophysiol. 2014;7:187-189.
Chevalier P, et al. Prophylactic radiofrequency ablation in asymptomatic patients with Wolff-Parkinson-White is not yet a good strategy: a decision analysis. Circ Arrhythmia Electrophysiol. 2013; 6:185-190.
Kubus P, Vit P, Gebauer RA, et al. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ Arrhythmia Electrophysiol. 2014;7:218-223.
Zipes DP, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e315-e325.
Rivera S, et al. The retrograde P-wave theory: explaining ST segment depression in supraventricular tachycardia by retrograde AV node conduction. Pacing Clin Electrophysiol. 2014;37:1100-1105.
Maden O, et al. Comparison of the accuracy of three algorithms in predicting accessory pathways among adult Wolff-Parkinson-White syndrome patients. J Interv Card Electrophysiol. 2015;44: 213-219.
Taguchi N, et al. A simple algorithm for localizing accessory pathways in patients with Wolff-Parkinson-White syndrome using only the R/S ratio. J Arrhythmia. 2014;30:439-443.
Tai C-T, et al. A new electrocardiographic algorithm using retrograde P waves for differentiating atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway. J Am Coll Cardiol. 1997;29: 394-402.
Fitzgerald DM, Hawthorne HR, Crossley GH, et al. P wave morphology during atrial pacing along the atrioventricular ring. ECG localization of the site of origin of retrograde atrial activation. J Electrocardiol. 1996;29:1-10.
Capone CA, et al. Three-catheter technique for ablation of left-sided accessory pathways in Wolff-Parkinson-White is less expensive and equally successful when compared to a five-catheter technique. Pacing Clin Electrophysiol. 2015;38:1405-1411.
Wright JM, Singh D, Price A, et al. Two cases of supraventricular tachycardia after accessory pathway ablation. Circ Arrhythm Electrophysiol. 2013;6:26-31.
Kapa S, et al. Utilization of retrograde right bundle branch block to differentiate atrioventricular nodal from accessory pathway conduction. J Cardiovasc Electrophysiol. 2009;20:751-758.
Derval N, et al. Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction. Heart Rhythm. 2013;10:1785-1791.
Nakagawa H, Jackman WM. Para-Hisian pacing: useful clinical technique to differentiate retrograde conduction between accessory atrioventricular pathways and atrioventricular nodal pathways. Heart Rhythm. 2005;2:667-672.
Sauer WH, Lowery CM, Cooper JM, et al. Sequential dual chamber extrastimulation: a novel pacing maneuver to identify the presence of a slowly conducting concealed accessory pathway. Heart Rhythm. 2008;5:248-252.
Obeyesekere M, et al. Tachycardia induction with ventricular extrastimuli differentiates atypical atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2012;9:335-341.
Knight BP, et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2000;36:574-582.
Nagashima K, et al. Ventriculoatrial intervals <70 ms in orthodromic atrioventricular reciprocating tachycardia. Pacing Clin Electrophysiol. 2016;39:1108-1115.
Yang Y, et al. Quantitative effects of functional bundle branch block in patients with atrioventricular reentrant tachycardia. Am J Cardiol. 2000;85:826-831.
Crawford TC, et al. Utility of atrial and ventricular cycle length variability in determining the mechanism of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:698-703.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Maruyama M, et al. The VA relationship after differential atrial overdrive pacing: a novel tool for the diagnosis of atrial tachycardia in the electrophysiologic laboratory. J Cardiovasc Electrophysiol. 2007;18:1127-1133.
Calvo D, et al. Differential responses of the septal ventricle and the atrial signals during ongoing entrainment. Circ Arrhythm Electrophysiol. 2015;8:1201-1209.
Verma N, Knight BP. Ventricular overdrive pacing: beyond V-A-V and V-A-A-V. Pacing Clin Electrophysiol. 2015;39:2015-2016.
Ho RT, Frisch DR, Pavri BB, et al. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias. Circ Arrhythm Electrophysiol. 2013;6:597-605.
Boyle PM, Veenhuyzen GD, Vigmond EJ. Fusion during entrainment of orthodromic reciprocating tachycardia is enhanced for basal pacing sites but diminished when pacing near Purkinje system end points. Heart Rhythm. 2013;10:444-451.
Akerstrom F, et al. Performance of the SA-VA difference to differentiate atrioventricular nodal reentrant tachycardia from orthodromic reentrant tachycardia in a large cohort of consecutive patients. Pacing Clin Electrophysiol. 2015;38:1066-1072.
Gonzalez-Torrecilla E, et al. Differences in ventriculoatrial intervals during entrainment and tachycardia: a simpler method for distinguishing paroxysmal supraventricular tachycardia with long ventriculoatrial intervals. J Cardiovasc Electrophysiol. 2011;22:915-921.
Platonov M, Schroeder K, Veenhuyzen GD. Differential entrainment: beware from where you pace. Heart Rhythm. 2007;4:1097-1099.
Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation. 2010;122:831-840.
Kannankeril PJ, Bonney WJ, Dzurik MV, et al. Entrainment to distinguish orthodromic reciprocating tachycardia from atrioventricular nodal reentry tachycardia in children. Pacing Clin Electrophysiol. 2010;33:469-474.
Gonzalez-Torrecilla E, et al. First postpacing interval after tachycardia entrainment with correction for atrioventricular node delay: a simple maneuver for differential diagnosis of atrioventricular nodal reentrant tachycardias versus orthodromic reciprocating tachycardias. Heart Rhythm. 2006;3:674-679.
Boonyapisit W, et al. Determining the site of accessory pathways in orthodromic reciprocating tachycardia by using the response to right ventricular pacing. Pacing Clin Electrophysiol. 2015;39:115-121.
Javier Garcia-Fernandez F, et al. Differentiation of atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia by the resetting response to ventricular extrastimuli: comparison to response to continuous ventricular pacing. J Cardiovasc Electrophysiol. 2013;24:534-541.
Segal OR, et al. Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2009;6:493-500.
Nagashima K, et al. Anterograde conduction to the His bundle during right ventricular overdrive pacing distinguishes septal pathway atrioventricular reentry from atypical atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2015;12:735-743.
Dandamudi G, et al. A novel approach to differentiating orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2010;7:1326-1329.
AlMahameed ST, Buxton AE, Michaud GF. New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010;3:578-584.
Akerstrom F, et al. Number of beats in the transition zone with fixed SA interval during right ventricular overdrive pacing determines accessory pathway location in orthodromic reentrant tachycardia. Pacing Clin Electrophysiol. 2015;39:21-27.
Perez-Rodon J, et al. Entrainment from the para-Hisian region for differentiating atrioventricular node reentrant tachycardia from orthodromic atrioventricular reentrant tachycardia. Europace. 2008;10:1205-1211.
Spotnitz MD, et al. Mechanisms and clinical significance of adenosine-induced dormant accessory pathway conduction after catheter ablation. Circ Arrhythm Electrophysiol. 2014;7:1136-1143.
Dai-Bianco JP, Levine RA. Anatomy of the mitral valve apparatus. Role of 2D and 3D echocardiography. Cardiol Clin. 2013;31:151-164.
Kim J. Anatomical discrepancy between the coronary sinus and the mitral annulus by fluoroscopy. 2016;17:14-19.
Chen M, et al. Right-sided free wall accessory pathway refractory to conventional catheter ablation: lessons from 3-dimensional electroanatomic mapping. J Cardiovasc Electrophysiol. 2010;21: 1317-1324.
Ho SY. Accessory atrioventricular pathways: getting to the origins. Circulation. 2008;117:1502-1504.
Fishberger SB, Hernandez A, Zahn EM. Electroanatomic mapping of the right coronary artery: a novel approach to ablation of right free-wall accessory pathways. J Cardiovasc Electrophysiol. 2009;20: 526-529.
Lee P-C, Chen S-A, Hwang B. Atrioventricular node anatomy and physiology: implications for ablation of atrioventricular nodal reentrant tachycardia. Curr Opin Cardiol. 2009;24:105-112.
Kurian T, Ambrosi C, Hucker W, et al. Anatomy and electrophysiology of the human AV node. Pacing Clin Electrophysiol. 201033:754-762.
Gonzalez-Torrecilla E, et al. Reappraisal of classical electrocardiographic criteria in detecting accessory pathways with a strict paraHisian location. Heart Rhythm. 2013;10:16-21.
DeMazumder D, Barcelon B, Cockrell J, et al. Ablation of an anteroseptal accessory pathway from the aortic root using electroanatomic mapping. Heart Rhythm. 2014;11:2122-2123.
Wilsmore BR, Tchou PJ, Kanj M, et al. Catheter ablation of an unusual decremental accessory pathway in the left coronary cusp of the aortic valve mimicking outflow tract ventricular tachycardia. Circ Arrhythm Electrophysiol. 2012;5:104-108.
Tanidir IC, et al. Cryoablation with an 8-mm-tip catheter for rightsided accessory pathways in children. Pacing Clin Electrophysiol. 2016;39:797-804.
Karadeniz C, Akdeniz C, Turan O, et al. Cryoablation of septal accessory pathways in children: midterm results. Pacing Clin Electrophysiol. 2014;37:1095-1099.
Collins KK. Cryoablation, limited fluoroscopy, and more. Pacing Clin Electrophysiol. 2014;37:1093-1094.
Swissa M, et al. Cryotherapy ablation of parahisian accessory pathways in children. Heart Rhythm. 2015;12:917-925.
Pap R, et al. Ablation of posteroseptal and left posterior accessory pathways guided by left atrium-coronary sinus musculature activation sequence. J Cardiovasc Electrophysiol. 2008;19:653-658.
Haghjoo M, et al. Electrocardiographic and electrophysiologic predictors of successful ablation site in patients with manifest posteroseptal accessory pathway. Pacing Clin Electrophysiol. 2008; 31:103-111.
Macedo PG, Patel SM, Bisco SE, et al. Septal accessory pathway: anatomy, causes for difficulty, and an approach to ablation. Indian Pacing Electrophysiol J. 2010;10:292-309.
Scanavacca MI, et al. Accessory atrioventricular pathways refractory to catheter ablation: role of percutaneous epicardial approach. Circ Arrhythm Electrophysiol. 2015;8:128-136.
Habib A, Lachman N, Christensen KN, et al. The anatomy of the coronary sinus venous system for the cardiac electrophysiologist. Europace. 2009;! 1 (suppl 5):v15-v2l.
Mah D, et al. Epicardial left atrial appendage and biatrial appendage accessory pathways. Heart Rhythm. 2010;7:1740-1745.
Stavrakis S, et al. Risk of coronary artery injury with radiofrequency ablation and cryoablation of epicardial posteroseptal accessory pathways within the coronary venous system. Circ Arrhythm Electrophysiol. 2014;7:113-119.
Mao J, et al. Catheter ablation of accessory pathways near the coronary sinus: value of defining coronary arterial anatomy. Heart Rhythm. 2015;12:508-514.
Lapage MJ, Walsh MJ, Reed JH, et al. Adenosine mapping for adenosine-dependent accessory pathway ablation. Pacing Clin Electrophysiol. 2014;37:610-615.
Roberts-Thomson КС, et al. Coronary artery injury due to catheter ablation in adults: presentations and outcomes. Circulation. 2009;120: 1465-1473.
Dobrzynski Н, et al. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Then 2013;139:260-288.
Lee Р-С, Chen S-A, Hwang В. Atrioventricular node anatomy and physiology: implications for ablation of atrioventricular nodal reentrant tachycardia. Curr Opin Cardiol. 2009;24:105-112.
Kurian T, Ambrosi C, Hucker W, et al. Anatomy and electrophysiology of the human AV node. Pacing Clin Electrophysiol. 2010;33: 754-762.
Faletra FF, Ho SY, Auricchio A. Anatomy of right atrial structures by real-time 3D transesophageal echocardiography. JACC Cardiovasc Imaging. 2010;3:966-975.
Yamaguchi T, et al. Anatomical and electrophysiological variations of Koch's triangle and the impact on the slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia: a study using 3D mapping. J Interv Card Electrophysiol. 2013;37:111-120.
Mani BC, Pavri BB. Dual atrioventricular nodal pathways physiology: a review of relevant anatomy, electrophysiology, and electrocardiographic manifestations. Indian Pacing Electrophysiol J. 2014;14:12-25.
Katritsis DG, et al. Coexistent types of atrioventricular nodal reentrant tachycardia. Circ Arrhythm Electrophysiol. 2015;8:1189-1193.
Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation. 2010;122:831-840.
Efimova E, et al. Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast atrioventricular nodal reentrant tachycardia: a prospective study. Heart Rhythm. 2014;1l: 871-876.
Katritsis DG, Josephson ME. Classification of electrophysiological types of atrioventricular nodal re-entrant tachycardia: a reappraisal. Europace. 2013;15:1231-1240.
Suzuki A, et al. Visualization of the antegrade fast and slow pathway inputs in patients with slow-fast atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol. 2014;37:874-883.
Nakatani Y, et al. Electrophysiological and anatomical differences of the slow pathway between the fast-slow form and slow-slow form of atrioventricular nodal reentrant tachycardia. Europace. 2014;16:551-557.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Gonza'lez-Torrecilla E, et al. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol. 2009;53: 2353-2358.
Hoffmann BA, et al. Ablation of atrioventricular nodal reentrant tachycardia in the elderly: results from the German Ablation Registry. Heart Rhythm. 2011;8:981-987.
Park JS, Hwang H, Joung B, et al. Clinical and electrophysiologic characteristics before and after radiofrequency ablation of sustained slow atrioventricular nodal pathway conduction. JACC Clin Electrophysiol. 2016;2:367-374.
Nakatani Y, et al. Differentiation of slow-slow form of AVNRT from AVRT through a posteroseptal accessory pathway by retrograde P-wave amplitude. Pacing Clin Electrophysiol. 2016;39:241-249.
Mendenhall GS, Voigt A, Saba S. Insights into atrioventricular nodal function from patients displaying dual conduction properties: interactive and orthogonal pathways. Circ Arrhythm Electrophysiol. 2013;6:364-370.
Derval N, et al. Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction. Heart Rhythm. 2013;10:1785-1791.
Obeyesekere M, et al. Tachycardia induction with ventricular extrastimuli differentiates atypical atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2012;9:335-341.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Akerstrom F, et al. Performance of the SA-VA difference to differentiate atrioventricular nodal reentrant tachycardia from orthodromic reentrant tachycardia in a large cohort of consecutive patients. Pacing Clin Electrophysiol. 2015;38:1066-1072.
Gonzalez-Torrecilla E, et al. Differences in ventriculoatrial intervals during entrainment and tachycardia: a simpler method for distinguishing paroxysmal supraventricular tachycardia with long ventriculoatrial intervals. J Cardiovasc Electrophysiol. 2011;22: 915-921.
Gonzalez-Torrecilla E, et al. First postpacing interval after tachycardia entrainment with correction for atrioventricular node delay: a simple maneuver for differential diagnosis of atrioventricular nodal reentrant tachycardias versus orthodromic reciprocating tachycardias. Heart Rhythm. 2006;3:674-679.
Kannankeril PJ, Bonney WJ, Dzurik MV, et al. Entrainment to distinguish orthodromic reciprocating tachycardia from atrioventricular nodal reentry tachycardia in children. Pacing Clin Electrophysiol. 2010;33:469-474.
Javier Garcia-Fernandez F, et al. Differentiation of atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia by the resetting response to ventricular extrastimuli: comparison to response to continuous ventricular pacing. J Cardiovasc Electrophysiol. 2013;24:534-541.
Nagashima K, et al. Anterograde conduction to the His bundle during right ventricular overdrive pacing distinguishes septal pathway atrioventricular reentry from atypical atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2015;12:735-743.
Segal OR, et al. Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2009;6:493-500.
Dandamudi G, et al. A novel approach to differentiating orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2010;7:1326-1329.
AlMahameed ST, Buxton AE, Michaud GF. New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol. 2010;3: 578-584.
Vijayaraman P, Lee BP, Kalahasty G, et al. Reanalysis of the 'pseudo A-A-V' response to ventricular entrainment of supraventricular tachycardia: importance of his-bundle timing. J Cardiovasc Electrophysiol. 2006;17:25-28.
Singh DK, et al. His overdrive pacing during supraventricular tachycardia: a novel maneuver for distinguishing atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia. Heart Rhythm. 2014;11:1327-1335.
Pe'rez-Rodon J, et al. Entrainment from the para-Hisian region for differentiating atrioventricular node reentrant tachycardia from orthodromic atrioventricular reentrant tachycardia. Europace. 2008;10:1205-1211.
Padanilam BJ, et al. Differentiating junctional tachycardia and atrioventricular node re-entry tachycardia based on response to atrial extrastimulus pacing. J Am Coll Cardiol. 2008;52:1711-1717.
Ho RT, Pietrasik G, Greenspon AJ. A narrow complex tachycardia with intermittent atrioventricular dissociation: What is the mechanism? Heart Rhythm. 2014;11:2116-2119.
Fan R, et al. Novel use of atrial overdrive pacing to rapidly differentiate junctional tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm. 2011;8:840-844.
Bagherzadeh A, Keshavarzi T, Farahani MM, et al. Determinants of immediate success for catheter ablation of atrioventricular nodal reentry tachycardia in patients without junctional rhythm. J Interv Card Electrophysiol. 2014;39:19-23.
Chen H, et al. Atrioventricular block during slow pathway ablation: entirely preventable? Circ Arrhythm Electrophysiol. 2015;8: 739-744.
Reddy CD, Silka MJ, Bar-Cohen Y. A comparison of AV nodal reentrant tachycardia in young children and adolescents: electrophysiology, ablation, and outcomes. Pacing Clin Electrophysiol. 2015;38:1325-1332.
Liao J-N, et al. Permanent pacemaker implantation for late atrioventricular block in patients receiving catheter ablation for atrioventricular nodal reentrant tachycardia. Am J Cardiol. 2013;lll: 569-573.
Pieragnoli P, et al. Cryoablation of typical AVNRT: younger age and administration of bonus ablation favor long-term success. Heart Rhythm. 2015;12:2125-2131.
Qureshi MY, Ratnasamy C, Sokoloski M, et al. Low recurrence rate in treating atrioventricular nodal reentrant tachycardia with triple freeze-thaw cycles. Pacing Clin Electrophysiol. 2013;36:279-285.
Hanninen M, et al. Cryoablation versus RF ablation for AVNRT: a meta-analysis and systematic review. J Cardiovasc Electrophysiol. 2013;24:1354-1360.
Drago F, et al. Cryoablation of AVNRT in children and adolescents: early intervention leads to a better outcome. J Cardiovasc Electrophysiol. 2014;25:398-403.
Kiplapinar N, et al. Assessment of atrioventricular conduction following cryoablation of atrioventricular nodal reentrant tachycardia in children. Pacing Clin Electrophysiol. 2014;37:712-716.
Sanchez-Quintana D, et al. Sinus node revisited in the era of electroanatomical mapping and catheter ablation. Heart. 2005;91:189-194.
Anderson RH, Yanni J, Boyett MR, et al. The anatomy of the cardiac conduction system. Clin Anat. 2009;22:99-113.
Murphy C, Lazzara R. Current concepts of anatomy and electrophysiology of the sinus node. J Interv Card Electrophysiol. 2016;46: 9-18.
Ho SY, Sanchez-Quintana D. Anatomy and pathology of the sinus node. J Interv Card ElectrophysioL 2016;46:3-8.
Fedorov VV, Glukhov AV, Chang R. Conduction barriers and pathways of the sinoatrial pacemaker complex: their role in normal rhythm and atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2012;302:H1773-H1783.
Unudurthi SD, Wolf RM, Hund TJ. Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking. Front Physiol. 2014,-5:446.
Nikolaidou T, Aslanidi OV, Zhang H, et al. Structure-function relationship in the sinus and atrioventricular nodes. Pediatr Cardiol. 2012;33:890-899.
Lau DH, Roberts-Thomson КС, Sanders P. Sinus node revisited. Curr Opin Cardiol. 2011;26:55-59.
Stiles MK, et al. High-density mapping of the sinus node in humans: role of preferential pathways and the effect of remodeling. J Cardiovasc ElectrophysioL 2010;21:532-539.
Baruscotti M, Bianco E, Bucchi A, et al. Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia: role of the If 'funny' current. J Interv Card ElectrophysioL 2016;46:19-28.
Sheldon RS, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41-e63.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Chiale PA, et al. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. Heart Rhythm. 2006;3:1182-1186.
Hildreth CM, Padley JR, Pilowsky PM, et al. Impaired serotonergic regulation of heart rate may underlie reduced baroreflex sensitivity in an animal model of depression. Am J Physiol Heart Circ Physiol. 2008;294:H474-H480.
Baruscotti M, et al. A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial inappropriate sinus tachycardia. Eur Heart J. 2017;38: 280-288.
Still A-M, et aL Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace. 2005;7:104-112.
Peyrol M, Levy S. Clinical presentation of inappropriate sinus tachycardia and differential diagnosis. J Interv Card ElectrophysioL 2016;46:33-41.
Palamarchuk IS, Baker JR, Kimpinski K. The utility of Valsalva maneuver in the diagnoses of orthostatic disorders. Am J Physiol Regul Integr Comp Physiol. 2016;310:R243-R252.
Nwazue VC, et al. Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity. J Am Heart Assoc. 2014;3:e000700.
Ptaszynski P, et al. Noninvasive assessment of autonomic cardiovascular activity in patients with inappropriate sinus tachycardia. Am J Cardiol. 2013;112:811-815.
Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66: 848-860.
Gamboa A, et al. Inspiratory resistance improves postural tachycardia: a randomized study. Circ Arrhythm ElectrophysioL 2015/1:651-658.
George SA, et al. The international POTS registry: evaluating the efficacy of an exercise training intervention in a community setting. Heart Rhythm. 2016;13:943-950.
Ptaszynski P, et al. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther. 2013;18:338-344.
Kumar Goyal V, Godara S, Chandra Sadasukhi T, et al. Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient. Drug Discov Ther. 2014;8:132-133.
Ptaszynski P, Kaczmarek K, Ruta J, et al. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin ElectrophysioL 2013;36:42-49.
Annamaria M, et al. Treatment of inappropriate sinus tachycardia with ivabradine. J Interv Card ElectrophysioL 2016;46:47-53.
Kreisel D, Bailey М, Lindsay BD, et al. A minimally invasive surgical treatment for inappropriate sinus tachycardia. J Thorac Cardiovasc Surg. 2005;130:598-599.
Selten K, Van Brakel TJ, Van Swieten HA, et al. Mapping-guided total excision of the sinoatrial node for inappropriate sinus tachycardia. J Thorac Cardiovasc Surg. 20l4;147:e56-e58.
Lin D, et al. Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia. Pacing Clin Electrophysiol. 2007; 30:236-242.
Nagarakanti R, Saksena S. Three-dimensional mapping and intracardiac echocardiography in the treatment of sinoatrial nodal tachycardias. J Interv Card Electrophysiol. 2016;46:55-61.
Gianni C, et al. Catheter ablation of inappropriate sinus tachycardia. J Interv Card Electrophysiol. 2016;46:63-69.
Jacobson JT, Kraus A, Lee R, et al. Epicardial/endocardial sinus node ablation after failed endocardial ablation for the treatment of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol. 2014; 25:236-241.
Rubenstein JC, Kim MH, Jacobson JT. A novel method for sinus node modification and phrenic nerve protection in resistant cases. J Cardiovasc Electrophysiol. 2009;20:689-691.
Rodrlguez-Manero M, et al. Ablation of inappropriate sinus tachycardia: a systematic review of the literature. JACC Clin Electrophysiol. 2017;3:253-265.
Ibarra-Cortez SH, et al. Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia. Heart Rhythm. 2016;13:1238-1245.
Cuculich PS, Cooper JA, Faddis MN. Superior vena cava obstruction caused by repeated radiofrequency sinus node modification procedures. Heart Rhythm. 2009;6:865-866.
Calkins Н, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275-e444.
Charitos EI, Purerfellner H, Glotzer TV, et al. Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. J Am Coll Cardiol. 2014;63:2840-2848.
Breithardt G, et al. Valvular heart disease among non-valvular atrial fibrillation: a misnomer, in search of a new term. Eur Heart J. 2015;36:1794-1797.
January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:el-e76.
Wyse DG, et al. Lone atrial fibrillation: does it exist? J Am Coll Cardiol. 2014;63:1715-1723.
Page SEE. The substrate in "early persistent" atrial fibrillation. JACC Clin Electrophysiol. 2016;2:140-142.
Lau OH, et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J. 2016;37:1573-1581.
Nattel S, Dobrev D. Controversies about atrial fibrillation mechanisms: aiming for order in chaos and whether it matters. Circ Res. 2017;120:1396-1398.
Staerk L, et al. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120:1501-1517.
Santangeli P, et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm. 2016;13:374-382.
Weiss JN, Qu Z, Shivkumar K. Ablating atrial fibrillation: a translational science perspective for clinicians. Heart Rhythm. 2016,13: 1868-1877.
Moe GK, et al. A computer model of atrial fibrillation. Am Heart J. 1964;67:200-220.
Quintanilla JG, et al. Mechanistic approaches to detect, target, and ablate the drivers of atrial fibrillation. Circ Arrhythmia Electrophysiol. 2016;9:1-12.
Carrick RT, Benson BE, Bates JHT, et al. Prospective, tissuespecific optimization of ablation for multiwavelet reentry: predicting the required amount, location, and configuration of lesions. Circ Arrhythmia Electrophysiol. 2016;9:e003555.
Hansen BJ, et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J. 2015;36:2390-2401.
Laughner J, et al. Practical considerations of mapping persistent atrial fibrillation with whole-chamber basket catheters. JACC Clin Electrophysiol. 2016;2:55-65.
Lalani GG, et al. Organized sources are spatially conserved in recurrent compared to pre-ablation atrial fibrillation: further evidence for non-random electrical substrates. J Cardiovasc Electrophysiol. 20l6;661-669.
Walters ТЕ, et al. Temporal stability of rotors and atrial activation patterns in persistent human atrial fibrillation: a high-density epicardial mapping study of prolonged recordings. JACC Clin Electrophysiol. 2015;1:14-24.
Haissaguerre M, et al. Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report. J Cardiovasc Electrophysiol. 2013;24:711-717.
Lim HS, et al. Noninvasive mapping to guide atrial fibrillation ablation. Card Electrophysiol Clin. 2015;7:89-98.
Schricker AA, Lalani GG, Krummen DE, et al. Rotors as drivers of atrial fibrillation and targets for ablation. Curr Cardiol Rep. 2014,16:509.
Hansen BJ, et al. Advances in arrhythmia and electrophysiology maintenance of atrial fibrillation are reentrant drivers with spatial stability the key? Circ Arrhythmia Electrophysiol. 2016;9: e004398.
Roney CH, et al. Spatial resolution requirements for accurate identification of drivers of atrial fibrillation. Circ Arrhythmia Electrophysiol. 2017;10:e004899.
Vijayakumar R, Vasireddi SK, Cuculich PS, et al. Methodology considerations in phase mapping of human cardiac arrhythmias. Circ Arrhythmia Electrophysiol. 2016;9:e004409.
Ng J, Goldberger JJ. Understanding and interpreting dominant frequency analysis of AF electrograms. J Cardiovasc Electrophysiol. 2007;18:680-685.
Dzeshka MS, Lip GYH, Snezhitskiy V, et al. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943-959.
Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J. 2013;34:2731-2738.
Nattel S. Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin Electrophysiol. 2017;3:425-435.
Hansen BJ, Zhao J, Fedorov VV. Fibrosis and atrial fibrillation: computerized and optical mapping. JACC Clin Electrophysiol. 2017;3:531-546.
Kottkamp H, Bender R, Berg J. Catheter ablation of atrial fibrillation how to modify the substrate? J Am Coll Cardiol. 2015;65: 196-206.
Dewland TA, et al. Inflammation as a mediator of the association between race and atrial fibrillation results from the health ABC study (Health, Aging, and Body Composition). JACC Clin Electrophysiol. 2015;1:248-255.
Sirish P, et al. Molecular mechanisms and new treatment paradigm for atrial fibrillation. Circ Arrhythm Electrophysiol. 2016; 9:e003721.
Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335-2345.
Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25:475-484.
Maury P, et al. Lack of correlations between electrophysiological and anatomical-mechanical atrial remodeling in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2015;38:617-624.
McManus DD, et al. Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart Rhythm. 2015;12:3-10.
Rivarola EW, et al. Targets and end points in cardiac autonomic denervation procedures. Circ Arrhythmia Electrophysiol. 2017;10:e004638.
Stavrakis S, et al. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol. 2015; 65:867-875.
Wang X, et al. Long-term effects of ganglionated plexi ablation on electrophysiological characteristics and neuron remodeling in target atrial tissues in a canine model. Circ Arrhythmia Electrophysiol. 2015;8:1276-1283.
Huang J-H, et al. Modulation of autonomic nervous activity in the termination of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2017;40:401-408.
Stavrakis S, et al. The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol. 2015;1:1-13.
Driessen AHG, et al. Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study. J Am Coll Cardiol. 2016;68:1155-1165.
Linz D, Ukena C, Mahfoud F, et al. Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? J Am Coll Cardiol. 2014;63:215-224.
Gorenek B, et al. European Heart Rhythm Association (EHRA)/ European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017;19: 190-225.
Enriquez A, Antzelevitch C, Bismah V, et al. Atrial fibrillation in inherited cardiac channelopathies: from mechanisms to management. Heart Rhythm. 2016;13:1878-1884.
Hayashi K, et al. Functional characterization of rare variants implicated in susceptibility to lone atrial fibrillation. Circ Arrhythmia Electrophysiol. 2015;8:1095-1104.
Anumonwo JMB, Kalifa J. Risk factors and genetics of atrial fibrillation. Cardiol Clin. 2014;32:485-494.
Lubitz SA, et al. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014;63:1200-1210.
Shoemaker MB, et al. Common genetic variants and response to atrial fibrillation ablation. Circ Arrhythmia Electrophysiol. 2015; 8:296-302.
Krijthe BP, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746-2751.
De Sisti A, et al. Evaluation of time course and predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fibrillation. Pacing Clin Electrophysiol. 2014;37:345-355.
Proietti R, et al. A systematic review on the progression of paroxysmal to persistent atrial fibrillation: shedding new light on the effects of catheter ablation. JACC Clin Electrophysiol. 2015; 1:105-115.
Kotecha D, Chudasama R, Lane DA, et al. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol. 2016;203:660-666.
Gomez-Outes A, et al. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2016;68:2508-2521.
Kirchhof P, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-2962.
Alonso A, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2:e000102.
Kolek MJ, et al. Evaluation of a prediction model for the development of atrial fibrillation in a repository of electronic medical records. JAMA Cardiol. 2016;1:1007-1013.
Rahman F, et al. Trajectories of risk factors and risk of new-onset atrial fibrillation in the Framingham Heart Study. Hypertens (Dallas, Tex. 1979). 2016;68:597-605.
Pistoia F, et al. The epidemiology of atrial fibrillation and stroke. Cardiol Clin. 2016;34:255-268.
Jurkko R, et al. Characteristics of atrial fibrillation and comorbidities in familial atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:768-774.
Miller JD, et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol. 2015;66:2899-2906.
Kotecha D. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol. 2016;68:2217-2228.
Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250-3257.
Trulock KM, Narayan SM, Piccini JP. Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation. J Am Coll Cardiol. 2014;64:710-721.
Violi F, Soliman EZ, Pignatelli P, et al. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. 2016;5: e003347.
Guo X-Y, et al. Atrial fibrillation is associated with an increased risk of myocardial infarction: insights from a meta-analysis. Atherosclerosis. 2016;254:1-7.
Soliman EZ, et al. Atrial fibrillation and risk of ST-segment-el-evation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;131:1843-1850.
Triedman JK. Atypical atrial tachycardias in patients with congenital heart disease. Heart Rhythm. 2008;5:315-317.
Arujuna A, de Bono J. Maximizing the effectiveness of ablation for arrhythmias in the congenital heart patients. Curr Cardiol Rep. 2016;18:69.
Philip Saul J, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease. Heart Rhythm. 2016;13:e251-e289.
Manuguerra R, Callegari S, Corradi D. Inherited structural heart diseases with potential atrial fibrillation occurrence. J Cardiovasc Electrophysiol. 2016;27:242-252.
Teuwen CP, et al. Time course of atrial fibrillation in patients with congenital heart defects. Circ Arrhythmia Electrophysiol. 2015;8:1065-1072.
Shukla A, et al. Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: a meta-analysis. JACC Clin Electrophysiol. 2015;1:41-51.
Qureshi WT, et al. Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol. 2015;116:1767-1773.
Wong CX, et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1:139-152.
Nalliah CJ, Sanders P, Kottkamp H, et al. The role of obesity in atrial fibrillation. Eur Heart J. 2015;37:1565-1572.
Pathak RK, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65:2159-2169.
Hatem SN. Atrial fibrillation and obesity not just a coincidence. J Am Coll Cardiol. 2015;66:12-13.
van Rosendael AR, et al. Association between posterior left atrial adipose tissue mass and atrial fibrillation. Circ Arrhythmia Electrophysiol. 20l7;l0:e004614.
Hajhosseiny R, Matthews GK, Lip GYH. Metabolic syndrome, atrial fibrillation, and stroke: tackling an emerging epidemic. Heart Rhythm. 2015;12:2332-2343.
Pallisgaard JL, et al. Risk of atrial fibrillation in diabetes melli-tus: a nationwide cohort study. Eur J Prev Cardiol. 2016;23:621-627.
Klein I, Danzi S. Thyroid disease and the heart. Curr Probl Cardiol. 2016;41:65-92.
Bikdeli B, Ziki M, Lip G. Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review. Semin Thromb Hemost. 2017;43:849-863.
Ng ACC, et al. The prevalence and incidence of atrial fibrillation in patients with acute pulmonary embolism. PLoS ONE. 2016;ll:e0150448.
Mohanty S, et al. Differential association of exercise intensity with risk of atrial fibrillation in men and women: evidence from a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1021-1029.
Redpath CJ, Backx PH. Atrial fibrillation and the athletic heart. Curr Opin Cardiol. 2015;30:17-23.
Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281-289.
Voskoboinik A, et al. Alcohol and atrial fibrillation: a sobering review. J Am Coll Cardiol. 2016;68:2567-2576.
McManus DD, et al. Alcohol consumption, left atrial diameter, and atrial fibrillation. J Am Heart Assoc. 2016;5:e004060.
Qiao Y, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4:e002349.
Dixit S, et al. Secondhand smoke and atrial fibrillation: data from the Health eHeart Study. Heart Rhythm. 2016;13:3-9.
Tamargo J, Caballero R, Delpdn E. Drug-induced atrial fibrillation. Expert Opin Drug Saf. 2012;11:615-634.
Turagam MK, et al. Circulating biomarkers predictive of postoperative atrial fibrillation. Cardiol Rev. 2016;24:76-87.
Bidar E, et al. A prospective randomized controlled trial on the incidence and predictors of late-phase postoperative atrial fibrillation up to 30 days and the preventive value of biatrial pacing. Heart Rhythm. 2014;11:1156-1162.
Yadava M, Hughey AB, Crawford TC. Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates. Cardiol Clin. 2014;32:627-636.
Kiaii B, et al. Postoperative atrial fibrillation is not pulmonary vein dependent: results from a randomized trial. Heart Rhythm. 2015;12:699-705.
На ACT, Mazer CD, Verma S, et al. Management of postoperative atrial fibrillation after cardiac surgery. Curr Opin Cardiol. 2016;31:183-190.
Garimella RS, et al. Accuracy of patient perception of their prevailing rhythm: a comparative analysis of monitor data and questionnaire responses in patients with atrial fibrillation. Heart Rhythm. 2015;12:658-665.
Xiong Q, Proietti M, Senoo K, et al. Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes. Int J Cardiol. 2015;191: 172-177.
Dillon P, Ghanbari H. Diagnostic evaluation and follow-up of patients with atrial fibrillation. Cardiol Clin. 2014;32:507-519.
Benezet-Mazuecos J, Rubio JM, Farr J. Atrial high rate episodes in patients with dual-chamber cardiac implantable electronic devices: unmasking silent atrial fibrillation. Pacing Clin Electrophysiol. 2014;37:1080-1086.
Chen-Scarabelli C, Scarabelli TM, Ellenbogen KA, et al. Devicedetected atrial fibrillation: what to do with asymptomatic patients? J Am Coll Cardiol. 2015;65:281-294.
Witt CT, et al. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy. Heart Rhythm. 2015;12: 2368-2375.
Surapaneni P, Safadi A, Contractor T, et al. Device-detected atrial fibrillation-perils and pitfalls. An update. Cardiol Clin. 2016; 34:299-306.
Tomson TT, Passman R. Management of device-detected atrial high-rate episodes. Card Electrophysiol Clin. 2015;7:515-525.
Glotzer TV, Ziegler PD. Cryptogenic stroke: is silent atrial fibrillation the culprit? Heart Rhythm. 2015;12:234-241.
Martin DT, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36:1660-1668.
Kabra R, Girotra S, Vaughan Sarrazin M. Refining stroke prediction in atrial fibrillation patients by addition of African-American ethnicity to CHA2DS2-VASc score. J Am Coll Cardiol. 2016;68:461-470.
Vanassche T, et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2015;36:281-287.
Steinberg BA, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial. Eur Heart J. 2015;36:288-296.
Ganesan AN, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37:1591-1602.
Chao TF, et al. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: which scoring system should be used for Asians? Heart Rhythm. 2016;13:46-53.
Chao T-F, et al. Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation? J Thorac Dis. 2015;7:172-177.
Van Den Ham HA, Klungel OH, Singer DE, et al. Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database. J Am Coll Cardiol. 2015;66:1851-1859.
Hijazi Z, et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016;37:1582-1590.
O'Brien EC, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36:3258-3264.
Ringwala SM, Tomson TT, Passman RS. Cardiac monitoring for atrial fibrillation in cryptogenic stroke. Cardiol Clin. 2016;34: 287-297.
Moran PS, Teljeur C, Ryan M, et al. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2016;(6): CD009586.
Dong Y, Dong Q. New oral anticoagulants: how do we use them wisely? Curr Cardiol Rep. 2015;17:1-8.
Masoudi FA, et al. 2015 ACC/HRS/SCAI left atrial appendage occlusion device societal overview. Heart Rhythm. 2015;l2:el2 2-el36.
Lau YC, Lip GYH. Which drug should we use for stroke prevention in atrial fibrillation? Curr Opin Cardiol. 2014;29:293-300.
Chao T-F, et al. Rate-control treatment and mortality in atrial fibrillation. Circulation. 2015;132:1604-1612.
Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J. 2015;36:1831-1838.
Ouyang A-J, et al. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Am J Cardiol. 2015; 115:901-906.
Turakhia MP, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014;64:660-668.
Allen LA, et al. Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort. J Am Coll Cardiol. 2015;65:2691-2698.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:el-e76.
Rajagopalan B, et al. Efficacy of intravenous magnesium in facilitating cardioversion of atrial fibrillation. Circ Arrhythmia ElectrophysioL 2016;9:e003968.
Gronberg T, et al. Can we predict the failure of electrical cardioversion of acute atrial fibrillation? the FinCV study. Pacing Clin ElectrophysioL 2015;38:368-375.
Hanley CM, Robinson VM, Kowey PR. Status of antiarrhythmic drug development for atrial fibrillation: new drugs and new molecular mechanisms. Circ Arrhythmia ElectrophysioL 2016;9:1-9.
Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation. Cardiol Clin. 2014;32:533-549.
Noheria A, et al. Rhythm control versus rate control and clinical outcomes in patients with atrial fibrillation. JACC Clin Electrophysiol. 2015;2:221-229.
Chatterjee S, Sardar P, Lichstein E, et al. Aikat, S. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin ElectrophysioL 2013;36:122-133.
Zakeri R, et al. The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm. 2017;4: 763-782.
Wu L, et al. Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: a propensity score matched analysis. J Cardiovasc ElectrophysioL 2016;27:531-535.
Prabhu S, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction. J Am Coll Cardiol. 2017;70: 1949-1961.
Carrizo AG, Morillo CA. Catheter ablation as first-line therapy for atrial fibrillation: ready for prime-time? Curr Cardiol Rep. 2016;18:71.
Padeletti L, et al. New-generation atrial antitachycardia pacing (reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. Heart Rhythm. 2015;12:1717-1725.
Pathak RK, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J Am Coll Cardiol. 2015;66:985-996.
Chatterjee S, Sardar P, Mukherjee D, et al. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis. Pacing Clin Electrophysiol. 2013;36:1017-1023.
Kolek MJ, et al. Genetic and clinical risk prediction model for postoperative atrial fibrillation. Circ Arrhythmia Electrophysiol. 2015;8:25-31.
Sezai A, et al. Carperitide and atrial fibrillation after coronary bypass grafting: the Nihon University Working Group Study of Low-Dose HANP Infusion Therapy during Cardiac Surgery Trial for Postoperative Atrial Fibrillation. Circ Arrhythmia Electrophysiol. 2015;8:546-553.
Verma A, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372:1812-1822.
Goldenberg GR, et al. Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success: a meta-analysis. J Interv Card Electrophysiol. 2016;47:171-176.
Kaitani K, et al. Efficacy of Antiarrhythmic Drugs Short-Term Use after Catheter Ablation for Atrial Fibrillation (EAST-AF) trial. Eur Heart J. 2016;37:610-618.
Wu S, et al. Meta-analysis of efficacy and safety of new oral anticoagulants compared with uninterrupted vitamin К antagonists in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol. 2016;117:926-934.
Zhao Y, et al. New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation. J Interv Card Electrophysiol. 2017;48:267-282.
Calkins H, et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med. 2017;376:1627-1636.
Gabus V, et al. Short-term heparin kinetics during catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2015;38: 1142-1150.
Briceno DF, Natale A, Di Biase L. Heparin kinetics: The 'holy grail' of periprocedural anticoagulation for ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2015;38:1137-1141.
Briceno DF, et al. Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and metaregression. J Cardiovasc Electrophysiol. 2016;27:683-693.
Nishikii-Tachibana M, et al. Prevalence and clinical determinants of left atrial appendage thrombus in patients with atrial fibrillation before pulmonary vein isolation. Am J Cardiol. 2015;116:1368-1373.
Di Biase L, et al. Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry. Heart Rhythm. 2016;13:1197-1202.
Kistler PM, et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation. 2003;108:1968-1975.
Squara F, et al. Electrical connection between ipsilateral pulmonary veins: prevalence and implications for ablation and adenosine testing. Heart Rhythm. 2015;12:275-282.
Ghanbari H, et al. Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: a randomized controlled trial. Heart Rhythm. 2016;13:407-415.
Prabhu S, et al. Determining the optimal dose of adenosine for unmasking dormant pulmonary vein conduction following atrial fibrillation ablation: electrophysiological and hemodynamic assessment. DORMANT-AF study. J Cardiovasc Electrophysiol. 2016;28:13-22.
Zhang B, Zhen Y, Tao A, et al. Efficacy of selective arrhythmogenic pulmonary veins isolation versus empirical all pulmonary veins isolation for atrial fibrillation: a meta-analysis of randomized and observational studies. J Interv Card Electrophysiol. 2014;39:233-240.
Rordorf R, et al. Anatomical mapping for atrial fibrillation ablation: a head-to-head comparison of ultrasound-assisted reconstruction versus fast anatomical mapping. Pacing Clin Electrophysiol. 2015;38:187-195.
Okumura Y, et al. Effect of catheter tip-tissue surface contact on three-dimensional left atrial and pulmonary vein geometries: potential anatomic distortion of 3D ultrasound, fast anatomical mapping, and merged 3D CT-derived images. J Cardiovasc Electrophysiol. 2013;24:259-266.
El Haddad M, et al. Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation. Circ Arrhythmia Electrophysiol. 2017;10:e004867.
Baldinger SH, et al. The timing and frequency of pulmonary veins unexcitability relative to completion of a wide area circumferential ablation line for pulmonary vein isolation. JACC Clin Electrophysiol. 2016;2:14-23.
Yuyun MF, Stafford PJ, Sandilands AJ, et al. The impact of power output during percutaneous catheter radiofrequency ablation for atrial fibrillation on efficacy and safety outcomes: a systematic review. J Cardiovasc Electrophysiol. 2013;24:1216-1223.
Su W, et al. Best practice guide for cryoballoon ablation in atrial fibrillation: the compilation experience of more than 3000 procedures. Heart Rhythm. 2015;12:1658-1666.
Sharma A, et al. Outcomes following cryoballoon ablation for atrial fibrillation guided by pressure waveform monitoring without the routine use of pulmonary venography. J Interv Card Electrophysiol. 2017;49:75-82.
Stroker E, et al. Second-generation cryoballoon ablation in the setting of left common pulmonary veins: procedural findings and clinical outcome. Heart Rhythm. 2017;14:1311-1318.
Heeger C-H, et al. Acute efficacy, safety, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with a left common pulmonary vein: a multicenter study. Heart Rhythm. 2017;14:1111-1118.
Andrade JG, Dubuc M, Collet D, et al. Pulmonary vein signal interpretation during cryoballoon ablation for atrial fibrillation. Heart Rhythm. 2015;12:1387-1394.
Aryana A, et al. Verification of a novel atrial fibrillation cryoablation dosing algorithm guided by time-to-pulmonary vein isolation: results from the Cryo-DOSING Study (Cryoballoonablation DOSING Based on the Assessment of Time-to-Effect and Pulmonary Vein Isolation Guidance). Heart Rhythm. 2017;14: 1319-1325.
lacopino S, et al. Second generation cryoballoon ablation without the use of real-time recordings: a novel strategy based on a temperature guided approach to ablation. Heart Rhythm. 2016; 14:322-328.
Chun KRJ, et al. Individualized cryoballoon energy pulmonary vein isolation guided by real time pulmonary vein recordings, the randomized 'ICE-T' Trial. Heart Rhythm. 2016;14: 495-500.
Mondesert B, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7:605-611.
Franceschi F, et al. Electromyographic monitoring for prevention of phrenic nerve palsy in second-generation cryoballoon procedures. Circ Arrhythmia Electrophysiol. 2015;8:303-307.
Kowalski M, Ellenbogen KA, Koneru JN. Prevention of phrenic nerve injury during interventional electrophysiologic procedures. Heart Rhythm. 2014;11:1839-1844.
Ghosh J, Sepahpour A, Chan КН, et al. Immediate balloon deflation for prevention of persistent phrenic nerve palsy during pulmonary vein isolation by balloon cryoablation. Heart Rhythm. 2013;10:646-652.
Aryana A, et al. Catheter ablation using the third-generation cryoballoon provides an enhanced ability to assess time to pulmonary vein isolation facilitating the ablation strategy : short-and long-term results of a multicenter study. Heart Rhythm. 2016;13:2306-2313.
Attanasio P, et al. Pain reactions during pulmonary vein isolation under deep sedation: cryothermal versus radiofrequency ablation. Pacing Clin Electrophysiol. 2016;39:452-457.
Kajiyama T, et al. Anatomic parameters predicting procedural difficulty and balloon temperature predicting successful applications in individual pulmonary veins during 28-mm second-generation cryoballoon ablation. JACC Clin Electrophysiol. 2016;3: 580-588.
Bordignon S, et al. Energy titration strategies with the endoscopic ablation system: lessons from the high-dose vs. low-dose laser ablation study. Europace. 2013;15:685-689.
Dukkipati SR, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6:467-472.
Dukkipati SR, et al. Pulmonary vein isolation using the visually guided laser balloon a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J Am Coll Cardiol. 2015;66:1350-1360.
Buch E, Shivkumar K. Catheter ablation of atrial fibrillation advent of second-generation technologies. J Am Coll Cardiol. 2015; 66:1361-1363.
Leong-Sit P, et al. Inducibility of atrial fibrillation and flutter following pulmonary vein ablation. J Cardiovasc Electrophysiol. 2013;24:617-623.
Gula LJ, et al. Pulmonary vein isolation with incomplete antral ablation lines: is more ablation necessary? Results of a randomized trial. J Cardiovasc Electrophysiol. 2016;27:298-302.
Cardoso R, et al. Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation : a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1151-1159.
Liu X-H, Chen C-F, Gao X-F, et al. Safety and efficacy of different catheter ablations for atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2016;39:883-899.
Koektuerk B, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8:1073-1079.
Guhl EN, et al. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:423-427.
Boveda S, et al. Outcomes after cryoballoon or radiofrequency ablation for persistent atrial fibrillation : a multicentric propensityscore matched study. J Interv Card Electrophysiol. 2016;47:133-142.
Ichihara N, et al. Prevalence and pre-procedural predictors associated with right phrenic nerve injury in electromyography-guided, second-generation cryoballoon ablation. JACC Clin Electrophysiol. 2016;2:508-514.
Zhang Z, et al. Linear ablation following pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis. Pacing Clin Electrophysiol. 2016;39:623-630.
Wynn GJ, et al. Biatrial linear ablation in sustained nonpermanent AF: results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial. Heart Rhythm. 2016;13:399-406.
Wong KCK, et al. No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: benefit of complex ablation study. Circ Arrhythmia Electrophysiol. 2015;8:1316-1324.
Bai R, et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm. 2016;13:132-140.
Mohanty S, et al. Impact of rotor ablation in non-paroxysmal AF patients: results from a randomized trial (OASIS). J Am Coll Cardiol. 2016;68:274-282.
Higuchi S, et al. Is it necessary to achieve a complete box isolation in the case of frequent esophageal temperature rises? Feasibility of shifting to a partial box isolation strategy for patients with non-paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:897-904.
Cutler MJ, et al. Impact of voltage mapping to guide whether to perform ablation of the posterior wall in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:13-21.
He X, et al. Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol. 2016;46:267-274.
Coffey JO, et al. Catheter ablation of scar-related atypical atrial flutter. Europace. 2013;15:414-419.
Navarrete A, Conte F, Moran M, et al. Ablation of atrial fibrillation at the time of cavotricuspid isthmus ablation in patients with atrial flutter without documented atrial fibrillation derives a better long-term benefit. J Cardiovasc Electrophysiol. 2011;22:34-38.
Mohanty S, et al. Results from a single-blind, randomized study comparing the impact of different ablation approaches on longterm procedure outcome in coexistent atrial fibrillation and flutter (approval). Circulation. 2013;127:1853-1860.
Sommer P, et al. Successful repeat catheter ablation of recurrent longstanding persistent atrial fibrillation with rotor elimination as the procedural endpoint: a case series. J Cardiovasc Electrophysiol. 2016;27:274-280.
Zaman JAB, Peters NS, Narayan SM. Rotor mapping and ablation to treat atrial fibrillation. Curr Opin Cardiol. 2015;30:24-32.
Narayan SM, Krummen DE, Clopton P, et al. Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol. 2013;62:138-147.
Narayan SM, et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation). J Am Coll Cardiol. 2014;63:1761-1768.
Benharash P, et al. Quantitative analysis of localized sources identified by focal impulse and rotor modulation mapping in atrial fibrillation. Circ Arrhythmia Electrophysiol. 2015;8:554-561.
Berntsen RF, Haland TF, Skardal R, et al. Focal impulse and rotor modulation as a stand-alone procedure for the treatment of paroxysmal atrial fibrillation: a within-patient controlled study with implanted cardiac monitoring. Heart Rhythm. 2016;13: 1768-1774.
Gianni C, et al. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. Heart Rhythm. 2016;13: 830-835.
Buch E, et al. Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: a multicenter experience. Heart Rhythm. 2016;13:636-641.
Schade A, et al. Spatial relationship of focal impulses, rotors and low voltage zones in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:507-514.
Steinberg JS, et al. Focal impulse and rotor modulation: acute procedural observations and extended clinical follow-up. Heart Rhythm. 2017;14:192-197.
Aksu T, timer T, Guler E, et al. Unanswered questions in complex fractionated atrial. Pacing Clin Electrophysiol. 2016;39: 1269-1278.
Lau DH, et al. Indices of bipolar complex fractionated atrial electrograms correlate poorly with each other and atrial fibrillation substrate complexity. Heart Rhythm. 2015;12:1415-1423.
Sohal M, et al. Is mapping of complex fractionated electrograms obsolete? Arrhythmia Electrophysiol Rev. 2015;4:109-115.
Oketani N, et al. Ablation of complex fractionated electrograms is useful for catheter ablation of persistent atrial fibrillation: protagonist point of view. Heart Rhythm. 2016;13:2098-2100.
Conti S, Verma A. Ablation of complex fractionated electrograms may not be useful for catheter ablation of persistent atrial fibrillation. Heart Rhythm. 2016;13:2098-2100.
Vogler J, et al. Pulmonary vein isolation versus defragmentation the CHASE-AF Clinical Trial. J Am Coll Cardiol. 2015;66: 2743-2752.
Providencia R, et al. Is there still a role for complex fractionated atrial electrogram ablation in addition to pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation? Circ Arrhythmia Electrophysiol. 2015;8:1017-1029.
Katritsis DG, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol. 2013;62:2318-2325.
Pokushalov E, et al. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm. 2013;10:1280-1286.
Kurotobi T, et al. Features of intrinsic ganglionated plexi in both atria after extensive pulmonary isolation and their clinical significance after catheter ablation in patients with atrial fibrillation. Heart Rhythm. 2015;12:470-476.
Zhao Y, et al. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm. 2016;13:141-149.
Theis C, et al. Arrhythmia termination versus elimination of dormant pulmonary vein conduction as a procedural end point of catheter ablation for paroxysmal atrial fibrillation. Circ Arrthym Electrophysiol. 2015;8:1080-1087.
Santangeli P, Marchlinski FE. Techniques for provocation, localization and ablation of nonpulmonary vein triggers for atrial fibrillation. Heart Rhythm. 2017;14:1087-1096.
Hojo R, et al. Development of nonpulmonary vein foci increases risk of atrial fibrillation recurrence after pulmonary vein isolation. JACC Clin Electrophysiol. 2017;3:547-555.
Rodriguez-Manero M, Schurmann P, Valderrabano M. Ligament and vein of Marshall: a therapeutic opportunity in atrial fibrillation. Heart Rhythm. 2016;13:593-601.
Lerman BB. Ablating the obscure: the curious case of the vein of Marshall. J Cardiovasc Electrophysiol. 2017;28:394-395.
Lee JH, et al. Radiofrequency catheter ablation targeting the vein of Marshall in difficult mitral isthmus ablation or pulmonary vein isolation. J Cardiovasc Electrophysiol. 2017;28:386-393.
Baez-Escudero JL, Keida T, Dave AS, et al. Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation. J Am Coll Cardiol. 2014;63:1892-1901.
Miyazaki S, et al. Role of arrhythmogenic superior vena cava on atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25:380-386.
Ejima K, et al. Impact of an empiric isolation of the superior vena cava in addition to circumferential pulmonary vein isolation on the outcome of paroxysmal atrial fibrillation ablation. Am J Cardiol. 2015;116:1711-1716.
Miyazaki S, et al. Factors predicting an arrhythmogenic superior vena cava in atrial fibrillation ablation: insight into the mechnism. Heart Rhythm. 2014;11:1560-1566.
Sharma SP, Sangha RS, Dahal K, et al. The role of empiric superior vena cava isolation in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2016;48:61-67.
Higuchi K, Yamauchi Y, Hirao K, et al. The importance of superior vena cava isolation in ablation strategy for atrial fibrillation. Curr Opin Cardiol. 2013;28:2-6.
Miyazaki S, et al. Electrical superior vena cava isolation using a novel pace-and-ablate technique under diaphragmatic electromyography monitoring. Heart Rhythm. 2017;14:678-684.
Morita H, Zipes DP, Morita ST, et al. The role of coronary sinus musculature in the induction of atrial fibrillation. Heart Rhythm. 2012;9:581-589.
Reissmann B, et al. Durability of wide-area left atrial appendage isolation: results from extensive catheter ablation for treatment of persistent atrial fibrillation. Heart Rhythm. 2017;14: 314-319.
Di Biase L, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation. J Am Coll Cardiol. 2016;68:1929-1940.
Rillig A, et al. Unexpectedly high incidence of stroke and left atrial appendage thrombus formation after electrical isolation of the left atrial appendage for the treatment of atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2016;9:e003461.
Hayashi K, et al. Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2015;12:1918-1924.
Blandino A, et al. Left atrial substrate modification targeting low-voltage areas for catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2017;40:199-212.
Yang G, et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation. Circ Arrhythmia Electrophysiol. 2016;9:e003382.
Kottkamp H, Berg J, Bender R, et al. Box isolation of fibrotic areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:22-30.
Yamaguchi T, et al. Efficacy of left atrial voltage-based catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2015;2015:1055-1063.
Rolf S, Dagres N, Hindricks G. Voltage-based ablation: the growing evidence for the role of individually tailored substrate modification for atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27: 31-33.
Voskoboinik A, et al. Revisiting pulmonary vein isolation alone for persistent atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2017;14:661-667.
Siontis КС, et al. Radiofrequency ablation versus antiarrhyth-mic drug therapy for atrial fibrillation: meta-analysis of quality of life. Morb Mortal. 2016;2:170-180.
Liang JJ, et al. Early recurrence of atrial arrhythmias following pulmonary vein antral isolation: timing and frequency of early recurrences predicts long-term ablation success. Heart Rhythm. 2015;12:2461-2468.
Alipour P, et al. Defining blanking period post pulmonary vein antrum isolation. JACC Clin Electrophysiol. 2016;3:568-576.
Sadek MM, et al. Recurrent atrial arrhythmias in the setting of chronic pulmonary vein isolation. Heart Rhythm. 2016;13:2174-2180.
Barbhaiya CR, et al Recurrence of atrial arrhythmias despite persistent pulmonary vein isolation after catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2016;2:723-731.
Moser J, et al. Complication rates of catheter ablation of atrial fibrillation in patients aged > 75years versus <75 years — results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2016;28:258-265.
Teunissen C, et al. Incidence of pulmonary vein stenosis after radiofrequency catheter ablation of atrial fibrillation. JACC Clin Electrophysiol. 2016;3:589-598.
Narui R, et al. Incidence and factors associated with the occurrence of pulmonary vein narrowing after cryoballoon ablation. Circ Arrhythmia Electrophysiol. 2017;10:e004588.
Matsuda J, et al. Pu Imonary vein stenosis after second-generation cryoballoon ablation. J Cardiovasc Electrophysiol. 2017;28:298-303.
Kumar N, et al. Pulmonary vein stenosis after laser balloon ablation for atrial fibrillation. JACC Clin Electrophysiol. 2015;1:220-221.
Barbhaiya CR, et al. Global survey of esophageal injury in atrial fibrillation ablation. JACC Clin Electrophysiol. 2016;2:143-150.
Muller P, et al. Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes. Heart Rhythm. 2015;12:1464-1469.
Furnkranz A, et al. Reduced incidence of esophageal lesions by luminal esophageal temperature-guided second-generation cryoballoon ablation. Heart Rhythm. 2015;12:268-274.
Eitel C, et al. Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation: a case series. Circ Arrhythmia Electrophysiol. 2013;6:675-681.
Black-Maier E, et al. Risk of atrioesophageal fistula formation with contact force-sensing catheters. Heart Rhythm. 2017;14: 1328-1333.
Pedersen MEF, et al. Management of tamponade complicating catheter ablation for atrial fibrillation. JACC Clin Electrophysiol. 2016;3:367-373.
Michowitz Y, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation results from a worldwide survey in 34943 atrial fibrillation ablation procedures. Circ Arrhythmia Electrophysiol. 2014;7:274-280.
Chun KRJ, et al. Complications in catheter ablation of atrial fibrillation in 3,000 consecutive procedures. JACC Clin Electrophysiol. 2017;3:154-161.
Yamada T, Kay GN. Recognition and prevention of complications during epicardial ablation. Card Electrophysiol Clin. 2010;2: 127-134.
Aksu T, Golcuk S, Guler ТЕ, et al. Gastroparesis as a complication of atrial fibrillation ablation. Am J Cardiol. 2015;116:92-97.
Miyazaki S, et al. Esophagus-related complications during second-generation cryoballoon ablation—insight from simultaneous esophageal temperature monitoring from 2 esophageal probes. J Cardiovasc Electrophysiol. 2016;27:1038-1044.
Kuwahara T, et al. Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol. 2013;24:847-851.
Lakkireddy D, et al. Effect of atrial fibrillation ablation on gastric motility: the Atrial Fibrillation Gut Study. Circ Arrhythmia Electrophysiol. 2015;8:531-536.
Knopp H, et al. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm. 2014;11:574-578.
Yang Y, et al. Stiff left atrial syndrome: a complication undergoing radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:884-889.
Khurram IM, et al. Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation. Circ Arrhythmia Electrophysiol. 2016;9:1-10.
Verma I, Tripathi H, Sikachi RR, et al. Pulmonary hypertension due to radiofrequency catheter ablation (RFCA) for atrial fibrillation: the lungs, the atrium or the ventricle? Heart Lung Circ. 2016;25:1177-1183.
Nery PB, et al. Relationship between pulmonary vein reconnection and atrial fibrillation recurrence. JACC Clin Electrophysiol. 2016;2:474-483.
Liang JJ, et al. Pulmonary vein antral isolation and nonpulmo-nary vein trigger ablation are sufficient to achieve favorable long-term outcomes including transformation to paroxysmal arrhythmias in patients with persistent and long-standing persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9: e004239.
Buch E, Shivkumar K. Could less be more in catheter ablation for persistent atrial fibrillation? Pulmonary vein isolation reconsidered. Heart Rhythm. 2017,14:668-669.
Goldenberg GR, et al. The incremental benefit of non-pulmonary vein left atrial ablation in patients undergoing a repeat persistent atrial fibrillation ablation procedure. J Interv Card Electrophysiol. 2017;48:185-191.
Vijayaraman P, Naperkowski A, Ellenbogen KA, et al. Electrophysiologic insights into site of atrioventricular block lessons from permanent His bundle pacing. JACC Clin Electrophysiol. 2015;1:571-581.
Vijayaraman P, Dandamudi G, Bauch T, et al. Imaging evaluation of implantation site of permanent direct His bundle pacing lead. Heart Rhythm. 2014;11:529-530.
Kulkarni N, et al. His bundle pacing for identifying optimal ablation sites in patients undergoing atrioventricular junction ablation. Pacing Clin Electrophysiol. 2017;40:242-246.
Issa ZF, Amr BS, Laham H. Long-term follow-up in AV junction ablation via the SVC in patients undergoing concurrent device implantation: a single center experience. Pacing Clin Electrophysiol. 2015;38:254-258.
Reddy YM, et al. Impact of tricuspid regurgitation on the success of atrioventricular node ablation for rate control in patients with atrial fibrillation: the Node Blast Study. Am J Cardiol. 2015; 116:900-903.
Chatterjee NA, et al. Atrioventricular nodal ablation in atrial fibrillation a meta-analysis and systematic review. Circ Arrhythmia Electrophysiol. 2012;5:68-76.
Naksuk N, Padmanabhan D, Yogeswaran V, et al. Left atrial appendage. JACC Clin Electrophysiol. 2016;2:403-412.
Saw J, et al. Comparing measurements of CT angiography, TEE, and fluoroscopy of the left atrial appendage for percutaneous closure. J Cardiovasc Electrophysiol. 2016;27:414-422.
Meier B, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. EuroIntervention. 2015;10:1109-1125.
Enomoto Y, et al. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device. Heart Rhythm. 2016;14:19-24.
Boersma LV, et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2O17;14: 1302-1308.
Holmes DR, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2O15;65:2614-2623.
Main ML, et al. Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fibrillation (from the PROTECT-AF trial). Am J Cardiol. 2016;117:1127-1134.
Freixa X, et al. The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. EuroIntervention. 2013;8:1094-1098.
Lam SCC, et al. Left atrial appendage closure using the Amulet device: an initial experience with the second generation Amplatzer cardiac plug. Catheter Cardiovasc Interv. 2015;85:297-303.
Sedaghat A, et al. Thrombus formation after left atrial appendage occlusion with the Amplatzer Amulet device. JACC Clin Electrophysiol. 2017;3:71-75.
Tzikas A, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug. EuroIntervention. 2016;11:1170-1179.
Bartus К, et al. Anatomic analysis of the left atrial appendage after closure with the LARIAT device. Circ Arrhythmia Electrophysiol. 2014;7:764-767.
Syed FF, Friedman PA. Left atrial appendage closure for stroke prevention emerging technologies. Card Electrophysiol Clin. 2014;6: 141-160.
Koneru JN, Badhwar N, Ellenbogen KA, et al. LAA ligation using the LARIAT suture delivery device: tips and tricks for a successful procedure. Heart Rhythm. 2014;11:911-921.
Lakkireddy D, et al. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: results from a US multicenter evaluation. Heart Rhythm. 2016;13:1030-1036.
Romanov A, et al. Effect of left atrial appendage excision on procedure outcome in patients with persistent atrial fibrillation undergoing surgical ablation. Heart Rhythm. 2016;13:1803-1809.
Lakkireddy D, et al. Left atrial appendage ligation and ablation for persistent atrial fibrillation: the LAALA-AF registry. JACC Clin Electrophysiol. 2015;1:153-160.
Afzal MR, et al. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015;12:52-59.
Kreidieh B, et al. Left atrial appendage remodeling after lariat left atrial appendage ligation. Circ Arrhythmia Electrophysiol. 2015;8:1351-1358.
Pillarisetti J, et al. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015;12:1501-1507.
Aryana A, et al. Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization. Heart Rhythm. 2015;12:1431-1437.
Tsai Y-C, et al. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a metaanalysis. Eur J Cardiothoracic Surg. 2015;47:847-854.
Sherwin ED, Triedman JK, Walsh EP. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythm Electrophysiol. 2013;6: 1032-1040.
Triedman JK. Atypical atrial tachycardias in patients with congenital heart disease. Heart Rhythm. 2008;5:315-317.
Anguera I, et al. Long-term outcome after ablation of right atrial tachyarrhythmias after the surgical repair of congenital and acquired heart disease. Am J Cardiol. 2015;115:1705-1713.
Moore JP, Russell M, Mandapati R, et al. Catheter ablation of tachycardia arising from the pulmonary venous atrium after surgical repair of congenital heart disease. Heart Rhythm. 2015;12:297-304.
Teuwen CP, et al. Time course of atrial fibrillation in patients with congenital heart defects. Circ Arrhythm Electrophysiol. 2015;8: 1065-1072.
Arujuna A, de Bono J. Maximizing the effectiveness of ablation for arrhythmias in the congenital heart patients. Curr Cardiol Rep. 2016;18:69.
Philip Saul J, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease. Heart Rhythm. 2016;13:e251-e289.
Kanter RJ. Pearls for ablation in congenital heart disease. J Cardiovasc Electrophysiol. 2010;21:223-230.
Wu M-H, et al. Arrhythmic burdens in patients with tetralogy of Fallot: a national database study. Heart Rhythm. 2015;12: 604-609.
Houck CA, Teuwen CP, Bogers AJ, et al. Atrial tachyarrhythmias after atrial switch operation for transposition of the great arteries: treating old surgery with new catheters. Heart Rhythm. 2016;13: 1731-1738.
Wu J, et al. Acute and long-term outcome after catheter ablation of supraventricular tachycardia in patients after the Mustard or Senning operation for D-transposition of the great arteries. Europace. 2013;15:886-891.
Lasa JJ, Glatz AC, Daga A, et al. Prevalence of arrhythmias late after the fontan operation. Am J Cardiol. 2014;113:1184—1188.
Correa R, et al. Mechanism and ablation of arrhythmia following total cavopulmonary connection. Circ Arrhythm Electrophysiol. 2015;8:318-325.
Moore JP, et al. Catheter ablation of supraventricular tachyarrhythmia after extracardiac Fontan surgery. Heart Rhythm. 2016;13: 1891-1897.
Khairy P, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm. 20l4;1l:e102-e165.
McLeod CJ, Warnes С. Recognition and management of arrhythmias in adult congenital heart disease. Curr Opin Cardiol. 2016;31: 117-123.
Patients ASE, Marchese P, Ho SY, et al. Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease. Circ Arrhythm Electrophysiol. 2013;6:606-613.
Tzeis S, Andrikopoulos G, Deisenhofer I, et al. Transseptal catheterization: considerations and caveats. Pacing Clin Electrophysiol. 2010;33:231-242.
Santangeli P, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8:1669-1675.
Li X, et al. Safety and feasibility of transseptal puncture for atrial fibrillation ablation in patients with atrial septal defect closure devices. Heart Rhythm. 2014;11:330-335.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J. Resetting and entrainment of reentrant arrhythmias: part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Miyazaki H, Stevenson WG, Stephenson K, et al. Entrainment mapping for rapid distinction of left and right atrial tachycardias. Heart Rhythm. 2006;3:516-523.
Saoudi N, et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol. 2001;12:852-866.
Bun SS, Latcu DG, Marchlinski F, et al. Atrial flutter: more than just one of a kind. Eur Heart J. 2015;36:2356-2363.
Garan H. Atypical atrial flutter. Heart Rhythm. 2008;5:618-621.
Hoffmayer KS, Scheinman MM. Intraisthmus reentry. Card Electrophysiol Clin. 2012;4:539-543.
Anguera I, et al. Long-term outcome after ablation of right atrial tachyarrhythmias after the surgical repair of congenital and acquired heart disease. Am J Cardiol. 2015;115:1705-1713.
Kanagasundram AN, et al. A novel criterion for conduction block after catheter ablation of right atrial tachycardia after mitral valve surgery. Circ Arrhythm Electrophysiol. 2013;6:39-47.
Wieczorek M, Hoeltgen R. Right atrial tachycardias related to regions of low-voltage myocardium in patients without prior cardiac surgery: catheter ablation and follow-up results. Europace. 2013;15:1642-1650.
Medi C, Kalman JM. Prediction of the atrial flutter circuit location from the surface electrocardiogram. Europace. 2008;10: 786-796.
Adachi T, et al. Left septal atrial tachycardia after open-heart surgery: relevance to surgical approach, anatomical and electrophysiological characteristics associated with catheter ablation, and procedural outcomes. Circ Arrhythm Electrophysiol. 2015;8: 59-67.
Huo Y, et al. Atrial arrhythmias following surgical AF ablation: electrophysiological findings, ablation strategies, and clinical outcome. J Cardiovasc Electrophysiol. 2014;25:725-738.
Miyazaki S, Shah AJ, Hocini M, et al. Recurrent spontaneous clinical perimitral atrial tachycardia in the context of atrial fibrillation ablation. Heart Rhythm. 2015;12:104-110.
Zhang J, et al. Electroanatomic characterization and ablation outcome of nonlesion related left atrial macroreentrant tachycardia in patients without obvious structural heart disease. J Cardiovasc Electrophysiol. 2013;24:53-90.
Fukamizu S, et al. Macroreentrant atrial tachycardia in patients without previous atrial surgery or catheter ablation: clinical and electrophysiological characteristics of scar-related left atrial anterior wall reentry. J Cardiovasc Electrophysiol. 2013;24:404-412.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Chang S-L, et al. Differentiating macroreentrant from focal atrial tachycardias occurred after circumferential pulmonary vein isolation. J Cardiovasc Electrophysiol. 2011;22:748-755.
Yuniadi Y, et al. A new electrocardiographic algorithm to differentiate upper loop re-entry from reverse typical atrial flutter. J Am Coll Cardiol. 2005;46:524-528.
Wo H, et al. Successful treatment of macroreentrant atrial tachycardia by radiofrequency ablation targeting channels with continuous activation. Pacing Clin Electrophysiol. 2014;37:927-938.
Gerstenfeld EP, et al. Surface electrocardiogram characteristics of atrial tachycardias occurring after pulmonary vein isolation. Heart Rhythm. 2007;4:1136-1143.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J. Resetting and entrainment of reentrant arrhythmias: part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: part I: concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36:508-532.
Anter E, Tschabrunn CM, Josephson ME. High-resolution mapping of scar-related atrial arrhythmias using smaller electrodes with closer interelectrode spacing. Circ Arrhythm Electrophysiol. 2015;8:537-545.
Pascale P, et al. Pattern and timing of the coronary sinus activation to guide rapid diagnosis of atrial tachycardia after atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2013;6:481-490.
De Ponti R, et al. Electroanatomic mapping and ablation of macroreentrant atrial tachycardia: comparison between successfully and unsuccessfully treated cases. J Cardiovasc Electrophysiol. 2010; 21:155-162.
Latcu DG, et al. Selection of critical isthmus in scar-related atrial tachycardia using a new automated ultrahigh resolution mapping system. Circ Arrhythm Electrophysiol. 2017;10:e0045l0.
Anter E, et al. Evaluation of a novel high-resolution mapping technology for ablation of recurrent scar-related atrial tachycardias. Heart Rhythm. 2016;13:2048-2055.
Schaeffer B, et al. Characterization, mapping, and ablation of complex atrial tachycardia: initial experience with a novel method of ultra high-density 3D mapping. J Cardiovasc Electrophysiol. 2016;27: 1139-1150.
Derejko P, Podziemski P, Zebrowski JJ, et al. Effect of the restitution properties of cardiac tissue on the repeatability of entrainment mapping response. Circ Arrhythm Electrophysiol. 2014;7: 497-504.
Vollmann D, et al. Misleading long post-pacing interval after entrainment of typical atrial flutter from the cavotricuspid isthmus. J Am Coll Cardiol. 2012;59:819-824.
Wong KCK, Rajappan K, Bashir Y, et al. Entrainment with long postpacing intervals from within the flutter circuit: what is the mechanism? Circ Arrhythm Electrophysiol. 2012;5:e90-e92.
Maruyama M, et al. Number needed to entrain: a new criterion for entrainment mapping in patients with intra-atrial reentrant tachycardia. Circ Arrhythm Electrophysiol. 2014;7:490-496.
Miyazaki H, Stevenson WG, Stephenson K, et al. Entrainment mapping for rapid distinction of left and right atrial tachycardias. Heart Rhythm. 2006;3:516-523.
Santucci PA, et al. Electroanatomic mapping of postpacing intervals clarifies the complete active circuit and variants in atrial flutter. Heart Rhythm. 2009;6:1586-1595.
Esato M, et al. Color-coded three-dimensional entrainment mapping for analysis and treatment of atrial macroreentrant tachycardia. Heart Rhythm. 2009;6:349-358.
Barbhaiya CR, et al. Avoiding tachycardia alteration or termination during attempted entrainment mapping of atrial tachycardia related to atrial fibrillation ablation. Heart Rhythm. 2015;12:32-35.
Tai C-T, Chen S-A. Noncontact mapping of the heart: how and when to use. J Cardiovasc Electrophysiol. 2009;20:123-126.
Huang JL, et al. Substrate mapping to detect abnormal atrial endocardium with slow conduction in patients with atypical right atrial flutter. J Am Coll Cardiol. 2006;48:492-498.
Steven D, Seiler J, Roberts-Thomson КС, et al. Mapping of atrial tachycardias after catheter ablation for atrial fibrillation: use of bi-atrial activation patterns to facilitate recognition of origin. Heart Rhythm. 2010;7:664-672.
Enriquez A, et al. Postoperative atrial tachycardias following mitral valve surgery: mechanisms and outcomes of catheter ablation. Heart Rhythm. 2016;14:520-526.
Gopinathannair R, et al. Atrial tachycardias after surgical atrial fibrillation ablation, clinical characteristics, electrophysiological mechanisms, and ablation outcomes from a large, multicenter study. J Am Coll Cardiol EP. 2017;3:865-874.
Shah AJ, et al. Prevalence and types of pitfall in the assessment of mitral isthmus linear conduction block. Circ Arrhythm Electrophysiol. 2012;5:957-967.
Asirvatham SJ, Stevenson WG. Inequalities for left atrial ablation. Circ Arrhythm Electrophysiol. 2016;9:1-3.
Yokokawa M, Sundaram B, Garg A, et al. Impact of mitral isthmus anatomy on the likelihood of achieving linear block in patients undergoing catheter ablation of persistent atrial fibrillation. Heart Rhythm. 2011;8:1404-1410.
Berruezo A, Bisbal F, Fernandez-Armenta J. Transthoracic epicardial ablation of mitral isthmus for treatment of recurrent perimi-tral flutter. Heart Rhythm. 2014;11:26-33.
Tzeis S, et al. The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol. 2010;21: 665-670.
Coffey JO, et al. Catheter ablation of scar-related atypical atrial flutter. Europace. 2013;15:414-419.
Saoudi N, et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol. 2001;12:852-866.
Bun SS, Latcu DG, Marchlinski F, et al. Atrial flutter: more than just one of a kind. Eur Heart J. 2015;36:2356-2363.
Asirvatham SJ. Correlative anatomy and electrophysiology for the interventional electrophysiologist: right atrial flutter. J Cardiovasc Electrophysiol. 2009;20:113-122.
Faletra FF, Ho SY, Auricchio A. Anatomy of right atrial structures by real-time 3D transesophageal echocardiography. JACC Cardiovasc Imaging. 2010;3:966-975.
Tai C-T, Chen S-A. Cavotricuspid isthmus: anatomy, electrophysiology, and long-term outcome of radiofrequency ablation. Pacing Clin Electrophysiol. 2009;32:1591-1595.
Saremi F, et al. Right atrial cavotricuspid isthmus: anatomic characterization with multi-detector row CT. Radiology. 2008;247:658-668.
Garni AS, et al. Electrophysiological anatomy of typical atrial flutter: the posterior boundary and causes for difficulty with ablation. J Cardiovasc Electrophysiol. 2010;21:144-149.
Anselme F. Macroreentrant atrial tachycardia: pathophysiological concepts. Heart Rhythm. 2008;5:S18-S21.
Huang J-L, et al. Right atrial substrate properties associated with age in patients with typical atrial flutter. Heart Rhythm. 2008;5: 1144-1151.
Tai C-T, Chen S-A. Conduction barriers of atrial flutter: relation to the anatomy. Pacing Clin Electrophysiol. 2008;31:1335-1342.
Bui HM, Khrestian CM, Ryu K, et al. Fixed intercaval block in the setting of atrial fibrillation promotes the development of atrial flutter. Heart Rhythm. 2008;5:1745-1752.
Morita N, et al. The undetermined geometrical factors contributing to the transverse conduction block of the crista terminalis. Pacing Clin Electrophysiol. 2009;32:868-878.
Santucci PA, et al. Electroanatomic mapping of postpacing intervals clarifies the complete active circuit and variants in atrial flutter. Heart Rhythm. 2009;6:1586-1595.
Nakanishi T, et al. Crista terminalis as the anterior pathway of typical atrial flutter: insights from entrainment map with 3D intracardiac ultrasound. Pacing Clin Electrophysiol. 2015;38:608-616.
Waldo AL, Feld GK. Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol. 2008;51:779-786.
Waldo AL. More musing about the inter-relationships of atrial fibrillation and atrial flutter and their clinical implications. Circ Arrhythm Electrophysiol. 2013;6:453-454.
Luria DM, et al Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias. J Cardiovasc Electrophysiol 19:1145-1150 (2008).
Navarrete A, Conte F, Moran M, et al. Ablation of atrial fibrillation at the time of cavotricuspid isthmus ablation in patients with atrial flutter without documented atrial fibrillation derives a better long-term benefit. J Cardiovasc Electrophysiol. 2011; 22:34-38.
Mohanty S, et al. Results from a single-blind, randomized study comparing the impact of different ablation approaches on longterm procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation. 2013;127:1853-1860.
Schneider R, et al. Pulmonary vein triggers play an important role in the initiation of atrial flutter: initial results from the prospective randomized Atrial Fibrillation Ablation in Atrial Flutter (Triple A) trial. Heart Rhythm. 2015;12:865-871.
Ellis K, et al. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol. 2007;18:799-802.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2016;133:e506-e574.
Chao T-F, et al. Rate-control treatment and mortality in atrial fibrillation. Circulation. 2015;132:1604-1612.
Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J. 2015;36:1831-1838.
Ouyang A-J, et al. Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Am J Cardiol. 2015; 115:901-906.
Turakhia MP, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014;64:660-668.
Allen LA, et al. Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort. J Am Coll Cardiol. 2015;65:2691-2698.
January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:el-e76.
Tomson TT, et al. Risk of stroke and atrial fibrillation after radiofrequency catheter ablation of typical atrial flutter. Heart Rhythm. 2012;9:1779-1784.
Voight J, et al. Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter. Heart Rhythm. 2014;11:1884-1889.
Medi C, Kalman JM. Prediction of the atrial flutter circuit location from the surface electrocardiogram. Europace. 2008;10:786-796.
Sasaki K, et al. Revisit of typical counterclockwise atrial flutter wave in the ECG: electroanatomic studies on the determinants of the morphology. Pacing Clin Electrophysiol. 2013;36:978-987.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Miyazaki H, Stevenson WG, Stephenson K, et al. Entrainment mapping for rapid distinction of left and right atrial tachycardias. Heart Rhythm. 2006;3:516-523.
Bochoeyer A, et al. Surface electrocardiographic characteristics of right and left atrial flutter. Circulation. 2003;108:60-66.
Garan H. Atypical atrial flutter. Heart Rhythm. 2008;5:618-621.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: Part I: concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36:508-532.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J. Resetting and entrainment of reentrant arrhythmias: Part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Vollmann D, et al. Misleading long post-pacing interval after entrainment of typical atrial flutter from the cavotricuspid isthmus. J Am Coll Cardiol. 2012;59:819-824.
Wong KCK, Rajappan K, Bashir Y, et al. Entrainment with long postpacing intervals from within the flutter circuit: what is the mechanism? Circ Arrhythm Electrophysiol. 2012;5:e90-e92.
Maruyama M, et al. Number needed to entrain: a new criterion for entrainment mapping in patients with intra-atrial reentrant tachycardia. Circ Arrhythm Electrophysiol. 2014;7:490-496.
Mechulan A, et al. Further evidence for the 'muscle bundle' hypothesis of cavotricuspid isthmus conduction: physiological proof, with clinical implications for ablation. J Cardiovasc Electrophysiol. 2013;24:47-52.
Gula LJ, et al. Reduction in atrial flutter ablation time by targeting maximum voltage: results of a prospective randomized clinical trial. J Cardiovasc Electrophysiol. 2009;20:1108-1112.
Subbiah RN, et al. Rapid ablation for atrial flutter by targeting maximum voltage-factors associated with short ablation times. J Cardiovasc Electrophysiol. 2007;18:612-616.
Hindricks G, et al. Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study. J Cardiovasc Electrophysiol. 2009;20:734-740.
Lo L-W, et al. Characteristics of the cavotricuspid isthmus in predicting recurrent conduction in the long-term follow-up. J Cardiovasc Electrophysiol. 2009;20:39-43.
Shah D, et al. High-density mapping of activation through an incomplete isthmus ablation line. Circulation. 1999;99:211-215.
Bastani H, et al. Cryothermal vs. radiofrequency ablation as atrial flutter therapy: a randomized comparison. Europace. 2013;15: 420-428.
Kuniss M, et al. Prospective randomized comparison of durability of bidirectional conduction block in the cavotricuspid isthmus in patients after ablation of common atrial flutter using cryothermy and radiofrequency energy: the CRYOTIP study. Heart Rhythm. 2009;6:1699-1705.
Zambito PE, Palma EC. DP+1: another simple endpoint for atrial flutter ablation. J Cardiovasc Electrophysiol. 2008;19:10-13.
Morales GX, et al. Adenosine testing in atrial flutter ablation: unmasking of dormant conduction across the cavotricuspid isthmus and risk of recurrence. J Cardiovasc Electrophysiol. 2013;24:995-1001.
Lehrmann H, et al. 'Dormant transisthmus conduction' revealed by adenosine after cavotricuspid isthmus ablation. Heart Rhythm. 2012;9:1942-1946.
Bazan V, et al. Incremental pacing for the diagnosis of complete cavotricuspid isthmus block during radiofrequency ablation of atrial flutter. J Cardiovasc Electrophysiol. 2010;21:33-39.
Valles E, et al. Burning the gap: electrical and anatomical basis of the incremental pacing maneuver for cavotricuspid isthmus block assessment. J Cardiovasc Electrophysiol. 2016;27:694-698.
Valles E, et al. Incremental His-to-coronary sinus maneuver: a nonlocal electrogram-based technique to assess complete cavotricuspid isthmus block during typical flutter ablation. Circ Arrhythm Electrophysiol. 2013;6:784-789.
Villacastin J, et al. Usefulness of unipolar electrograms to detect isthmus block after radiofrequency ablation of typical atrial flutter. Circulation. 2000;102:3080-3085.
Lin Y-J, et al. Characteristics of virtual unipolar electrograms for detecting isthmus block during radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol. 2004;43:2300-2304.
Perez FJ, et al. Long-term outcomes after catheter ablation of cavotricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol. 2009;2:393-401.
Mykytsey A, et al. Right coronary artery occlusion during RF ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2010; 21:818-821.
Patel NJ, et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm. 2016;13:1317-1325.
Clementy N, et al. Outcomes after ablation for typical atrial flutter (from the Loire Valley Atrial Fibrillation Project). Am J Cardiol. 2014;114:1361-1367.
Saoudi N, et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North A. J Cardiovasc Electrophysiol. 2001; 12:852-866.
Scheinman MM, Yang Y, Cheng J. Atrial flutter: part II nomenclature. Pacing Clin Electrophysiol. 2004;27:504-506.
Chugh A. Adenosine and atrial tachycardia. Circ Arrhythmia Electrophysiol. 2016;9:e004449.
Hu Y-F, et al. Electrophysiologic characteristics and catheter ablation of focal atrial tachycardia with more than one focus. Heart Rhythm. 2009;6:198-203.
Medi C, et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009;53:1791-1797.
Kistler PM, et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol. 2006;48:1010-1017.
Kistler PM, et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation. 2003;108:1968-1975.
Liu CF, et al. Unifying algorithm for mechanistic diagnosis of atrial tachycardia. Circ Arrhythm Electrophysiol. 2016;9:e004028.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Circulation. 2016;133:e506-e574.
Porter MJ, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1:393-396.
Hillock RJ, Kalman JM, Roberts-Thomson КС, et al. Multiple focal atrial tachycardias in a healthy adult population: characterization and description of successful radiofrequency ablation. Heart Rhythm. 2007;4:435-438.
Brown JP, Krummen DE, Feld GK, et al. Using electrocardiographic activation time and diastolic intervals to separate focal from macro-re-entrant atrial tachycardias. J Am Coll Cardiol. 2007;49: 1965-1973.
Wang Y, Cuculich PS, Woodard PK, et al. Focal atrial tachycardia after pulmonary vein isolation: noninvasive mapping with electrocardiographic imaging (ECGI). Heart Rhythm. 2007;4:1081-1084.
Shah AJ, et al. Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J Am Coll Cardiol. 2013;62:889-897.
Huo Y, et al. Diagnosis of atrial tachycardias originating from the lower right atrium: importance of P-wave morphology in the precordial leads V3-V6. Europace. 2013;15:570-577.
Uhm JS, et al. An electrocardiography algorithm combined with clinical features could localize the origins of focal atrial tachycardias in adjacent structures. Europace. 2014;16:1061-1068.
Teh AW, Kistler PM, Kalman JM. Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia. J Cardiovasc Electrophysiol. 2009;20:706-709, quiz 705.
Wellens HJ, Josephson ME. A regular narrow QRS tachycardia in a young man. Heart Rhythm. 2016;13:812-813.
Wong MCG, et al. Left septal atrial tachycardias: electrocardiographic and electrophysiologic characterization of a paraseptal focus. J Cardiovasc Electrophysiol. 2013;24:413-418.
Iwai S, et al. Electrophysiologic properties of para-Hisian atrial tachycardia. Heart Rhythm. 2011;8:1245-1253.
Madaffari A, et al. Electrocardiographic and electrophysiological characteristics of atrial tachycardia with early activation close to the His-bundle. J Cardiovasc Electrophysiol. 2016;27:175-182.
Wang Z, et al. Focal atrial tachycardia surrounding the anterior septum: strategy for mapping and catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:575-582.
Kistler PM, et al. Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol. 2003;41:2212-2219.
Das S, et al. Catheter ablation of peri-AV nodal atrial tachycardia from the noncoronary cusp of the aortic valve. J Cardiovasc Electrophysiol. 2008;19:231-237.
Medi C, Kalman JM. Prediction of the atrial flutter circuit location from the surface electrocardiogram. Europace. 2008;10:786-796.
Crawford TC, et al. Utility of atrial and ventricular cycle length variability in determining the mechanism of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:698-703.
Maruyama M, et al. The VA relationship after differential atrial overdrive pacing: a novel tool for the diagnosis of atrial tachycardia in the electrophysiologic laboratory. J Cardiovasc Electrophysiol. 2007;18:1127-1133.
Colombowala IK, et al. Variability in post-pacing intervals predicts global atrial activation pattern during tachycardia. J Cardiovasc Electrophysiol. 2008;19:142-147.
Vijayaraman P, Lee BP, Kalahasty G, et al. Reanalysis of the 'pseudo A-A-V' response to ventricular entrainment of supraventricular tachycardia: importance of his-bundle timing. J Cardiovasc Electrophysiol. 2006;17:25-28.
Katritsis DG, Camm AJ. Atrioventricular nodal reentrant tachycardia. Circulation. 2010;122:831-840.
Long DY, et al. Electroanatomical mapping of the right atrium during atrial tachycardia originating from right superior pulmonary vein: additional insights on differential diagnosis. Pacing Clin Electrophysiol. 2015;38:91-98.
Chang K-C, Chen J-Y, Lin Y-C, et al. Usefulness of interatrial conduction time to distinguish between focal atrial tachyarrhythmias originating from the superior vena cava and the right superior pulmonary vein. J Cardiovasc Electrophysiol. 2008;19: 1231-1235.
Hayashi K, et al. Pace mapping for the identification of focal atrial tachycardia origin. Circ Arrhythm Electrophysiol. 2016;9:e003930.
Mohamed U, et al. A novel pacing maneuver to localize focal atrial tachycardia. J Cardiovasc Electrophysiol. 2007;18:1-6.
Okubo K, et al. Rapid mapping of right atrial tachycardia using a new multielectrode basket catheter. J Cardiovasc Electrophysi-ol. 2016;27:73-79.
Wetzel U, et al. A stepwise mapping approach for localization and ablation of ectopic right, left, and septal atrial foci using elec-troanatomic mapping. Eur Heart J. 2002;23:1387-1393.
Pap R, et al. Should the aortic root be the preferred route for ablation of focal atrial tachycardia around the AV node? Support from intracardiac echocardiography. JACC Clin Electrophysiol. 2016;2:193-199.
Yang J-D, et al. Focal atrial tachycardias from the parahisian region: strategies for mapping and catheter ablation. Heart Rhythm. 2017;14:1344-1350.
Lyan E, et al. Comparison of strategies for catheter ablation of focal atrial tachycardia originating near the His bundle region. Heart Rhythm. 2016;14:998-1005.
Tada H. Catheter ablation of tachyarrhythmias from the aortic sinuses of Valsalva. Circ J. 2012;76:791-800.
Markowitz SM. What is the optimal approach to ablation of parahisian atrial tachycardias? JACC Clin Electrophysiol. 2016;2:200-202.
Tovia-brodie O, Rosso R, Belhassen B. Atrial tachycardia originating in the vicinity of the noncoronary sinus of Valsalva : report of a series including the first case of ablation-related complete. Pacing Clin Electrophysiol. 2016;39:1165-1173.
Johnsrude C. Cryoablation of focal tachycardia originating from the right atrial free wall during upstream phrenic pacing to avoid phrenic nerve injury. Pacing Clin Electrophysiol. 2015;38:120-128.
Surawicz В, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee. Circulation. 2009;119:e235-e240.
El-Sherif N, Jalife J. Paroxysmal atrioventricular block: are phase 3 and phase 4 block mechanisms or misnomers? Heart Rhythm. 2009;6:1514-1521.
Cabo C. Post-repolarization refractoriness increases vulnerability to block and initiation of reentrant impulses in heterogeneous infarcted myocardium. Comput Biol Med. 2015;65:209-219.
Brignole M, et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol. 2011;58:167-173.
Divakara Menon SM, Ribas CS, Ribas Meneclier CA, et al. Intermittent atrioventricular block: what is the mechanism? Heart Rhythm. 2012;9:154-155.
Carbone V, Carerj S, Calabro MP. Bundle branch block on alternate beats during atrial fibrillation. J Electrocardiol. 2004;37:67-72.
Dobrzynski H, et al. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Ther. 2013;139:260-288.
Syed FF, Hai JJ, Lachman N, et al. The infrahisian conduction system and endocavitary cardiac structures: relevance for the invasive electrophysiologist. J Interv Card Electrophysiol. 2014;39:45-56.
Kaneko Y, et al. Discrimination between His-bundle and the right bundle branch during electrophysiologic studies. Pacing Clin Electrophysiol. 2009;32:72-75.
Boyden PA, Hirose M, Dun W. Cardiac Purkinje cells. Heart Rhythm. 2010;7:127-135.
Severs NJ. The cardiac muscle cell. Bioessays. 2000;22:188-199.
Gorenek B, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHR A, ACCA, and EAPCI task force. EuroIntervention. 2015;10:1095-1108.
Vijayaraman P, Naperkowski A, Ellenbogen KA, et al. Electrophysiologic insights into site of atrioventricular block lessons from permanent His bundle pacing. JACC Clin Electrophysiol. 2015; 1:571-581.
Dandamudi G, Vijayaraman P. How to perform permanent his bundle pacing in routine clinical practice. Hear Rhythm. 2016;13:1-5.
Elizari MV, Acunzo RS, Ferreiro M. Hemiblocks revisited. Circulation. 2007;115:1154-1163.
Eschalier R, et al. Nonspecific intraventricular conduction delay: definitions, prognosis, and implications for cardiac resynchronization therapy. Heart Rhythm. 2015;12:1071-1079.
Tzogias L, et al. Electrocardiographic features and prevalence of bilateral bundle-branch delay. Circ Arrhythm Electrophysiol. 2014;7:640-644.
Kumar V, et al. Implications of left bundle branch block in patient treatment. Am J Cardiol. 2013;111:291-300.
Lewinter C, Torp-Pedersen C, Cleland JGF, et al. Right and left bundle branch block as predictors of long-term mortality following myocardial infarction. Eur J Heart Fail. 2011;13:1349-1354.
Bussink BE, et al. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Eur Heart J. 2013;34:138-146.
Fernandez-Lozano I, Brugada J. Right bundle branch block: are we looking in the right direction? Eur Heart J. 2013;34:86-88.
Breithardt G, Breithardt О-A. Left bundle branch block, an old-new entity. J Cardiovasc Transl Res. 2012;5:107-116.
Josephson ME, Wellens HJJ. The ECG in left bundle branch block and heart failure. Heart Rhythm. 2015;12:250-251.
Mascioli G, et al. Electrocardiographic criteria of true left bundle branch block: a simple sign to predict a better clinical and instrumental response to CRT. Pacing Clin Electrophysiol. 2012;35:927-934.
Galeotti L, van Dam PM, Loring Z, et al. Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations. Europace. 2013;15:1816-1821.
Strauss DG, Selvester RH, Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cardiol. 2011;107:927-934.
Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guide. Circulation. 2013;l27:e283-e352.
Padanilam BJ, et al. The surface electrocardiogram predicts risk of heart block during right heart catheterization in patients with preexisting left bundle branch block: implications for the definition of complete left bundle branch block. J Cardiovasc Electrophysiol. 2010;21:781-785.
Dobrzynski Н, et al. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Ther. 2013;139:260-288.
Nikolaidou T, Aslanidi OV, Zhang H, et al. Structure-function relationship in the sinus and atrioventricular nodes. Pediatr Cardiol. 2012;33:890-899.
Chhabra L, Devadoss R, Chaubey VK, et al. Interatrial block in the modern era. Curr Cardiol Rev. 2014;10:181-189.
Teuwen CP, et al. Relevance of conduction disorders in Bachmann's bundle during sinus rhythm in humans. Circ Arrhythm Electrophysiol. 2016;9:e003972.
Faletra FF, Ho SY, Auricchio A. Anatomy of right atrial structures by real-time 3D transesophageal echocardiography. JACC Car-diovasc Imaging. 2010;3:966-975.
Lee P-C, Chen S-A, Hwang B. Atrioventricular node anatomy and physiology: implications for ablation of atrioventricular nodal reentrant tachycardia. Curr Opin Cardiol. 2009;24:105-112.
Kurian T, Ambrosi C, Hucker W, et al. Anatomy and electrophysiology of the human AV node. Pacing Clin Electrophysiol. 2010;33:754-762.
Syed FF, Hai JJ, Lachman N, et al. The infrahisian conduction system and endocavitary cardiac structures: relevance for the invasive electrophysiologist. J Interv Card Electrophysiol. 2014;39:45-56.
Dandamudi G, Vijayaraman P. The complexity of the His bundle: understanding its anatomy and physiology through the lens of the past and the present. Pacing Clin Electrophysiol. 2016;39: 1294-1297.
Eliasson H, et al. Outcome in young patients with isolated complete atrioventricular block and permanent pacemaker treatment: a nationwide study of 127 patients. Heart Rhythm. 2015;12:2278-2284.
DE Caluwe E, et al. Long-term follow-up of children with heart block born from mothers with systemic lupus erythematosus: a retrospective study from the Database Pediatric and Congenital Heart Disease in University Hospitals Leuven. Pacing Clin Electrophysiol. 2016;39:935-943.
Lazzerini PE, Capecchi PL, Laghi-Pasini F. Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications. Heart Rhythm. 2015;12:449-454.
Brugada J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15:1337-1382.
Khairy P, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). En. Heart Rhythm. 2O14;11: e!02-el65.
Milanesi R, Bucchi A, Baruscotti M. The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction. J Interv Card Electrophysiol. 2015;43:121-134.
Priori SG, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. Heart Rhythm. 2013;10:1932-1963.
Park DS, Fishman GI. The cardiac conduction system. Circulation. 2011;123:904-915.
Brignole M, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Europace. 2013;15:1070-1118.
Gang UJO, et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace. 2012;14: 1639-1645.
Nguyen HL, et al. Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: a population-based perspective. Am Heart J. 2008;156:227-233.
Gorenek B, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and E APCI task force. EuroIntervention. 2015;10:1095-1108.
Robinson ML, Kobayashi T, Higgins Y, et al. Lyme carditis. Infect Dis Clin North Am. 2015;29:255-268.
Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guide. Circulation. 2013;127:e28 3-e352.
Nunes MCP, Dones W, Morillo CA, et al. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62:767-776.
Sekhri V, Sanai S, Delorenzo LJ, et al. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci. 2011;7:546-554.
Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305-1323.
Uberoi A, et al. Interpretation of the electrocardiogram of young athletes. Circulation. 2011;124:746-757.
Gross GJ, Chiu CC, Hamilton RM, et al. Natural history of postoperative heart block in congenital heart disease: implications for pacing intervention. Heart Rhythm. 2006;3:601-604.
Ayyildiz P, et al. Evaluation of permanent or transient complete heart block after open heart surgery for congenital heart disease. Pacing Clin Electrophysiol. 2015;39:160-165.
Gersh BJ, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:e21 2-e260.
Huynh H, et al. Permanent pacemaker implantation following aortic valve replacement: current prevalence and clinical predictors. Pacing Clin Electrophysiol. 2009;32:1520-1525.
Leyva F, et al. Long-term requirement for pacemaker implantation after cardiac valve replacement surgery. Heart Rhythm. 2017;14:529-534.
Siontis GCM, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64:129-140.
Rivard L, et al. Electrocardiographic and electrophysiological predictors of atrioventricular block after transcatheter aortic valve replacement. Heart Rhythm. 2015;12:321-329.
Dijk KB, et al. Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pace. 2014;37:1-10.
Ramazzina C, et al. Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation. Pacing Clin Electrophysiol. 2014;37:1592-1601.
Tovia-Brodie O, et al. The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI. J Interv Card Electrophysiol. 2017;48:121-130.
Sheldon RS, et al. Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;l2:e41-e63.
Brignole M, et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol. 2011;58:167-173.
Brignole M, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: third international study on syncope of uncertain etiology (ISSUE-3): a randomized trial. Circulation. 2012;125:2566-2571.
El-Sherif N, Jalife J. Paroxysmal atrioventricular block: are phase 3 and phase 4 block mechanisms or misnomers? Heart Rhythm. 2009;6:1514-1521.
Brignole M, Deharo JC, Guieu R. Syncope and idiopathic (paroxysmal) AV block. Card Electrophysiol Clin. 2013;5:487-493.
Brignole M, et al. Mechanism of syncope without prodromes with normal heart and normal electrocardiogram. Heart Rhythm. 2016;14: 234-239.
Cho MS, et al. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block. Heart Rhythm. 2015;12:498-505.
Magnani JW, et al. Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol. 2013;6:84-90.
Nikolaidou T, Ghosh JM, Clark AL. Outcomes related to first-degree atrioventricular block and therapeutic implications in patients with heart failure. JACC Clin Electrophysiol. 2016;2:181-192.
Spodick DH, Ariyarajah V. Interatrial block: the pandemic remains poorly perceived. Pacing Clin Electrophysiol. 2009;32:667-672.
Nelson WP. Diagnostic and prognostic implications of surface recordings from patients with atrioventricular block. Card Electrophysiol Clin. 2016;8:25-35.
Bonner AJ, Zipes DP. Lidocaine and His bundle extrasystoles. His bundle discharge conducted with functional right of left bundlebranch block, or blocked entirely (concealed). Arch Intern Med. 1976;136:700-704.
Vijayaraman P, Naperkowski A, Ellenbogen KA, et al. Electrophysiologic insights into site of atrioventricular block: lessons from permanent His bundle pacing. JACC Clin Electrophysiol. 2015;!: 571-581.
Gillis AM, et al. HRS/ ACCF expert consensus statement on pacemaker device and mode selection. J Am Coll Cardiol. 2012;60:682-703.
Khurshid S, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014,11:1619-1625.
Kaye GC, et al. Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study. Eur Heart J. 2015;36:856-862.
Hussain MA, Furuya-Kanamori L, Kaye G, et al. The effect of right ventricular apical and nonapical pacing on the short- and longterm changes in left ventricular ejection fraction: a systematic review and meta-analysis of randomized-controlled trials. Pacing Clin ElectrophysioL 2015;38:1121-1136.
Arenas IA, Jacobson J, Lamas GA. Routine use of biventricular pacing is not warranted for patients with heart block. Circ Arrhythmia ElectrophysioL 2015;8:730-737.
Kiehl EL, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 2016;13:2272-2278.
Curtis AB, et aL Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl / Med. 2013;368:1585-1593.
Fang F, Sanderson JE, Yu CM. All heart block patients with a pacemaker indication should receive biventricular pacing: one move, double the gains? Circ Arrhythmia Electrophysiol. 2015;8:722-728.
Vijayaraman P, Dandamudi G, Bauch T, et al. Imaging evaluation of implantation site of permanent direct His bundle pacing lead. Heart Rhythm. 2014;l 1:529-530.
Sharma PS, et al. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 2015;12:305-312.
Dandamudi G. Vijayaraman, P. How to perform permanent His bundle pacing in routine clinical practice. Heart Rhythm. 2016;13:1-5.
Vijayaraman P, Dandamudi G. How to perform permanent His bundle pacing: tips and tricks. Pacing Clin Electrophysiol. 2016;39: 1298-1304.
Sharma PS, Ellenbogen KA, Trohman RG. Permanent His bundle pacing: the past, present and future. J Cardiovasc ElectrophysioL 2017;28:458-465.
Sanchez-Quintana D, et al. Sinus node revisited in the era of elec-troanatomical mapping and catheter ablation. Heart. 2005;91: 189-194.
Anderson RH, Yanni J, Boyett MR, et al. The anatomy of the cardiac conduction system. Clin Anat. 2009;22:99-113.
Murphy С, Lazzara R. Current concepts of anatomy and electrophysiology of the sinus node. J Interv Card Electrophysiol. 2016; 46:9-18.
Ho SY, Sanchez-Quintana D. Anatomy and pathology of the sinus node. J Interv Card Electrophysiol. 2016;46:3-8.
Lau DH, Roberts-Thomson КС, Sanders P. Sinus node revisited. Curr Opin Cardiol. 2011;26:55-59.
Unudurthi SD, Wolf RM, Hund TJ. Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking. Front Physiol. 2014;5:446.
Nikolaidou T, Aslanidi OV, Zhang H, et al. Structure-function relationship in the sinus and atrioventricular nodes. Pediatr Cardiol. 2012;33:890-899.
Milanesi R, Bucchi A, Baruscotti M. The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction. J Interv Card Electrophysiol. 2015;43:121-134.
Monfredi O, Dobrzynski H, Mondal T, et al. The anatomy and physiology of the sinoatrial node—a contemporary review. Pacing Clin Electrophysiol. 2010;33:1392-1406.
Fedorov W, Glukhov AV, Chang R. Conduction barriers and pathways of the sinoatrial pacemaker complex: their role in normal rhythm and atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2012;302:Н1773-Н1783.
Stiles MK, et al. High-density mapping of the sinus node in humans: role of preferential pathways and the effect of remodeling. J Cardiovasc Electrophysiol. 2010;21:532-539.
Lou Q, et al. Upregulation of adenosine Al receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dualsided intramural optical mapping. Circulation. 2014;130:315-324.
Luo M, et al. Diabetes increases mortality after myocardial infarction by oxidizing СаМКП. J Clin Invest. 2013;123:1262-1274.
Wolf RM, et al. Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis. Am J Physiol Heart Circ Physiol. 2013;304:H1253-H1266.
Csepe TA, Kalyanasundaram A, Hansen BJ, et al. Fibrosis: a structural modulator of sinoatrial node physiology and dysfunction. Front Physiol. 2015;6:37.
Chang H-Y, et al. Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling. Europace. 2013;15:205-211.
Joung B, et al. Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillation. Heart Rhythm. 2010;7:88-95.
Yeh Y-H, et al. Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: a molecular basis for tachycardia-bradycardia syndrome. Circulation. 2009; 119:1576-1585.
Lou Q, et al. Tachy-brady arrhythmias: the critical role of adenosine-induced sinoatrial conduction block in post-tachycardia pauses. Heart Rhythm. 2013;10:110-118.
O'Neal WT, et al. Chronotropic incompetence and risk of atrial fibrillation: the Henry Ford Exercise Testing (FIT) project. JACC Clin Electrophysiol. 2016;2:645-652.
Tellez JO, et al. Ageing-dependent remodelling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol. 2011;96:1163-1178.
Li G, et al. Atrial electrical remodeling in a canine model of sinus node dysfunction. Int J Cardiol. 2011;146:32-36.
Yanni J, et al. Changes in ion channel gene expression underlying heart failure-induced sinoatrial node dysfunction. Circ Heart Fail. 2011;4:496-508.
Medi C, et al. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electrophysiol. 2012;23:614-620.
Dimitri H, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9:321-327.
Nof E, Glikson M, Antzelevitch C. Genetics and sinus node dysfunction. J Atr Fibrillation. 2009;1:328-336.
Park DS, Fishman GI. The cardiac conduction system. Circulation. 2011;123:904-915.
Brugada J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15:1337-1382.
Chiang DY, et al. Loss-of-function SCN5A mutations associated with sinus node dysfunction, atrial arrhythmias, and poor pacemaker capture. Circ Arrhythm Electrophysiol. 2015;8: 1105-1112.
Verkerk AO, Wilders R. Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in hcn4 on the hyperpolarization-activated current. Int J Mol Sci. 2015;16:3071-3094.
Ishikawa T, et al. Novel mutation in the a-myosin heavy chain gene is associated with sick sinus syndrome. Circ Arrhythm Elec-trophysiol. 2015;8:400-408.
Khairy P, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Heart Rhythm. 2014;ll:el02-el65.
Sheldon RS, et al. Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41-e63.
Uberoi A, et al. Interpretation of the electrocardiogram of young athletes. Circulation. 2011;124:746-757.
Jensen PN, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol. 2014;64:531-538.
Gillis AM, et al. HRS/ACCF expert consensus statement on pacemaker device and mode selection. J Am Coll Cardiol. 2012;60: 682-703.
Graff B, et al. Electrophysiological features in patients with sinus node dysfunction and vasovagal syncope. Arch Med Sci. 2011;7: 963-970.
Epstein AE, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guide. Circulation. 2013;127:e28 3-e352.
Chen YW, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37:403-411.
Kirkfeldt RE, Andersen HR, Nielsen JC. System upgrade and its complications in patients with a single lead atrial pacemaker: data from the DANPACE trial. Europace. 2013;15:1166-1173.
Auricchio A, Ellenbogen KA. Reducing ventricular pacing frequency in patients with atrioventricular block. Circ Arrhythm Electro-physioL 2016;9:e004404.
Botto GL, et al. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Heart Rhythm. 2014;11:992-1000.
Magnani JW, et al. Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol. 2013;6:84-90.
Padeletti L, et al. New-generation atrial antitachycardia pacing (reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: results from the MINERVA randomized multicenter international trial. Heart Rhythm. 2015,12:1717-1725.
Swedberg K, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet (London, England). 2010;376:875-885.
Dhillon PS, Gonna Н, Li A, et al. Skin burns associated with radiofrequency catheter ablation of cardiac arrhythmias. Pacing Clin Electrophysiol. 2013;36:764-767.
Koruth JS, et al. Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits. Heart Rhythm. 2012;9:1932-1941.
Nguyen DT, et al. Clinical and biophysical evaluation of variable bipolar configurations during radiofrequency ablation for treatment of ventricular arrhythmias. Heart Rhythm. 2016;13:2161-2171.
Boersma LV, et al. Multielectrode pulmonary vein isolation versus single tip wide area catheter ablation for paroxysmal atrial fibrillation: a multinational multicenter randomized clinical trial. Circ. Arrhythm. Electrophysiol. 2016;9:1-8.
Greef YDE, et al. Impact of radiofrequency characteristics on acute pulmonary vein reconnection and clinical outcome after PVAC ablation. J Cardiovasc Electrophysiol. 2013;24:290-296.
Compier MG, et al. Duty-cycled bipolar/unipolar radiofrequency ablation for symptomatic atrial fibrillation induces significant pulmonary vein narrowing at long-term follow-up. Europace. 2013;15:690-696.
Shin DI, et al. Initial results of using a novel irrigated multielectrode mapping and ablation catheter for pulmonary vein isolation. Heart Rhythm. 2014;11:375-383.
Rosso R, et al. Radiofrequency ablation of paroxysmal atrial fibrillation with the new irrigated multipolar nMARQ ablation catheter: verification of intracardiac signals with a second circular mapping catheter. Heart Rhythm. 2014;11:559-565.
Stabile G, et al. Safety and efficacy of pulmonary vein isolation using a circular, open-irrigated mapping and ablation catheter: a multicenter registry. Heart Rhythm. 2015;12:1782-1788.
Garabelli PJ, Stavrakis S, Po SS. A case series and review of the literature regarding coronary artery complications associated with coronary sinus catheter ablation. Heart Case Reports. 2015;l: 315-319.
Yamada T. Transthoracic epicardial catheter ablation. Circ J. 2013;77: 1672-1680.
Nguyen DT, et al. Effect of irrigant characteristics on lesion formation after radiofrequency energy delivery using ablation catheters with actively cooled tips. J Cardiovasc Electrophysiol. 2015;26:792-798.
Koruth JS, et al. Occurrence of steam pops during irrigated RF ablation: novel insights from microwave radiometry. J Cardiovasc Electrophysiol. 2013;24:1271-1277.
Ikeda A, et al. Relationship between catheter contact force and radiofrequency lesion size and incidence of steam pop in the beating canine heart: electrogram amplitude, impedance, and electrode temperature are poor predictors of electrode-tissue contact force and lesion. Circ. Arrhythmia Electrophysiol. 2014;7:1174-1180.
Shah DC, Namdar M. Real-time contact force measurement: a key parameter for controlling lesion creation with radiofrequency energy. Circ. Arrhythmia Electrophysiol. 2015;8:713-721.
Akca F, et al. Radiofrequency ablation at low irrigation flow rates using a novel 12-hole gold open-irrigation catheter. Pacing Clin Electrophysiol. 2013;36:1373-1381.
Akca F, et al. High-volume lesions using a new second-generation open irrigation radiofrequency catheter are associated with the development of inhomogeneous lesions. Pacing Clin Electrophysiol. 2014;37:864-873.
Hussein AA, et al. Radiofrequency ablation with an enhanced-irrigation flexible-tip catheter versus a standard-irrigation rigid-tip catheter. Pacing Clin Electrophysiol. 2015;38:1151-1158.
Reichlin T, et al. Initial impedance decrease as an indicator of good catheter contact: insights from radiofrequency ablation with force sensing catheters. Heart Rhythm. 2014;11:194-201.
Chinitz JS, et al. Sites with small impedance decrease during catheter ablation for atrial fibrillation are associated with recovery of pulmonary vein conduction. J Cardiovasc Electrophysiol. 2016;27:1390-1398.
Kosmidou I, Houde-Walter H, Foley L, et al. Loss of pace capture after radiofrequency application predicts the formation of uniform transmural lesions. Europace. 2013;15:601-606.
Kapa S, Asirvatham SJ. Maintaining contact for effective mapping and ablation. Circ. Arrhythmia Electrophysiol. 2014;7:781-784.
Di Biase L, et al. Visual, tactile, and contact force feedback: which one is more important for catheter ablation? Results from an in vitro experimental study. Heart Rhythm. 2014;11:506-513.
Kumar S, et al. Predictive value of impedance changes for realtime contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm. 2013;10:962-969.
Anter E, Tschabrunn CM, Contreras-Valdes FM, et al. Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation. Heart Rhythm. 2014;11:783-790.
Okumura Y, et al. Effect of catheter tip-tissue surface contact on three-dimensional left atrial and pulmonary vein geometries: potential anatomic distortion of 3D ultrasound, fast anatomical mapping, and merged 3D CT-derived images. J Cardiovasc Electrophysiol. 2013;24:259-266.
Bunch TJ, Day JD. The atrial fibrillation ablation theory of relativity. J Cardiovasc Electrophysiol. 2013;24:267-268.
Sasaki N, et al. Relations between contact force, bipolar voltage amplitude, and mapping point distance from the left atrial surfaces of 3D ultrasound - and merged 3D CT-derived images: implication for atrial fibrillation mapping and ablation. Heart Rhythm. 2015;12:36-43.
Bourier F, et al. Electromagnetic contact-force sensing electrophysiological catheters: how accurate is the technology? J Cardiovasc Electrophysiol. 2016;27:347-350.
Afzal MR, et al. Use of contact force sensing technology during radiofrequency ablation reduces recurrence of atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2015;12: 1990-1996.
Koutalas E, et al. Contemporary mapping techniques of complex cardiac arrhythmias—identifying and modifying the arrhythmogenic substrate. Arrhythmia Electrophysiol Rev. 2015;4:19.
Barnett AS, Bahnson TD, Piccini JP. Recent advances in lesion formation for catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9:e003299.
Andreu D, et al. Contact force threshold for permanent lesion formation in atrial fibrillation ablation: a cardiac magnetic resonancebased study to detect ablation gaps. Heart Rhythm. 2016;13:37-45.
Reddy VY, et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012;9:1789-1795.
Williams SE, et al. The effect of contact force in atrial radiofrequency ablation electroanatomical, cardiovascular magnetic resonance, and histological assessment in a chronic porcine model. JACC Clin Electrophysiol. 2015;1:421-431.
Reddy VY, et al. Relationship between catheter stability and 12-month success after pulmonary vein isolation. JACC Clin Electrophysiol. 2016;2:691-699.
Fujiwara R, et al. The importance of catheter stability evaluated by Visitag(TM) during pulmonary vein isolation. J Interv Card Electrophysiol. 2016;46:161-166.
Okumura Y, et al. Clinical utility of automated ablation lesion tagging based on catheter stability information (VisiTag Module of the CARTO 3 System) with contact force-time integral during pulmonary vein isolation for atrial fibrillation. J Interv Card Electrophysiol. 2016;47:245-252.
Sarkozy A, et al. Contact force in atrial fibrillation: role of atrial rhythm and ventricular contractions: co-force atrial fibrillation study. Circ Arrhythmia Electrophysiol. 2015;8:1342-1350.
Chik WWB, et al. Electrogram-gated radiofrequency ablations with duty cycle power delivery negate effects of ablation catheter motion. Circ Arrhythmia Electrophysiol. 2014;7:920-928.
Wright M, et al. Visualizing intramyocardial steam formation with a radiofrequency ablation catheter incorporating near-field ultrasound. J Cardiovasc Electrophysiol. 2013;24:1403-1409.
Chung FP, Chen SA. Avoiding steam explosions during catheter ablation: 'Stopping before popping'. J Cardiovasc Electrophysiol. 2013;24:1410-1411.
Guerra JM, et al. Effects of open-irrigated radiofrequency ablation catheter design on lesion formation and complications: in vitro comparison of 6 different devices. J Cardiovasc Electrophysiol. 2013;24:1157-1163.
Winterfield JR, et al. Lesion size and safety comparison between the novel flex tip on the FlexAbility ablation catheter and the solid tips on the ThermoCool and ThermoCool SF ablation catheters. J Cardiovasc Electrophysiol. 2016;27:102-109.
Hocini М, Condie С, Stewart МТ, et al. Predictability of lesion durability for AF ablation using phased radiofrequency: power, temperature, and duration impact creation of transmural lesions. Heart Rhythm. 2016;13:1521-1526.
Wieczorek M, et al. Investigation into causes of abnormal cerebral MRI findings following PVAC duty-cycled, phased RF ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:121-128.
Debruyne P, et al. Formation of thermal coagulum on multielectrode catheters during phased radiofrequency energy ablation of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2014;37: 188-196.
Kiss A, Sa'ndorfi G, Nagy-balo' E, et al. Phased RF ablation: results and concerns. J Atr Fibrillation. 2015;8:1240.
Wieczorek M, Hoeltgen R, Brueck M. Does the number of simultaneously activated electrodes during phased RF multielectrode ablation of atrial fibrillation influence the incidence of silent cerebral microembolism? Heart Rhythm. 2013;10:953-959.
Mittal S, Steinberg JS. The last shot for 'one shot' pulmonary vein isolation with radiofrequency energy? J Cardiovasc Electrophysiol. 2014;25:346-348.
Nagy-Balo E, et al. Predictors of cerebral microembolization during phased radiofrequency ablation of atrial fibrillation: analysis of biophysical parameters from the ablation generator. Heart Rhythm. 2014;11:977-983.
Weber S, Hbher M, Schultes D. First results and follow-up of a second-generation circular mapping and ablation catheter. J Interv Card Electrophysiol. 2016;47:213-219.
Burri H, et al. Pulmonary vein isolation for paroxysmal atrial fibrillation using a circular multipolar ablation catheter: safety and efficacy using low-power settings. J Cardiovasc Electrophysiol. 2016;27:170-174.
Rosso R, et al. Radiofrequency ablation of atrial fibrillation: nonrandomized comparison of circular versus point-by-point 'smart' ablation for achieving circumferential pulmonary vein isolation and curing arrhythmic symptoms. J Cardiovasc Electrophysiol. 2016;[Epub ahead of print].
Avitall B, Kalinski A. Cryotherapy of cardiac arrhythmia: from basic science to the bedside. Heart Rhythm. 2015;12:2195-2203.
Andrade JG, Khairy P, Dubuc M. Catheter cryoablation: biology and clinical uses. Circ Arrhythmia Electrophysiol. 2013;6:218-227.
Kaszala K, Ellenbogen KA. Biophysics of the second-generation cryoballoon: cryobiology of the big freeze. Circ Arrhythmia Electrophysiol. 2015;8:15-17.
Hernandez-Romero D, et al. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation. Pacing Clin Electrophysiol. 2013;36:31-36.
Malmborg H, Christersson C, Lonnerholm S, et al. Comparison of effects on coagulation and inflammatory markers using a duty-cycled bipolar and unipolar radiofrequency pulmonary vein ablation catheter vs. a cryoballoon catheter for pulmonary vein isolation. Europace. 2013;15:798-804.
Ciconte G, et al. On the quest for the best freeze: predictors of late pulmonary vein reconnections after second-generation cryoballoon ablation. Circ Arrhythmia Electrophysiol. 2015;8:1359-1365.
Bessiere F, et al. Focal transcatheter cryoablation: is a four-minute application still required? J Cardiovasc Electrophysiol. 2017;28: 559-563.
Kenigsberg DN, Martin N, Lim HW, et al. Quantification of the cryoablation zone demarcated by pre- and postprocedural electroana-tomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. Heart Rhythm. 2015;12:283-290.
Betts TR, et al. Feasibility of mitral isthmus and left atrial roof linear lesions using an 8 mm tip cryoablation catheter. J Cardiovasc Electrophysiol. 2013;24:775-781.
Kiplapinar N, et al. Assessment of atrioventricular conduction following cryoablation of atrioventricular nodal reentrant tachycardia in children. Pacing Clin Electrophysiol. 2014;37:712-716.
Pieragnoli P, et al. Cryoablation of typical AVNRT: younger age and administration of bonus ablation favor long-term success. Heart Rhythm. 2015;12:2125-2131.
Qureshi MY, Ratnasamy C, Sokoloski M, et al. Low recurrence rate in treating atrioventricular nodal reentrant tachycardia with triple freeze-thaw cycles. Pacing Clin Electrophysiol. 2013;36:279-285.
Hanninen M, et al. Cryoablation versus RF ablation for AVNRT: a meta-analysis and systematic review. J Cardiovasc Electrophysiol. 2013;24:1354-1360.
Karadeniz C, Akdeniz C, Turan O, et al. Cryoablation of septal accessory pathways in children: midterm results. Pacing Clin Electrophysiol. 2014;37:1095-1099.
Collins KK. Cryoablation, limited fluoroscopy, and more. Pacing Clin Electrophysiol. 2014;37:1093-1094.
Swissa M, et al. Cryotherapy ablation of parahisian accessory pathways in children. Heart Rhythm. 2015;12:917-925.
Cardoso R, et al. Cryoballoon versus radiofrequency catheter ablation in atrial fibrillation: a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1151-1159.
Liu X-H, Chen C-F, Gao X-F, et al. Safety and efficacy of different catheter ablations for atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2016;39:883-899.
Koektuerk B, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8:1073-1079.
Guhl EN, et al. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:423-427.
Boveda S, et al. Outcomes after cryoballoon or radiofrequency ablation for persistent atrial fibrillation: a multicentric propensityscore matched study. J Interv Card Electrophysiol. 2016;47:133-142.
Di Biase L, et al. Safety and outcomes of cryoablation for ventricular tachyarrhythmias: results from a multicenter experience. Heart Rhythm. 2011;8:968-974.
Bordignon S, et al. Energy titration strategies with the endoscopic ablation system: lessons from the high-dose vs. low-dose laser ablation study. Europace. 2013;15:685-689.
Dukkipati SR, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6:467-472.
Dukkipati SR, et al. Pulmonary vein isolation using the visually guided laser balloon a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J Am Coll Cardiol. 2015;66:1350-1360.
Buch E, Shivkumar K. Catheter ablation of atrial fibrillation advent of second-generation technologies. J Am Coll Cardiol. 2015;66: 1361-1363.
Miller DL, et al. Overview of therapeutic ultrasound applications and safety considerations. J Ultrasound Med. 2012;31:623-634.
Laughner JI, Sulkin MS, Wu Z, et al. Three potential mechanisms for failure of high intensity focused ultrasound ablation in cardiac tissue. Circ Arrhythmia Electrophysiol. 2012;5:409-416.
Wu Z, Kumon RE, Laughner JI, et al. Electrophysiological changes correlated with temperature increases induced by high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41:432-448.
Neven K, Metzner A, Schmidt B, et al. Two-year clinical followup after pulmonary vein isolation using high-intensity focused ultrasound (HIFU) and an esophageal temperature-guided safety algorithm. Heart Rhythm. 2012;9:407-413.
Tse H-F, et al. Determinants of lesion dimensions during transcatheter microwave ablation. Pacing Clin Electrophysiol. 2009; 32:201-208.
Vicol C, et al. Long-term results after ablation for long-standing atrial fibrillation concomitant to surgery for organic heart disease: is microwave energy reliable? J Thorac Cardiovasc Surg. 2008;136:1156-1159.
DeSimone CV, Kapa S, Asirvatham SJ. Electroporation past and future of catheter ablation. Circ Arrhythmia Electrophysiol. 2014; 7:573-575.
Kotnik T, et al. Electroporation-based applications in biotechnology. Trends Biotechnol. 2015;33:480-488.
Jiang C, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng. 2015;62:4-20.
van Driel VJHM, et al. Pulmonary vein stenosis after catheter ablation: electroporation versus radiofrequency. Circ Arrhythmia Electrophysiol. 2014;7:734-738.
Du Pre BC, et al. Minimal coronary artery damage by myocardial electroporation ablation. Europace. 2013;15:144-149.
Neven K, et al. Myocardial lesion size after epicardial electroporation catheter ablation after subxiphoid puncture. Circ Arrhythmia Electrophysiol. 2014;7:728-733.
Del Carpio Munoz F, Buescher TL, Asirvatham SJ. Three-dimensional mapping of cardiac arrhythmias: what do the colors really mean? Circ Arrhythmia Electrophysiol. 2010;3:e6-ell.
Koutalas E, et al. Contemporary mapping techniques of complex cardiac arrhythmias—identifying and modifying the arrhythmo-genic substrate. Arrhythmia Electrophysiol Rev. 2015;4:19.
Kumar P, Mounsey JP, Chung EH. Adjusting voltage criteria can unmask conducting channels in a patient with arrhythmogenic right ventricular cardiomyopathy and ventricular tachycardia. Heart Case Reports. 2015;1:275-278.
Okumura Y, et al. Effect of catheter tip-tissue surface contact on three-dimensional left atrial and pulmonary vein geometries: potential anatomic distortion of 3D ultrasound, fast anatomical mapping, and merged 3D CT-derived images. J Cardiovasc Electrophysiol. 2013;24:259-266.
Kimura M, et al. Validation of accuracy of three-dimensional left atrial CartoSound™ and CT image integration: influence of respiratory phase and cardiac cycle. J Cardiovasc Electrophysiol. 2013;24:1002-1007.
Mantziari L, et al. Utility of a novel rapid high-resolution mapping system in the catheter ablation of arrhythmias an initial human experience of mapping the atria and the left ventricle. JACC Clin Electrophysiol. 2015;1:411-420.
Ptaszek LM, et al. Rapid acquisition of high-resolution electroanatomical maps using a novel multielectrode mapping system. J Interv Card Electrophysiol. 2013;36:233-242.
Thajudeen A, et al. Correlation of scar in cardiac MRI and high-resolution contact mapping of left ventricle in a chronic infarct model. Pacing Clin Electrophysiol. 2015;38:663-674.
Anter E, Tschabrunn CM, Contreras-Valdes FM, et al. Pulmonary vein isolation using the Rhythmia mapping system: verification of intracardiac signals using the Orion mini-basket catheter. Heart Rhythm. 2015;12:1927-1934.
Bun S-S, et al. Ultra-high-definition mapping of atrial arrhythmias. Circ J. 2016;80:579-586.
Gabriel D, Bun S, Viera F. Selection of critical isthmus in scar-related atrial tachycardia using a new automated ultrahigh resolution mapping system. Circ Arrhythm Electrophysiol. 2017;l0:pi i:e004510.
Bollmann A, Hilbert S, John S, et al. Initial experience with ultra high-density mapping of human right atria. J Cardiovasc Electrophysiol. 2016;27:154-160.
Schaeffer B, et al. Characterization, mapping, and ablation of complex atrial tachycardia: initial experience with a novel method of ultra high-density 3D mapping. J Cardiovasc Electrophysiol. 2016;27:1139-1150.
El Haddad M, et al. Novel algorithmic methods in mapping of atrial and ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2014;7:463-472.
Stevenson WG, Soejima K. Recording techniques for clinical electrophysiology. J Cardiovasc Electrophysiol. 2005;16:1017-1022.
Jadidi AS, Lehrmann H, Weber R, et al. Optimizing signal acquisition and recording in an electrophysiology laboratory. Card Electrophysiol Clin. 2013;5:137-142.
De Ponti R, et al. Electroanatomic mapping and ablation of macroreentrant atrial tachycardia : comparison between successfully and unsuccessfully treated cases. J Cardiovasc Electrophysiol. 2010;21:155-162.
Heist EK, et al. Comparison of electroanatomical mapping systems: accuracy in left atrial mapping. Pacing Clin Electrophysiol. 2013;36: 626-631.
Tanawuttiwat T, Nazarian S, Calkins H. The role of catheter ablation in the management of ventricular tachycardia. Eur Heart J. 2016;37:594-609.
Anter E, Tschabrunn CM, Josephson ME. High-resolution mapping of scar-related atrial arrhythmias using smaller electrodes with closer interelectrode spacing. Circ Arrhythmia Electrophysiol. 2015;8:537-545.
Berte B, et al. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J Cardiovasc Electrophysiol. 2016;27:80-87.
Berte B, et al. Characterization of the left-sided substrate in arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythmia Electrophysiol. 2015;8:1403-1412.
Casella M, et al. Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy. Circ Arrhythmia Electrophysiol. 2015;8:625-632.
Tzou WS, et al. Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias. Circ Arrhythmia Electrophysiol. 2015;8:353-361.
Fernandez-Armenta J, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014; 11:747-754.
Philips B, et al. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015;12:716-725.
Anter Е, Josephson ME. Bipolar voltage amplitude: what does it really mean? Heart Rhythm. 2016;13:326-327.
Josephson ME, Anter E. Substrate mapping for ventricular tachycardia assumptions and misconceptions. JACC Clin Electrophysiol. 2015;1:341-352.
Gianni C, Natale A. Voltage mapping for ventricular tachycardia ablation: we can work it out. Heart Rhythm. 2016;13:2003.
Tung R, Ellenbogen KA. Emergence of multielectrode mapping. Circ Arrhythmia Electrophysiol. 2016;9:e004281.
Tung R, Josephson ME, Bradfield JS, et al. Directional influences of ventricular activation on myocardial scar characterization: voltage mapping with multiple wavefronts during ventricular tachycardia ablation. Circ Arrhythmia Electrophysiol. 2016;9: e004155.
Proietti R, et al. A historical perspective on the role of functional lines of block in the re-entrant circuit of ventricular tachycardia. Pacing Clin Electrophysiol. 2016;39:490-496.
Mountantonakis SE, et al. Relationship between voltage map 'channels' and the location of critical isthmus sites in patients with postinfarction cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2013;61:2088-2095.
Rav-Acha M, et al. A novel annotation technique during mapping to facilitate the termination of atrial tachycardia following ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2016;[Epub ahead of print].
Proietti R, Roux J-F, Essebag V. Recent advances in ablation of ventricular tachycardia associated with structural heart disease. Curr Opin Cardiol. 2016;31:64-71.
Jamil-Copley S, et al. Application of ripple mapping with an elec-troanatomic mapping system for diagnosis of atrial tachycardias. J Cardiovasc Electrophysiol. 2013;24:1361-1369.
Koa-Wing M, et al. A diagnostic algorithm to optimize data collection and interpretation of ripple maps in atrial tachycardias. Int J Cardiol. 2015;! 99:391 -400.
Luther V, et al. A prospective study of ripple mapping in atrial tachycardias. Circ Arrhythmia Electrophysiol. 2016;9:e003582.
Jamil-Copley S, et al. Application of ripple mapping to visualize slow conduction channels within the infarct-related left ventricular scar. Circ Arrhythmia Electrophysiol. 2015;8:76-86.
Bunch TJ, Day JD. The atrial fibrillation ablation theory of relativity. J Cardiovasc Electrophysiol. 2013;24:267-268.
Andreu D, et al. Displacement of the target ablation site and ventricles during premature ventricular contractions: relevance for radiofrequency catheter ablation. Heart Rhythm. 2012;9:1050-1057.
Romero J, et al. Electroanatomic mapping systems (CARTO/EnSite NavX) vs. conventional mapping for ablation procedures in a training program. J Interv Card Electrophysiol. 2016;45:71-80.
Kapa S, Asirvatham SJ. You can't know where you're going until you know where you've been: the clinical relevance of differences in accurate assessment of catheter location with mapping technologies. J Cardiovasc Electrophysiol. 2014;25:84-86.
Bourier F, et al. Accuracy assessment of catheter guidance technology in electrophysiology procedures: a comparison of a new 3D-based fluoroscopy navigation system to current electroanatomic mapping systems. J Cardiovasc Electrophysiol. 2014;25:74-83.
Zhang F, et al. Noncontact mapping to guide ablation of right ventricular outflow tract arrhythmias. Heart Rhythm. 2013;10: 1895-1902.
Yamabe H, Kanazawa H, Ito M. Prevalence and mechanism of rotor activation identified during atrial fibrillation by noncontact mapping: lack of evidence for a role in the maintenance of atrial fibrillation. Heart Rhythm. 2016;13:2323-2330.
Dixit S, et al. Noncontact electroanatomic mapping to characterize typical atrial flutter: participation of right atrial posterior wall in the reentrant circuit. J Cardiovasc Electrophysiol. 2011 ;22:422-430.
Zhang F, et al. Noncontact mapping to guide ablation of right ventricular outflow tract arrhythmias. Heart Rhythm. 2013;10: 1895-1902.
Sommer P, et al. Successful repeat catheter ablation of recurrent longstanding persistent atrial fibrillation with rotor elimination as the procedural endpoint: a case series. J Cardiovasc Electrophysiol. 2016;27:274-280.
Zaman JAB, Peters NS, Narayan SM. Rotor mapping and ablation to treat atrial fibrillation. Curr Opin Cardiol. 2015;30:24-32.
Benharash P, et al. Quantitative analysis of localized sources identified by focal impulse and rotor modulation mapping in atrial fibrillation. Circ Arrhythmia Electrophysiol. 2015;8:554-561.
Schricker AA, Lalani GG, Krummen DE, et al. Rotors as drivers of atrial fibrillation and targets for ablation. Curr Cardiol Rep. 2014;l6:509.
Mohanty S, et al. Impact of rotor ablation in non-paroxysmal AF patients: results from a randomized trial (OASIS). J Am Coll Cardiol. 2016;68:274-282.
Narayan SM, et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). J Am Coll Cardiol. 2014; 63:1761-1768.
Kim JJ, et al. Magnetic versus manual catheter navigation for ablation of free wall accessory pathways in children. Circ Arrhythmia Electrophysiol. 2012;5:804-808.
Kim SH, et al. Long-term outcomes of remote magnetic navigation for ablation of supraventricular tachycardias. J Interv Card Electrophysiol. 2015;43:187-192.
Zhang F, et al. Magnetic versus manual catheter navigation for mapping and ablation of right ventricular outflow tract ventricular arrhythmias: a randomized controlled study. Heart Rhythm. 2013;10:1178-1183.
Shurrab M, et al. Robotically assisted ablation of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2013; 169:157-165.
Jin Q, Pehrson S, Jacobsen PK, et al. Impact of catheter ablation with remote magnetic navigation on procedural outcomes in patients with persistent and long-standing persistent atrial fibrillation. J Interv Card Electrophysiol. 2015;44:197-204.
Wong KCK, et al. Mitral isthmus ablation is feasible, efficacious, and safe using a remote robotic catheter system. Pacing Clin Electrophysiol. 2013;36:1364-1373.
Luther V, et al. Non-randomised comparison of acute and longterm outcomes of robotic versus manual ventricular tachycardia ablation in a single centre ischemic cohort. J Interv Card Electrophysiol. 2015;43:175-185.
Rolf S, et al. Catheter ablation of atrial fibrillation supported by novel nonfluoroscopic 4D navigation technology. Heart Rhythm. 2013;10:1293-1300.
Sommer P, et al. Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system. Europace. 2013;15:578-581.
Sommer P, et aL MediGuide in supraventricular tachycardia: initial experience from a multicentre registry. Europace. 2013;15: 1292-1297.
Bear L, Cuculich PS, Bernus O, et al. Introduction to noninvasive cardiac mapping. Card Electrophysiol Clin. 2015;7:1-16.
Cakulev I, Sahadevan J, Waldo AL. Noninvasive diagnostic mapping of supraventricular arrhythmias (Wolf-Parkinson-White syndrome and atrial arrhythmias). Card Electrophysiol Clin. 2015;7:79-88.
Jamil-Copley S, et al. Noninvasive electrocardiographic mapping to guide ablation of outflow tract ventricular arrhythmias. Heart Rhythm. 2014;11:587-594.
Ploux S, et al. Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. J Am Coll Cardiol. 2013;61:2435-2443.
Rudy Y. Noninvasive electrocardiographic imaging of arrhyth-mogenic substrates in humans. Circ Res. 2013;112:863-874.
Rudy Y. The forward problem of electrocardiography revisited. Circ Arrhythmia Electrophysiol. 2015;8:526-528.
Cakulev I, et al. Confirmation of novel noninvasive high-density electrocardiographic mapping with electrophysiology study: implications for therapy. Circ Arrhythmia Electrophysiol. 2013; 6:68-75.
Bear LR, et al. Forward problem of electrocardiography: is it solved? Circ Arrhythmia Electrophysiol. 2015;8:677-684.
Rudy Y, Lindsay BD. Electrocardiographic imaging of heart rhythm disorders. From bench to bedside. Card Electrophysiol Clin. 2015;7:17-35.
Shah AJ, et al. Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J Am Coll Cardiol. 2013;62:889-897.
Scheinman M, Gerstenfeld E. Mapping of complex atrial tachycardia circuits by 3-dimensional body surface mapping: the first step in the dawn of a new era. J Am Coll Cardiol. 2013;62:898-899.
Shah AJ, et al. Noninvasive mapping of ventricular arrhythmias. Card Electrophysiol Clin. 2015;7:99-107.
Shah AJ, Hocini M, Jais P, et al. Advent of noninvasive mapping of atrial tachycardias. Card Electrophysiol Clin. 2013;5:265-270.
Sapp JL, Dawoud F, Clements JC, et al. Inverse solution mapping of epicardial potentials: quantitative comparison with epicardial contact mapping. Circ Arrhythmia Electrophysiol. 2012;5:1001-1009.
Erkapic D, et al. Clinical impact of a novel three-dimensional electrocardiographic imaging for non-invasive mapping of ventricular arrhythmias — a prospective randomized trial. Europace. 2015;17:591-597.
Ernst S, et al. Utility of noninvasive arrhythmia mapping in patients with adult congenital heart disease. Card Electrophysiol Clin. 2015;7:117-123.
Shah A, Hocini M, Haissaguerre M, et al. Non-invasive mapping of cardiac arrhythmias. Curr Cardiol Rep. 2015;17:1-11.
Zhang J, et al. Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI. Pacing Clin Electrophysiol. 2016;39:781-791.
Leong KMW, Lim PB, Kanagaratnam P. Comparative analysis of diagnostic 12-lead electrocardiography and 3-dimensional noninvasive mapping. Card Electrophysiol Clin. 2015;7:71-78.
Hussein A, et al. Assessment of ventricular tachycardia scar substrate by intracardiac echocardiography. Pacing Clin Electrophysiol. 2014;37:412-421.
Yamashita S, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythmia Electrophysiol. 2016;9:e003901.
Komatsu Y, et al. Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythmia Electrophysiol. 2013;6:342-350.
Yamashita S, et al. Role of high-resolution image integration to visualize left phrenic nerve and coronary arteries during epicardial ventricular tachycardia ablation. Circ Arrhythmia Electrophysiol. 2015;8:371-380.
Yamashita S, et al. Image integration to guide catheter ablation in scar-related ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:699-708.
Anand R, et al. Prospective randomized comparison of rotational angiography with three-dimensional reconstruction and computed tomography merged with electro-anatomical mapping: a two center atrial fibrillation ablation study. J Interv Card Electrophysiol. 2016;46:1-9.
Carpen M, et al. First experience of 3D rotational angiography fusion with NavX electroanatomical mapping to guide catheter ablation of atrial fibrillation. Heart Rhythm. 2013;10:422-427.
Stevenson WG, Soejima К. Recording techniques for clinical electrophysiology. J Cardiovasc Electrophysiol. 2005;16:1017-1022.
Jadidi AS, Lehrmann H, Weber R, et al. Optimizing signal acquisition and recording in an electrophysiology laboratory. Card Electrophysiol Clin. 2013;5:137-142.
El Haddad M, et al. Novel algorithmic methods in mapping of atrial and ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2014;7:463-472.
Cantwell CD, et al. Techniques for automated local activation time annotation and conduction velocity estimation in cardiac mapping. Comput Biol Med. 2015;65:229-242.
Venkatachalam KL, Herbrandson JE, Asirvatham SJ. Signals and signal processing for the electrophysiologist: part I: electrogram acquisition. Circ Arrhythmia Electrophysiol. 2011;4:965-973.
Sorgente A, et al. Negative concordance pattern in bipolar and unipolar recordings: an additional mapping criterion to localize the site of origin of focal ventricular arrhythmias. Heart Rhythm. 2016;13:519-526.
Tedrow UB, Stevenson WG. Recording and interpreting unipolar electrograms to guide catheter ablation. Heart Rhythm. 2011;8: 791-796.
van der Does LJME, de Groot NMS. Inhomogeneity and complexity in defining fractionated electrograms. Heart Rhythm. 2017;14: 616-624.
Pisani CF, Lara S, Scanavacca M. Epicardial ablation for cardiac arrhythmias: techniques, indications and results. Curr Opin Cardiol. 2014;29:59-67.
Wong MCG, et al. Left septal atrial tachycardias: electrocardiographic and electrophysiologic characterization of a paraseptal focus. J Cardiovasc Electrophysiol. 2013;24:413-418.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: part I: concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36:508-532.
Kaiser DW, et al. The precise timing of tachycardia entrainment is determined by the postpacing interval, the tachycardia cycle length, and the pacing rate: theoretical insights and practical applications. Heart Rhythm. 2016;13:695-703.
Tung R. Challenges and pitfalls of entrainment mapping of ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2017:e004560.
Almendral J. Resetting and entrainment of reentrant arrhythmias: part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Deo R, Berger R. The clinical utility of entrainment pacing. J Cardiovasc Electrophysiol. 2009;20:466-470.
Derejko P, Podziemski P, Zebrowski JJ, et al. Effect of the restitution properties of cardiac tissue on the repeatability of entrainment mapping response. Circ Arrhythmia Electrophysiol. 2014;7:497-504.
Vollmann D, et al. Misleading long post-pacing interval after entrainment of typical atrial flutter from the cavotricuspid isthmus. J Am Coll Cardiol. 2012;59:819-824.
Wong KCK, Rajappan K, Bashir Y, et al. Entrainment with long postpacing intervals from within the flutter circuit: what is the mechanism? Circ Arrhythm Electrophysiol. 2012;5:e90-e92.
Kinjo T, et al. Long postpacing interval after entrainment of tachycardia including a slow conduction zone within the circuit. J Cardiovasc Electrophysiol. 2016;27:923-929.
Maruyama M, et al. Number needed to entrain: a new criterion for entrainment mapping in patients with intra-atrial reentrant tachycardia. Circ Arrhythmia Electrophysiol. 2014;7:490-496.
Esato M, et al. Color-coded three-dimensional entrainment mapping for analysis and treatment of atrial macroreentrant tachycardia. Heart Rhythm. 2009;6:349-358.
Santucci PA, et al. Electroanatomic mapping of postpacing intervals clarifies the complete active circuit and variants in atrial flutter. Heart Rhythm. 2009;6:1586-1595.
Miyazaki H, Stevenson WG, Stephenson K, et al. Entrainment mapping for rapid distinction of left and right atrial tachycardias. Heart Rhythm. 2006;3:516-523.
Li A, et al. Relationship between distance and change in surface ECG morphology during pacemapping as a guide to ablation of ventricular arrhythmias implications for the spatial resolution of pacemapping. Circ Arrhythm Electrophysiol. 2017;10:e004447.
Luker J, et al. Automated template matching correlates with earliest activation during mapping of idiopathic premature ventricular contractions. IJC Heart Vessel. 2014;4:25-29.
Luther V, Qureshi N, Kanagaratnam P, et al. Automated activation and pace-mapping to guide ablation within the outflow tract. J Cardiovasc Electrophysiol. 2016;27:127-128.
Kuteszko R, et al. Utility of automated template matching for the interpretation of pace mapping in patients ablated due to outflow tract ventricular arrhythmias. Europace. 2015;17:1428-1434.
Hutchinson MD, Garcia FC. An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias. J Cardiovasc Electrophysiol. 2013;24:1189-1197.
Zhang F, et al. Noncontact mapping to guide ablation of right ventricular outflow tract arrhythmias. Heart Rhythm. 2013:1895-1902.
Haines DE, et al. Heart Rhythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm. 2014Д1: e9-e51.
Lu F, Lin J, Benditt DG. Conscious sedation and anesthesia in the cardiac electrophysiology laboratory. J Cardiovasc Electrophysiol. 2013;24:237-245.
Haddy S. Anesthesia for structural heart interventions. Cardiol Clin. 2013;31:455-465.
Anderson R, Harukuni I, Sera V. Anesthetic considerations for electrophysiologic procedures. Anesthesiol Clin. 2013;31:479-489.
de Bono J. Propofol: a safe drug for physician-led procedures? Europace. 2012;14:303-305.
Thomas SP, Thakkar J, Kovoor P, et al. Sedation for electrophysiological procedures. Pacing Clin Electrophysiol. 2014;37: 781-790.
Rozner MA, McKay RE. Components of safe propofol sedation: defining the formula. Heart Rhythm. 2012;9:347-348.
Trentman TL, Fassett SL, Mueller JT, et al. Airway interventions in the cardiac electrophysiology laboratory: a retrospective review. J Cardiothorac Vase Anesth. 2009;23:841-845.
Salukhe TV, et al. Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patients undergoing atrial fibrillation ablation. Europace. 2012;14:325-330.
Wutzler A, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace. 2013;15:1019-1024.
Nazer B, et al. Importance of ventricular tachycardia induction and mapping for patients referred for epicardial ablation. Pacing Clin Electrophysiol. 2015;38:1333-1342.
Gaitan BD, Trentman TL, Fassett SL, et al. Sedation and analgesia in the cardiac electrophysiology laboratory: a national survey of electrophysiologists investigating the who, how, and why? J Cardiothorac Vase Anesth. 2011;25:647-659.
Tanaka-Esposito CC, et al. Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin. J Interv Card Electrophysiol. 2013;37:163-168.
Errahmouni A, Bun SS, Latcu DG, et al. Ultrasound-guided venous puncture in electrophysiological procedures: a safe method, rapidly learned. Pacing Clin Electrophysiol. 2014;37:1023-1028.
Rodriguez Munoz D, et al. Wireless ultrasound guidance for femoral venous cannulation in electrophysiology: impact on safety, efficacy, and procedural delay. Pacing Clin Electrophysiol. 2015; 38:1058-1065.
Mori S, et al. Clinical cardiac structural anatomy reconstructed within the cardiac contour using multidetector-row computed tomography: left ventricular outflow tract. Clin Anat. 2016;29:353-363.
Sun H, Wang Y, Zhang Z, et al. Predicting interatrial septum rotation: is the position of the heart or the direction of the coronary sinus reliable? Pacing Clin Electrophysiol. 2015;38:514-519.
Gabus V, et al. Short-term heparin kinetics during catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2015;38:1142-1150.
Briceno DF, Natale A, Di Biase L. Heparin kinetics: the 'holy grail' of periprocedural anticoagulation for ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2015;38:1137-1141.
Tzeis S, Andrikopoulos G, Deisenhofer I, et al. Transseptal catheterization: considerations and caveats. Pacing Clin Electrophysiol. 2010;33:231-242.
Giudici МС, Mickelsen SR, Bhave PD, et al. A safe, simple technique for transseptal catheterization. Pacing Clin Electrophysiol. 2015;38:295-296.
Esch JJ, Triedman JK, Cecchin F, et al. Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Pacing Clin Electrophysiol. 2013;36:607-611.
Winkle RA, Mead RH, Engel G, et al. The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm. 2011;8:1411-1415.
Knecht S, et al. Radiofrequency puncture of the fossa ovalis for resistant transseptal access. Circ Arrhythm Electrophysiol. 2008Д: 169-174.
Greenstein E, Passman R, Lin AC, et al. Incidence of tissue coring during transseptal catheterization when using electrocautery and a standard transseptal needle. Circ Arrhythm Electrophysiol. 2012;5:341-344.
Santangeli P, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8:1669-1675.
Li X, et al. Safety and feasibility of transseptal puncture for atrial fibrillation ablation in patients with atrial septal defect closure devices. Heart Rhythm. 2014;11:330-335.
Katritsis GD, Siontis GCM, Giazitzoglou E, et al. Complications of transseptal catheterization for different cardiac procedures. Int J Cardiol. 2013;168:5352-5354.
Wasmer K, et al. Incidence and management of inadvertent puncture and sheath placement in the aorta during attempted transseptal puncture. Europace. 2017;19:447-457.
Singh SM, Douglas PS, Reddy VY. The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath. Circ Arrhythm Electrophysiol. 2011;4:166-171.
Alkhouli M, Sarraf M, Zack CJ, et al Iatrogenic atrial septal defect following transseptal cardiac interventions. Int J Cardiol. 2016;209: 142-148.
Aznaouridis K, Hobson N, Rigg C, et al. Emergency percutaneous closure of an iatrogenic atrial septal defect causing right-to-left shunt and severe refractory hypoxemia after pulmonary vein isolation. JACC Cardiovasc Interv. 2015;8:el79-el81.
Davies A, et al. Persistent iatrogenic atrial septal defects after pulmonary vein isolation: long-term follow-up with contrast transesophageal echocardiography. J Interv Card Electrophysiol. 2017;48:99-103.
Garikipati NV, Paruchuri V, Mittal S. How to learn epicardial intervention techniques in electrophysiology. Card Electrophysiol Clin. 2010;2:35-43.
Syed F, et al. The pericardial space: obtaining access and an approach to fluoroscopic anatomy. Card Electrophysiol Clin. 2010;2: 9-23.
Ernst S, Sanchez-Quintana D, Ho SY. Anatomy of the pericardial space and mediastinum: relevance to epicardial mapping and ablation. Card Electrophysiol Clin. 2010;2:1-8.
Lim HS, et al. Safety and prevention of complications during percutaneous epicardial access for the ablation of cardiac arrhythmias. Heart Rhythm. 2014;11:1658-1665.
Swale M, et al. Epicardial access: patient selection, anatomy, and a stepwise approach. J Innov Card Rhythm Manag. 2011;2:239-249.
Smith SE, Darling GE. Surface anatomy and surface landmarks for thoracic surgery: part II. Thorac Surg Clin. 2011;21:139-155.
Bradfield JS, Tung R, Boyle NG, et al. Our approach to minimize risk of epicardial access: standard techniques with the addition of electroanatomic mapping guidance. J Cardiovasc Electrophysiol. 2013;24:723-727.
Boyle NG, Shivkumar K. Epicardial interventions in electrophysiology. Circulation. 2012;126:1752-1769.
Yamada T, Kay GN. Recognition and prevention of complications during epicardial ablation. Card Electrophysiol Clin. 2010;2:127-134.
Koneru JN, Badhwar N, Ellenbogen KA, et al. LAA ligation using the LARIAT suture delivery device: tips and tricks for a successful procedure. Heart Rhythm. 2014;11:911-921.
Di Biase L, et al. Initial international multicenter human experience with a novel epicardial access needle embedded with a real time pressure/frequency monitoring to facilitate epicardial access: feasibility and safety. Heart Rhythm. 2017;14:981-988.
Kumar S, et al. 'needle-in-needle' epicardial access: preliminary observations with a modified technique for facilitating epicardial interventional procedures. Heart Rhythm. 2015;12:1691-1697.
Gunda S, et al. Differences in complication rates between large bore needle and a long micropuncture needle during epicardial access. Circ Arrhythm Electrophysiol. 2015;8:890-895.
D'Avila A, Koruth JS, Dukkipati S, et al. Epicardial access for the treatment of cardiac arrhythmias. Europace. 2012;14:13-18.
Tschabrunn CM, et al. Percutaneous epicardial ventricular tachycardia ablation after noncoronary cardiac surgery or pericarditis. Heart Rhythm. 2013;10:165-169.
Killu AM, et al. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery. Circ Arrhythm Electrophysiol. 2015;8: 94-101.
Killu AM, et al. Atypical complications encountered with epicardial electrophysiological procedures. Heart Rhythm. 2013;10: 1613-1621.
Stevenson WG, Soejima K. Recording techniques for clinical electrophysiology. J Cardiovasc Electrophysiol. 2005;16:1017-1022.
Tedrow UB, Stevenson WG. Recording and interpreting unipolar electrograms to guide catheter ablation. Heart Rhythm. 2011: 791-796.
Venkatachalam KL, Herbrandson JE, Asirvatham SJ. Signals and signal processing for the electrophysiologist: part I: electrogram acquisition. Circ Arrhythm Electrophysiol. 2011;4:965-973.
Jadidi AS, Lehrmann H, Weber R, et al. Optimizing signal acquisition and recording in an electrophysiology laboratory. Card Electrophysiol Clin. 2013;5:137-142.
Cantwell CD, et al. Techniques for automated local activation time annotation and conduction velocity estimation in cardiac mapping. Comput Biol Med. 2015;65:229-242.
Venkatachalam KL, Herbrandson JE, Asirvatham SJ. Signals and signal processing for the electrophysiologist: part II: signal processing and artifact. Circ Arrhythm Electrophysiol. 2011;4:974-981.
van der Does LJME, de Groot NMS. Inhomogeneity and complexity in defining fractionated electrograms. Heart Rhythm. 2017;14: 616-624.
Sorgente A, et al. Negative concordance pattern in bipolar and unipolar recordings: an additional mapping criterion to localize the site of origin of focal ventricular arrhythmias. Heart Rhythm. 2016;13:519-526.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: Part I: Concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36:508-532.
Noorman M, et al. Cardiac cell-cell junctions in health and disease: electrical versus mechanical coupling. J Mol Cell Cardiol. 2009; 47:23-31.
Michael G, Xiao L, Qi X-Y, et al. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovasc Res. 2009;81:491-499.
Hanson B, et al. Interaction of activation-repolarization coupling and restitution properties in humans. Circ Arrhythm Electrophysiol. 2009;2:162-170.
Elizari MV, Schmidberg J, Atienza A, et al. Clinical and experimental evidence of supernormal excitability and conduction. Curr Cardiol Rev. 2014;10:202-221.
Ho RT. An uncommon manifestation of atrioventricular block: what is the mechanism? Pacing Clin Electrophysiol. 2014;37:900-903.
Anumonwo JM, Pandit SV. Ionic mechanisms of arrhythmogenesis. Trends Cardiovasc Med. 2015;25:487-496.
Rosen MR, Nargeot J, Salama G. The case for the funny current and the calcium clock. Heart Rhythm. 2012;9:616-618.
Murphy C, Lazzara R. Current concepts of anatomy and electrophysiology of the sinus node. J Interv Card Electrophysiol. 2016;46:9-18.
Mangoni ME, Nargeot J. Genesis and regulation of the heart automaticity. Physiol Rev. 2008;88:919-982.
Bartos DC, Grandi E, Ripplinger CM. Ion channels in the heart. Compr Physiol. 2015;5:1423-1464.
Lakatta EG, Maltsev VA. Rebuttal: What If the shoe doesn't fit? 'The funny current has a major pacemaking role in the sinus node'. Heart Rhythm. 2012;9:459^60.
Yaniv Y, et al. Synchronization of sinoatrial node pacemaker cell clocks and its autonomic modulation impart complexity to heart beating intervals. Heart Rhythm. 2014;11:1210-1219.
Maltsev VA, Lakatta EG. The funny current in the context of the coupled-clock pacemaker cell system. Heart Rhythm. 2012;9: 302-307.
Boyden PA, Dun W, Robinson RB. Cardiac Purkinje fibers and arrhythmias; The GK Moe Award Lecture 2015. Heart Rhythm. 2016;13:1172-1181.
Tse G. Mechanisms of cardiac arrhythmias. J Arrhythm. 2016;32: 75-81.
Song Z, et al. Calcium-voltage coupling in the genesis of early and delayed afterdepolarizations in cardiac myocytes. Biophys J. 2015;108:1908-1921.
Qu Z, Weiss JN. Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence. Annu Rev Physiol. 2015;77:29-55.
Kim JJ, Nemec J, Li Q, et al. Synchronous systolic subcellular Ca2+-elevations underlie ventricular arrhythmia in drug-induced long QT type 2. Circ Arrhythmia Electrophysiol. 2015;8:703-712.
Liu MB, De Lange E, Garfinkel A, et al. Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue. Heart Rhythm. 2015;12:2115-2124.
Weiss JN, et al. Perspective: a dynamics-based classification of ventricular arrhythmias. J Mol Cell Cardiol. 2015;82:136-152.
Padfield GJ, et al. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of p-blockade. Heart Rhythm. 2016;13:609-613.
Qu Z, et al. Early afterdepolarizations in cardiac myocytes: beyond reduced repolarization reserve. Cardiovasc Res. 2013;99:6-15.
Belardinelli L, Giles WR, Rajamani S, et al. Cardiac late Na+ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to СаМКП and oxidative stress. Heart Rhythm. 2015;12:440-448.
Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84:431-488.
Antzelevitch C, Yan GX. J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm. 2015;12:1852-1866.
Xie Y, Liao Z, Grandi E, et al. Slow [Na]i Changes and positive feedback between membrane potential and [Caji underlie intermittent early afterdepolarizations and arrhythmias. Circ Arrhythmia Electrophysiol. 2015;8:1472-1480.
Nguyen TP, Singh N, Xie Y, et al. Repolarization reserve evolves dynamically during the cardiac action potential: effects of transient outward currents on early afterdepolarizations. Circ Arrhythmia Electrophysiol. 2015;8:694-702.
Maruyama M, et al. Genesis of phase 3 early afterdepolarizations and triggered activity in acquired long-QT syndrome. Circ Arrhythmia Electrophysiol. 2011;4:103-111.
Eijkemans MJC, et al. Predicting the unpredictable. Anesthesiology. 2010;112:41-49.
Nichols CG. Adenosine triphosphate-sensitive potassium currents in heart disease and cardioprotection. Card Electrophysiol Clin. 2016;8:323-335.
Weiss JN, Qu Z, Shivkumar K. Electrophysiology of hypokalemia and hyperkalemia. Circ Arrhythmia Electrophysiol. 2017;10:e004667.
Coronel R, et al. Electrophysiological changes in heart failure and their implications for arrhythmogenesis. Biochim Biophys Acta. 2013;1832:2432-2441.
Spector P. Principles of cardiac electric propagation and their implications for re-entrant arrhythmias. Circ Arrhythmia Electrophysiol. 2013;6:655-661.
Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The “leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res. 1977;41:9-18.
Dhein S, et al. Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. Front Physiol. 2014;5:1-13.
Ciaccio EJ, Coromilas J, Wit AL, et al. Formation of functional conduction block during the onset of reentrant ventricular tachycardia. Circ Arrhythmia Electrophysiol. 2016;9:e004462.
Kandel SM, Roth BJ. The mechanism of reflection type reentry: a simulation study. J Cardiovasc Electrophysiol. 2015;26:1370-1375.
Zaman JAB, Peters NS, Narayan SM. Rotor mapping and ablation to treat atrial fibrillation. Curr Opin Cardiol. 2015;30:24-32.
Pandit SV, Jalife J. Rotors and the dynamics of cardiac fibrillation. Circ Res. 2013;112:849-862.
Filgueiras-Rama D, Jalife J. Structural and functional bases of cardiac fibrillation differences and similarities between atria and ventricles. JACC Clin Electrophysiol. 2016;2:1-13.
Jalife J. Dynamics and molecular mechanisms of ventricular fibrillation in structurally normal hearts. Card Electrophysiol Clin. 2016;8:601-612.
Josephson ME, Almendral J, Callans DJ. Resetting and entrainment of reentrant ventricular tachycardia associated with myocardial infarction. Heart Rhythm. 2014;11:1239-1249.
Almendral J, Caulier-Cisterna R, Rojo-Alvarez JL. Resetting and entrainment of reentrant arrhythmias: part I: concepts, recognition, and protocol for evaluation: surface ECG versus intracardiac recordings. Pacing Clin Electrophysiol. 2013;36:508-532.
Almendral J. Resetting and entrainment of reentrant arrhythmias: part II: informative content and practical use of these responses. Pacing Clin Electrophysiol. 2013;36:641-661.
Kleber AG, Saffitz JE. Role of the intercalated disc in cardiac propagation and arrhythmogenesis. Front Physiol. 2014;5:404.
Kleber AG. Role of the cardiac sodium current in excitability and conduction. Card Electrophysiol Clin. 2014;6:657-664.
Unudurthi SD, Wolf RM, Hund TJ. Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking. Front Physiol. 2014;5:446.
Nikolaidou T, Aslanidi OV, Zhang H, et al. Structure-function relationship in the sinus and atrioventricular nodes. Pediatr Cardiol. 2012;33:890-899.
Rohr S, et al. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res. 2004;62:309-322.
Smaill БН, Zhao J, Trew ML. Three-dimensional impulse propagation in myocardium: arrhythmogenic mechanisms at the tissue level. Circ Res. 2013;112:834-848.
Ciaccio EJ, et al. Model of bipolar electrogram fractionation and conduction block associated with activation wavefront direction at infarct border zone lateral isthmus boundaries. Circ Arrhythmia Electrophysiol. 2014;7:152-163.
Segal OR, Chow AWC, Peters NS, et al. Mechanisms that initiate ventricular tachycardia in the infarcted human heart. Heart Rhythm. 2010;7:57-64.
Majumder R, Pandit R, Panfilov AV. Turbulent electrical activity at sharp-edged inexcitable obstacles in a model for human cardiac tissue. Am J Physiol Heart Circ Physiol. 2014;307.
Bao Y, Isom LL. Nav1.5 and regulatory [i subunits in cardiac sodium channelopathies. Card Electrophysiol Clin. 2014;6: 679-694.
Varga Z, et al. Direct measurement of cardiac Na+ channel conformations reveals molecular pathologies of inherited mutations. Circ Arrhythm Electrophysiol. 2015;8:1228-1239.
Belardinelli L, Giles WR, Rajamani S, et al. Cardiac late Na+ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKJI and oxidative stress. Heart Rhythm. 2015;12:440-448.
Shy D, Gillet L, Abriel H. Cardiac sodium channel Navi.5 distribution in myocytes via interacting proteins: the multiple pool model. Biochim Biophys Acta. 2013;1833:886-894.
Peters CH, Abdelsayed M, Ruben PC. Triggers for arrhythmogen-esis in the Brugada and long QT 3 syndromes. Prog Biophys Mol Biol. 2016;120:77-88.
Greer-Short A, George SA, Poelzing S, et al. Revealing the concealed nature of long-QT type 3 syndrome. Circ Arrhythm Electrophysiol. 2017;10:e004400.
Buch T, etal. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J Am Coll Cardiol. 2014; 64:66-79.
Antzelevitch C, Patocskai B. Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects. Curr Probl Cardiol. 2016; 41:7-57.
Adler A, Gollob MH. A practical guide to early repolarization. Curr Opin Cardiol. 2015;30:8-16.
Antzelevitch C, Yan GX. J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm. 2015;12:1852-1866.
Abe K, et al. Sodium channelopathy underlying familial sick sinus syndrome with early onset and predominantly male characteristics. Circ Arrhythm Electrophysiol. 2014;7:511-517.
Lieve KV, et al. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation. Int J Cardiol. 2017;236:187-193.
Mizusawa Y, Tan HL. Sodium current disorders. Card Electrophysiol Clin. 2014;6:819-824.
Crotti L, Ghidoni A, Insolia R, et al. The role of the cardiac sodium channel in perinatal early infant mortality. Card Electrophysiol Clin. 2014;6:749-759.
Amin AS, Wilde AAM. Genetic control of potassium channels. Card Electrophysiol Clin. 2016;8:285-306.
Nerbonne JM. Molecular basis of functional myocardial potassium channel diversity. Card Electrophysiol Clin. 2016;8:257-273.
Wu W, Sanguinetti MC. Molecular basis of cardiac delayed rectifier potassium channel function and pharmacology. Card Electrophysiol Clin. 2016;8:275-284.
Workman AJ, Marshall GE, Rankin AC, et al. Transient outward K+ current (ITO) reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes. J Physiol. 2012;17:4289-4305.
Skibsbye L, Ravens U. Mechanism of proarrhythmic effects of potassium channel blockers. Card Electrophysiol Clin. 2016;8:395-410.
Nguyen TP, Singh N, Xie Y, et al. Repolarization reserve evolves dynamically during the cardiac action potential: effects of transient outward currents on early afterdepolarizations. Circ Arrhythm Electrophysiol. 2015;8:694-702.
Algalarrondo V, Nattel S. Potassium channel remodeling in heart disease. Card Electrophysiol Clin. 2016;8:337-347.
Chen L, Sampson KJ, Kass RS. Cardiac delayed rectifier potassium channels in health and disease. Card Electrophysiol Clin. 2016;8:307-322.
Voigt N, Dobrev D. Atrial-selective potassium channel blockers. Card Electrophysiol Clin. 2016;8:411-421.
Altomare С, et al. IKr Impact on repolarization and its variability assessed by dynamic clamp. Circ Arrhythm Electrophysiol. 2015;8: 1265-1275.
Adler A, Viskin S. Clinical features of genetic cardiac diseases related to potassium charmelopathies. Card Electrophysiol Clin. 2016;8:361-372.
Tomson TT, Arora R. Modulation of cardiac potassium current by neural tone and ischemia. Card Electrophysiol Clin. 2016;8:349-360.
Foster MN, Coetzee WA. KATP channels in the cardiovascular system. Physiol Rev. 2016;96:177-252.
Nichols CG. Adenosine triphosphate-sensitive potassium currents in heart disease and cardioprotection. Card Electrophysiol Clin. 2016;8:323-335.
Zhou L, et al. Effects of regional mitochondrial depolarization on electrical propagation: implications for arrhythmogenesis. Circ Arrhythm Electrophysiol. 2014;7:143-151.
Zhang XD, Lieu DK, Chiamvimonvat N. Small-conductance Ca2+-activated K+ channels and cardiac arrhythmias. Heart Rhythm. 2015;12:1845-1851.
Mahida S. Expanding role of SK channels in cardiac electrophysiology. Heart Rhythm. 2014;11:1233-1238.
Dolphin AC. Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology. J Physiol. 2016;594:5369-5390.
Gurkoff G, Shahlaie K, Lyeth B, et al. Voltage-gated calcium channel antagonists and traumatic brain injury. Pharmaceuticals (Basel). 2013;6:788-812.
Zamponi GW, Striessnig J, Koschak A, et al. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67:821-870.
Catterall WA, Swanson TM. Structural basis for pharmacology of voltage-gated sodium and calcium channels. Mol Pharmacol. 2015;88:141-150.
Giudicessi JR, Ackerman MJ. Calcium revisited. Circ Arrhythm Electrophysiol. 2016;9:e002480.
Boczek NJ, et al. Identification and functional characterization of a novel CACNAlC-mediated cardiac disorder characterized by prolonged QT intervals with hypertrophic cardiomyopathy, congenital heart defects, and sudden cardiac death. Circ Arrhythm Electrophysiol. 2015;8:1122-1132.
Antzelevitch C, et al. J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American S. Heart Rhythm. 2016;13:e295-e324.
Khera S, Jacobson JT. Short QT syndrome in current clinical practice. Cardiol Rev. 2015;24:1-17.
Li N, et al. Molecular mapping of sinoatrial node HCN channel expression in the human heart. Circ Arrhythm Electrophysiol. 2015;8:1219-1227.
Sartiani L, Romanelli MN, Mugelli A, et al. Updates on HCN channels in the heart: function, dysfunction and pharmacology. Curr Drug Targets. 2015;16:868-876.
Ptaszynski P, et al. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther. 2013;18:338-344.
Kumar Goyal V, Godara S, Chandra Sadasukhi T, et al. Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient. Drug Discov Ther. 2014;8:132-133.
Ptaszynski P, Kaczmarek K, Ruta J, et al. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin Electrophysiol. 2013;36:42-49.
Page RL, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Circulation. 2016;133:e506-e574.
Duhme N, et al. Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. Eur Heart J. 2013;34:2768-2775.
Baruscotti M, et al. A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial inappropriate sinus tachycardia. Eur Heart J. 2017;38:280-288.
Wu P, et al. Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2. Science. 2016;80:354, aah5324.
Gyorke S. Molecular basis of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2009;6:123-129.
Marsman RF, et al. A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. J Am Coll Cardiol. 2014;63:259-266.
Paech C, et al. Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T>C and c.13781A>G, with the clinical presentation of idiopathic ventricular fibrillation. Pediatr Cardiol. 2014;35:1437-1441.
Nomikos M, et al. Altered RyR2 regulation by the calmodulin F90L mutation associated with idiopathic ventricular fibrillation and early sudden cardiac death. FEBS Lett. 2014;588:2898-2902.
Sendergaard MT, et al. Arrhythmogenic calmodulin mutations affect the activation and termination of cardiac ryanodine receptor-mediated Ca2+ release. J Biol Chem. 2015;290:26151-26162.
Altmann HM, et al. Homozygous/compound heterozygous triadin mutations associated with autosomal-recessive long-QT syndrome and pediatric sudden cardiac arrest: elucidation of the triadin knockout syndrome. Circulation. 2015;131:2051-2060.
Desplantez T, et al. Relating specific connexin co-expression ratio to connexon composition and gap junction function. J Mol Cell Cardiol. 2015;89:195-202.
Smaill BH, Zhao J, Trew ML. Three-dimensional impulse propagation in myocardium: arrhythmogenic mechanisms at the tissue level. Circ Res. 2013;112:834-848.
Leo-Macias A, Agullo-Pascual E, Delmar M. The cardiac connexome: non-canonical functions of connexin43 and their role in cardiac arrhythmias. Semin Cell Dev Biol. 2016;50:13-21.
Basheer WA, Shaw RM. Connexin 43 and Cavl.2 ion channel trafficking in healthy and diseased myocardium. Circ Arrhythm Electrophysiol. 2016;9:e001357.
Jassim A, Aoyama H, Ye WG, et al. Engineered Cx40 variants increased docking and function of heterotypic Cx40/Cx43 gap junction channels. J Mol Cell Cardiol. 2016;90:11-20.
Mese G, Richard G, White TW. Gap junctions: basic structure and function. J Invest Dermatol. 2007;127:2516-2524.
Lambiase PD, Tinker A. Connexins in the heart. Cell Tissue Res. 2015;360:675-684.
Temple IP, Inada S, Dobrzynski H, et al. Connexins and the atrioventricular node. Heart Rhythm. 2012;10:297-304.
Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84:431-488.
Dhein S, et al. Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. Front Physiol. 2014;5:1-13.
Wit AL, Peters NS. The role of gap junctions in the arrhythmias of ischemia and infarction. Heart Rhythm. 2012;9:308-311.
Delmar M, Makita N. Cardiac connexins, mutations and arrhythmias. Curr Opin Cardiol. 2012;27:236-241.
Sawant AC, Calkins H. Relationship between arrhythmogenic right ventricular dysplasia and exercise. Card Electrophysiol Clin. 2015;7:195-206.
Shaw RM. Reduced sodium channels in human ARVC. Heart Rhythm. 2013;10:420-421.
Noorman M, et al. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm. 2013;10: 412-419.
Zaza A. Control of the cardiac action potential: the role of repolarization dynamics. J Mol Cell Cardiol. 2010;48:106-111.
Spector P. Principles of cardiac electric propagation and their implications for re-entrant arrhythmias. Circ Arrhythmia Electrophysiol. 2013;6:655-661.
Grant AO. Cardiac ion channels. Circ Arrhythmia Electrophysiol. 2009;2:185-194.
Grant AO. Basic electrophysiology. Card Electrophysiol Clin. 2010;2:325-340.
Nerbonne JM. Molecular basis of functional myocardial potassium channel diversity. Card Electrophysiol Clin. 2016;8:257-273.
Adler A, Gollob MH. A practical guide to early repolarization. Curr Opin Cardiol. 2015;30:8-16.
Chen L, Sampson KJ, Kass RS. Cardiac delayed rectifier potassium channels in health and disease. Card Electrophysiol Clin. 2016;8:307-322.
Voigt N, Dobrev D. Atrial-selective potassium channel blockers. Card Electrophysiol Clin. 2016;8:411-421.
Belardinelli L, Giles WR, Rajamani S, et al. Cardiac late Na+ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress. Heart Rhythm. 2015;12:440-448.
Wu W, Sanguinetti MC. Molecular basis of cardiac delayed rectifier potassium channel function and pharmacology. Card Electrophysiol Clin. 2016;8:275-284.
Boyden PA, Dun W, Robinson RB. Cardiac Purkinje fibers and arrhythmias; The GK Moe Award Lecture 2015. Heart Rhythm. 2016;13:1172-1181.
Boyden PA, Hirose M, Dun W. Cardiac Purkinje cells. Heart Rhythm. 2010;7:127-135.
Workman AJ, Marshall GE, Rankin AC, et al. Transient outward K+ current (ITO) reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes. J Physiol. 2012;17:4289-4305.
Bartos DC, Grandi E, Ripplinger CM. Ion channels in the heart. Compr Physiol. 2015;5:1423-1464.
Murphy C, Lazzara R. Current concepts of anatomy and electrophysiology of the sinus node. J Interv Card Electrophysiol. 2016;46:9-18.
Difrancesco D, Noble D. The funny current has a major pacemaking role in the sinus node. Heart Rhythm. 2012;9:299-301.
Difrancesco D, Noble D. Rebuttal: The funny current in the context of the coupled clock pacemaker cell system. Heart Rhythm. 2012;9:457-458.
Elizari MV, Schmidberg J, Atienza A, et al. Clinical and experimental evidence of supernormal excitability and conduction. Curr Cardiol Rev. 2014;10:202-221.
Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84:431-488.
Temple IP, Inada S, Dobrzynski H, et al. Connexins and the atrioventricular node. Heart Rhythm. 2012;10:297-304.
Dhillon PS, et al. Relationship between gap-junctional conductance and conduction velocity in mammalian myocardium. Circ Arrhythmia Electrophysiol. 2013;6:1208-1214.
Smaill BH, Zhao J, Trew ML. Three-dimensional impulse propagation in myocardium: Arrhythmogenic mechanisms at the tissue level. Circ Res. 2013;112:834-848.
Kleber AG. Role of the cardiac sodium current in excitability and conduction. Card Electrophysiol Clin. 2014;6:657-664.
Dhein S, et al. Remodeling of cardiac passive electrical properties and susceptibility to ventricular and atrial arrhythmias. Front Physiol. 2014;5:1-13.
Kleber AG, Saffitz JE. Role of the intercalated disc in cardiac propagation and arrhythmogenesis. Front Physiol. 2014;5:404.
Huismans M, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169:510-522.e20.
Unudurthi SD, Wolf RM, Hund TJ. Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking. Front Physiol. 2014;5:446.
Delmar M, Liang FX. Connexin43 and the regulation of intercalated disc function. Heart Rhythm. 2012;9:835-838.
Syed FF, Hai JJ, Lachman N, et al. The infrahisian conduction system and endocavitary cardiac structures: Relevance for the invasive electrophysiologist. J Interv Card Electrophysiol. 2014;39:45-56.
Rohr S, et al. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res. 2004;62:309-322.
Nikolaidou T, Aslanidi OV, Zhang H, et al. Structure-function relationship in the sinus and atrioventricular nodes. Pediatr Cardiol. 2012;33:890-899.
Majumder R, Pandit R, Panfilov AV. Turbulent electrical activity at sharp-edged inexcitable obstacles in a model for human cardiac tissue. Am J Physiol Heart Circ Physiol. 2014;307:H1024-H1035.
Ciaccio EJ, Coromilas J, Wit AL, et al. Formation of functional conduction block during the onset of reentrant ventricular tachycardia. Circ Arrhythm Electrophysiol. 2016;9:e004462.
Kleber AG. Gap junctions and conduction of cardiac excitation. Heart Rhythm. 2011;8:1981-1984.
Wu P, et al. Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2. Science. 2016;80:354. aah5324.
